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Chapter 1 
1.1 General introduction. 
To obtain detailed information about the environment every living creature on earth 
has developed one or more sensory organs to satisfy vital needs and to survive in its 
habitat. The eye is the sensory organ that enables detection of light. In many 
invertebrate species the function of the eye is restricted to a photosensory function. 
However, vertebrates but also mollusks and insects have more complex eyes. They 
posses a focussing system (cornea and/or lens) and a light-sensitive tissue (retina), 
that not only allows them to detect light but also to generate an image of the 
environment.  
The energy of a photon projected onto and absorbed by the retina is converted into 
an electrochemical potential gradient in a highly specialized type of neuron, the 
photoreceptor cell. The photoreceptor cell absorbs light and translates it into a 
graded membrane hyperpolarization, which modulates neurotransmitter release at 
the synapse. The photoreceptor signals are then processed, integrated and passed 
on via several types of neuronal cells in the retina. Finally the signal is transmitted by 
ganglion cells via the optic nerve and eventually reaches the visual cortex in the 
brain.  
In addition to the visual cortex there is another brain center in mammals, the 
suprachiasmatic nucleus (SCN), which also receives signals upon light activation of a 
photoreceptor cell. In mammals the suprachiasmatic nucleus is part of the brain 
where the circadian or biological clock resides. The biological clock controls a wide 
variety of behavioral and physiological processes. The periodicity of the internal 
biological clock in mammals is near 24 hours and is generated by a feedback system 
involving a complicated network of proteins. Synchronization with the environment is 
accomplished by numerous external stimuli like light, sound, temperature, social cues 
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etc. The most important resetting-mechanism is synchronization to daylight 
(photoentrainment). It is not clear, yet, to what extent the photoreception system that 
entrains the biological clock is evolutionary conserved. In mammals, however, 
enucleation eliminates the process of photoentrainment suggesting that the circadian 
photoreceptor is located in the eye. Currently many studies are focussed upon the 
identification of the circadian photoreceptor and its transduction mechanism, since 
they are interesting targets for pharmaceutical treatment of clock related disorders. 
Much evidence has accumulated that the visual photoreceptors in sighted mammals 
are not essential for photoentrainment. However, the data we obtained by studying 
the blind mole rat, Spalax ehrenbergi,  strongly suggest that the visual 
photoreceptors in this blind mammal have been reprogrammed to play an important 
role in photoentrainment (Chapter 1 and 2). 
In addition to the fundamental role of rhodopsin in vision and a putative role in 
circadian photoentrainment, rod photoreceptors also critically contribute to the 
morphology of the retina. Numerous rod-specific gene mutations have been shown to 
lead to degeneration of the entire photoreceptor population indicating that the rod 
photoreceptor has a significant role in maintaining the structural integrity of the retina. 
These mutations are a major cause of the autosomal dominant form of retinitis 
pigmentosa (~20% of adRP), a hereditary disease eventually leading to vision 
impairment.  
The putative role of rhodopsin in circadian photoentrainment and its contribution in 
maintaining retina morphology are the central subjects of this thesis. The following 
sections aim to provide more insight in the role of visual pigments and their relation to 
the circadian system and in the contribution of rhodopsin to maintaining homeostasis 
of the photoreceptor cell.  
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1.2 The mammalian visual system. 
1.2.1 The anatomy of eye and retina. 
The eyeball is the sensory organ for detection and translation of light into 
electrochemical signals that are passed on to the brain (Figure 1A). It is protected by 
the orbital cavity of the skull and an outer fibrous tissue called sclera. At the anterior 
side of the eye the sclera transforms into the cornea. Both tissues are avascular. In 
contrast, the pigmented choroid, which together with the anterior ciliary body and the 
iris, forms the uveal tract, are highly vascularised and sensitive to metabolic changes. 
A circular opening in the center of the iris, called the pupil, controls the amount of 
light that enters the eye by means of sphincter and dilator muscles. Furthermore, the 
interior of the eye contains a lens. The lens further refracts the incoming light and 
divides the eye into a small anterior and large posterior chamber. The posterior 
chamber is filled with an optically clear gel-like mass called the vitreous. The shape 
of the lens can be altered by retraction or dilatation of the ciliary body muscles to 
allow to image objects at varying distance in focus onto the light sensitive retina. A 
small part of the retina, around the optic axis, is used for daylight vision and optical 
image formation. This spot is called fovea or yellow spot and receives most of the 
incoming light.  
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A.                                                              B. 
 
 
 
 
 
 
 
 
 
Abbreviations: ELM, external limiting membrane; ILM, internal limiting membrane; HC, horizontal cells; 
AC, amacrine cells; MC, Müller cells.  
  
Figure 1: Schematic structure of the human eye (A) and the light-sensitive retina (B).  
 
 The retina is comprised of a single layer of columnar neuro-epithelial cells termed 
retina epithelium and the multiple cell layered neurosensory retina (Figure 1B). Six 
neuronal cell types can be distinguished in the sensory retina: ganglion cells, 
amacrine cells, glia cells (astrocytes and Müller cells), horizontal cells, bipolar cells 
and photoreceptor cells. These cell types give rise to 8 layers: 1. nerve fiber layer 
(ganglion cell axons); 2. ganglion cell layer (GCL); 3. inner plexiform layer (IPL; 
synaptic connections of ganglion cells with bipolar and amacrine cells); 4. inner 
nuclear layer (INL; nuclei of the bipolar, amacrine and horizontal cells); 5. outer 
plexiform layer (OPL; synaptic connections of bipolar, photoreceptor and horizontal 
cells); 6. outer nuclear layer (ONL; photoreceptor nuclei); 7. outer and inner segment 
layer of photoreceptors (OS, IS); 8. retina pigment epithelium (RPE). The Müller cell 
 5
Chapter 1 
stretches from nerve fiber layer to the photoreceptor outer and inner segment layer 
and have a comparable structure and function as the astrocytes in the brain. Their 
function in the retina is to support the structure and to supply all cell types and in 
particular the photoreceptor cell with nutrients. 
 
1.2.2 The photoreceptor cells. 
The human retina contains approximately 125 million photoreceptors that can be 
subdivided into two types. They are named rods and cones after their morphology. 
Approximately 95% of the photoreceptor population consist of rods, which are located 
in the peripheral retina. The remaining 5% of cone photoreceptors are predominantly 
found in the foveal area, the center of our visual field.  
The rods and cones are specialized for use under complementary conditions (1). The 
rods are extremely light sensitive and function in dim light (scotopic vision). The 
cones are about 103 fold less light sensitive and can only function at higher light 
intensities (photopic vision). However, they offer a much higher spatial and temporal 
resolution than rods. In addition, the cone system allows color discrimination (color 
vision). All rods express only one type of visual pigment, rhodopsin (2). In man and 
some other primates, color vision is mediated by three types of cones (trichromats) 
each containing a distinct visual pigment absorbing maximally at 420 nm (blue or 
short wavelength sensitive pigment, SWS), 530 nm (green sensitive pigment) and 
560 nm (red sensitive pigment) (3). The latter two belong to the long wavelength 
sensitive (LWS) class of cone pigments. Most mammals posses only one LWS 
pigment in addition to a SWS pigment (dichromats). 
The rod and cone photoreceptors are highly specialized neuronal cells, which differ 
not only in function but also have a different structure. Morphologically rod and cone 
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photoreceptors can be divided into three subcellular domains: the outer segment, the 
inner segment and the synaptic terminal (Figure 2).  
A.               B.  
 
 
 
 
 
 
 
 
 
Figure 2: Schematic models for the rod and cone outer segments respectively (A) and the rod 
photoreceptor cell with in detail rhodopsin and its ligand 11-cis retinal (B). Picture adapted from (4). 
 
The outer segment is connected to the inner segment by a thin ciliary structure, the 
connecting cilium. In the outer segment light absorption and subsequent signal 
transduction takes place whereas the inner segment contains all intracellular 
organelles for cellular metabolic activity. The synaptic terminal at the proximal end of 
the cell contains neurotransmitter vesicles for signal transduction onto the bipolar and 
horizontal cells (Figure 2B). The characteristically shaped outer segment at the distal 
end of the rod cell is composed of an intracellular stack of numerous flattened 
membrane disks. In contrast, the shorter cone outer segments are composed of a 
stack of plasma membrane invaginations called sacs. The disks from the rod cell 
contain the visual pigment, rhodopsin (Figure 2B). The sacs of the cone 
photoreceptors contain a single one of the above mentioned cone pigments. Disks 
 7
Chapter 1 
and sacs are formed by invagination of the plasma membrane at the ciliary region 
and migrate, while the outer segment is under continuous renewal, through the entire 
length of the outer segment. They are removed at the distal end of the outer segment 
through phagocytosis by the retina pigment epithelium cells (5). However, despite 
their functional and structural differences, the phototransduction mechanism in rod 
and cone cells is based on the same principles (6,7).  
 
1.2.3 Visual pigments. 
The visual pigments belong to the large family of G-protein coupled receptors 
(GPCR) currently comprising over 500 members. They are integral membrane 
proteins containing seven transmembrane α helical segments. The visual pigments 
contain 348 (human rhodopsin and SWS or blue sensitive cone pigment) or 364 
amino acids (human LWS or green and red sensitive cone pigments) and have a 
molecular weight of approximately 40 kD. The protein moiety, called opsin, provides 
a pocket for a light sensitive vitamin A derivate, currently named 11-cis-retinal (Figure 
2B) (1,8) . This chromophore is covalently linked to opsin via a protonated Schiff’s 
base between the carbonyl group of the retinal and the ε-amino group of a lysine in 
the seventh transmembrane region of the protein (position 296 in human rhodopsin, 
312 in human LWS cone pigments; 293 in the SWS cone pigment) (9). The positive 
charge of the Schiff’s base is stabilized in the ground state by a counterion provided 
by an ionized glutamate residue in the third transmembrane region (position 113 in 
human rhodopsin; 129 in LWS cone pigments; 110 in SWS cone pigment) (10-12). 
Several amino acids in the transmembrane domain are highly conserved among the 
visual pigments and a small selection of amino acids, involving mainly hydroxyl 
bearing residues in the vicinity of the chromophore, is involved in tuning the spectral 
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properties of the pigment. Next to amino acids that interact directly with the 
chromophore, amino acids that change the tertiary structure of the chromophore 
binding pocket can also influence the spectral properties of a pigment (13). LWS 
pigments have developed an additional mechanism for spectral tuning: the binding of 
chloride ions to specific residues (anion site) which red-shifts the absorbance 
spectrum (14). These mechanisms of wavelength regulation permit vision from the 
ultraviolet up to and including the far red (350-650 nm). Spectral tuning of LWS 
pigments will be discussed in more detail in chapter 3.  
 
1.2.4   The phototransduction cascade and visual cycle. 
The phototransduction cascade of rhodopsin and the cone pigments is triggered by 
the absorption of a photon resulting in the isomerization of the chromophore to an all-
trans conformation. Successively the protein moiety very rapidly passes through 
several conformational intermediate states (15,16) which can be identified by their 
unique spectral properties (Figure 3 ).  
The catalytically active state from the signaling point of view is the metarhodopsin II 
intermediate which is able to bind and activate the G-protein transducin. Transducin 
is a membrane-associated heterotrimeric complex which is composed of the GTP-
binding α-subunit (Tα), a β-subunit (Tβ) and a γ-subunit (Tγ). Both the α and γ subunits 
possess lipid membrane anchors.  In its inactive form the α-subunit of the G-protein 
transducin complex binds GDP, but upon interaction with metarhodopsin II the GDP 
is exchanged for GTP. Subsequently the α-subunit (Tα-GTP) and the βγ-complex 
(Tβγ) separate and both dissociate from metarhodopsin II. The activated transducin 
 9
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Figure 3: Photobleaching processes of bovine rhodopsin and chicken green and red pigments. The 
absorbance maximum and half-life of the photointermediate conformations are given at indicated 
temperatures (15). A long-lived intermediate corresponding to the meta III intermediate of rhodopsin 
was not observed in iodopsin. 
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α-subunit (Tα-GTP) migrates into the cytosol where it binds to a cGMP 
phosphodiesterase (PDE).  Each phosphodiesterase complex consists of a catalytic 
and a regulatory  α and β subunit and two inhibitory γ subunits. The Tα-GTP subunits 
interact with the phosphodiesterase γ subunits, which releases their inhibitory effect 
and results in the activation of the PDE catalytic subunit and massive hydrolysis of 
cGMP into 5’GMP. This leads to a rapid local decrease of the cGMP concentration 
and local closure of cyclic nucleotide gated cation channels (CNGC). The closure 
reduces the influx of Na+, Ca2+ and Mg2+ ions, resulting in a hyperpolarization of the 
photoreceptor cell membrane which rapidly spreads to the synaptic terminal and 
induces a decrease in neurotransmitter release (Figure 4)[for recent reviews see 
refs(17,18)]. 
Vision requires high temporal and spatial resolution, hence the photoreceptor needs 
another mechanism than the slow decay of metarhodopsin II into opsin and all-trans 
retinal in order to inactivate the phototransduction cascade and to restore the resting 
state. The higher temporal resolution of cones is probably achieved by a more rapid 
response of the inactivation or feedback mechanism. Inactivation, also dubbed 
desensitization, of the phototransduction process occurs at several different levels 
(Figure 4).  Metarhodopsin II is rapidly inactivated through phosphorylation on several 
serine and threonine residues in its C-terminal region by rhodopsin kinase (19,20) 
and subsequent binding of arrestin to the phosphorylated receptor. This inhibits 
further activation of additional transducin α-subunits (21). The activity of rhodopsin 
kinase is regulated by one of several calcium sensors (calcium binding proteins) in 
the rod outer segment, S-modulin or recoverin (22). Furthermore, the endogenous 
Tα-GTPase activity is enhanced by GTP-ase proteins called regulator of G-protein 
signaling proteins (RGS) which accelerate the conversion of Tα-GTP into its inactive 
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form Tα-GDP (23). Additionally the protein phosducin inhibits in its dephosphorylated 
state the re-association of the transducin α-GDP subunit and βγ-complex by binding 
to the βγ-complex (24). During the recovery of the photoreceptor to the resting or dark 
state, phosducin is phosphorylated by a cAMP-dependent protein kinase, which then 
abolishes its inhibitory effect on the re-association of the transducin subunits (25). 
Calcium also plays a key role in the inactivation of phototranduction. The closure of 
the cation channels which inhibits the influx of calcium in the cell in combination with 
the continuous extrusion of calcium by the Na+/Ca2+/K+ exchanger (26,27), leads to a 
significant reduction of the cytosolic calcium concentration. This low cytosolic calcium 
concentration is responsible for at least three negative feedback mechanisms. First, 
low calcium levels activate three retinal specific guanylate cyclase activating proteins 
(GCAP1, GCAP2, GCAP3) (28-30). These proteins regulate the activity of two retinal 
specific isoforms of guanylate cyclase (GC1 and GC2) which restore the resting 
cGMP level through synthesis from GTP (31-33). Second, the release of calcium from 
calmodulin (CM) causes it to dissociate from the cation channel, which increases the 
cation channel’s affinity for cGMP (34). Despite the low cGMP levels this leads to 
partial re-opening of the cation channels. Finally, the decrease in intracellular calcium 
leads to the dissociation of calcium from recoverin which in turn leads to the 
dissociation of recoverin from the membrane. This releases its inhibitory effect on 
rhodopsin kinase (22). The resulting increase in rhodopsin kinase activity accelerates 
phosphorylation of the active receptor, metarhodopsin II.  
Recovery to the resting or dark state of the photoreceptor itself requires 
dephosphorylation of metarhodopsin II by protein phosphatase 2A (PP2A) (35,36), 
release from arrestin and conversion of the released all-trans retinal into the 11-cis 
isomer. Decay of metarhodopsin II involves release of the chromophore as all-trans 
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retinal by hydrolysis of the deprotonated Schiff base. The released all-trans retinal is 
reduced to all-trans retinol by an all-trans retinol dehydrogenase (RDH) in the outer 
segments (37). All-trans retinol is then transported from the photoreceptor to the 
retina pigment epithelium (RPE). This is most likely facilitated by the 
interphotoreceptor retinoid binding protein (IRBP) present in the interphotoreceptor 
matrix (38,39). This protein is thought to function as a shuttle for transport of all-trans 
retinol and 11-cis retinal between photoreceptor and RPE. Within the RPE cell all-
trans retinol is bound to a cellular retinol binding protein (CRBP) (39,40) and 
esterified by a lecithin:retinol acyltransferase (LRAT) into the all-trans retinyl ester. 
LRAT is also able to esterify 11-cis retinol into the 11-cis retinyl ester (41). In this 
ester-form the retinoids are stored in the RPE until called upon. When required a 
retinyl ester hydrolase (REH) converts the 11-cis retinyl ester into its corresponding 
alcohol, 11-cis retinol. The key enzyme of the visual cycle is the yet unidentified 
isomerohydrolase (IMH) which converts the all-trans retinyl ester into 11-cis retinal 
(42).  An oxidoreductase, 11-cis retinol dehydrogenase (11-cis RDH), catalyzes the 
oxidation of 11-cis retinol into 11-cis retinal (43,44). Subsequently the 11-cis retinal is 
bound to a cellular retinal binding protein (CRALBP) and transported to the apical 
membrane of the retinal pigment epithelium where it is secreted and transported to 
the photoreceptor cell (45). These enzymatic reactions that catalyze the conversion 
from all-trans retinal to 11-cis retinal comprise the light-independent part of the visual 
cycle (11-cis retinal Æ all-trans retinal Æ11-cis retinal) and take place in both 
photoreceptor and retina pigment epithelium cells. 
There are several lines of evidence that cones regenerate by  a different mechanism 
which has been studied in two cone-dominant species, chicken en ground squirrel 
(46). This study implies the involvement of Müller cells in the recycling of the visual 
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chromophore for the cone photoreceptor. After light induction all-trans retinal is 
reduced into all-trans retinol by a NADPH-dependent all-trans RDH in the cone outer 
segment. All-trans retinol is released into the extracellular space and like 11-cis 
retinol bound to IRBP. All-trans retinol is taken up by Müller cells which contain a 
novel all-trans retinal isomerase which catalyzes passive isomerization between all-
trans retinal and 11-cis retinol which can be bound by CRALBP. Isomerization of all-
trans retinol into 11-cis retinol is driven through the activity of a novel 11-cis retinyl 
ester (11cRE) synthase, which catalyzes esterification of 11-cis retinol using palm-
CoA (or other fatty-acyl-CoA’s) as an acyl-donor. Retinyl ester hydrolase (REH) is 
activated by apo-CRALBP to yield 11-cis retinol, which is released by the Müller cell 
and taken up by the cone cell. Within the cone outer segment a novel NADP-
dependent 11-cis retinol dehydrogenase (11-cis-RDH) is characterized which 
oxidizes 11-cis retinol into 11-cis retinaldehyde. 11-cis retinaldehyde combines with 
apo-opsin to regenerate cone opsin pigment (46). 
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1.3 The circadian system. 
1.3.1 Circadian timing. 
The visual system provides organisms with three dimensional information about their 
environment, which is quite essential for maintenance, reproduction etc. However, 
the fourth dimension, time, is quite crucial in the daily activity pattern of an organism, 
and periodic information is required to adapt its physiology and behavior to changing 
environmental conditions. This temporal program is controlled by an endogenous 
biological clock that oscillates with a period adapted to one solar cycle or day. 
Therefore this internal mechanism is called the circadian (circa= around, dia =day) 
system. The daily cycle of light and dark is the most recurring stimulus in the 
environment to which all organisms, including mammals have adapted. This has 
resulted in the typical cycling activity pattern of alternating periods of rest (sleep) and 
activity (waking). Two patterns of behavior have evolved, a diurnal pattern, which 
uses vision as a primary sense and results in activity during day and rest during 
night, and a nocturnal pattern which utilizes olfaction and audition as major senses 
and results in activity during night and rest during day. 
The mechanism underlying rhythmic circadian behavior is implemented in all 
organisms and comprised of three elements: input, pacemaker and output. The input 
pathway consists of receptors through which specific environmental signals called 
zeitgebers reset the internal oscillator or pacemaker to coincide with the current 
environmental cycles. This process of resetting is called entrainment and must be 
done on a regular basis because the endogenous period of the internal clock (τ) 
deviates (19 < τ < 28) from the external 24 hour cycle (T). When organisms are 
placed in temporal isolation, without any zeitgebers, the circadian behavior persists 
under control of the pacemaker, but in a period that differs from 24 hours. This 
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deviation between τ and T leads to a daily recurring phase shift resulting in a free-
running rhythm. The free-running rhythm is called  “delayed”  when τ < 24 hours and  
“advanced”  when τ >24 hours. Synchronization with the external environment can be 
achieved by the input of different zeitgebers, like temperature, sound and social 
signals. However, light is the most prominent and most reliable zeitgeber because 
the quality of light is subject to stable and systematic change during the day. 
Adjustment of the circadian phase difference by means of light is called 
photoentrainment. 
Characteristics of light like the amount (irradiance), the spectral composition and the 
position of the sun may be used by organisms for entraining the phase of the 
circadian pacemaker (47). The photoentrainment effect of light is also dependent on 
the time of day, that is, light effects the cycle of the pacemaker in a time-dependent 
manner which can be described by a phase response curve (PRC)(48). When light 
pulses are given during the subjective day (time that corresponds to the light phase) 
the phase of most circadian systems is not changed. This is also called the ‘dead 
zone’ of the PRC. When pulses are administered in the late subjective day or the 
early subjective night (dusk) the phase is delayed (activity of the next cycle starts 
later) while pulses given during the subjective night and the early subjective day 
(dawn) advances the phase (Figure 5). The transition between delays and advances 
is called the PRC ‘breakpoint’. All organisms have a PRC curve with generally the 
same shape but the amount and duration of the light pulse and the resulting 
amplitude of the phase shift varies from species to species. 
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Figure 5: The phase-response curve. Locomoter activity (horizontal bars) of animals maintained in 
constant darkness is recorded. At day 0 a light pulse is administered during or after a period of activity. 
Once the effects of light are determined, the PRC is constructed as shown. Picture adapted from (45). 
 
1.3.2 The Biological clock. 
In many organisms the clock is localized in specific areas of the central nervous 
system. In vertebrates like birds, reptiles and fish the pineal gland displays 
pacemaker properties. However, in mammals the biological clock (circadian 
pacemaker) is situated in the suprachiasmatic nucleus (SCN), a small bilaterally 
paired structure located above the optic chiasm and lateral to the third ventricle. In all 
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mammals the SCN can be subdivided in a core that receives predominantly ocular 
input and a shell that receives input from other zeitgeber areas. These subdivisions 
are distinguishable both by segregation of afferents and by the peptide content of 
neurons that comprise them (49). The SCN neurons are capable of adjusting the 
phase of the clock in a time-dependent manner by regulating its sensitivity to external 
stimuli. The afferent neurons of the retinal ganglion cells (retinohypothalamic tract, 
RHT), and the non-photic neurons from the raphe nuclei and the intergeniculate 
leaflet (IGL) utilize different neurotransmitters to which the neuronal cells of the SCN 
are sensible only during a certain period of day. During twilight at dawn and dusk, the 
sensitivity to phase resetting is determined by the pineal hormone, melatonin. 
Melatonin receptors in the SCN are thought to use a protein kinase C-mediated 
mechanism (50). This indicates that the changing pattern of sensitivities is controlled 
by multiple intracellular pathways.  Discerning the molecular mechanism of these 
interacting pathways will be essential to our understanding how the circadian 
pacemaker is regulated by photic and non-photic signals. 
Recently some eight genes have been identified that control the output of the 
mammalian clock, Clock, Bmal1 (Mop3), Period genes (in mouse mPer1-3), 
Cryptochrome genes (in mouse mCry1 and mCry2) and casein kinase I (CKIε). The 
clock consist of positive and negative transciptional/translational feedback loops 
(Figure 6). The major positive loop consists of the Clock and Bmal1 genes which in 
turn activate the period and cryptochrome genes that function in the negative 
feedback loop (51,52). In mammals, transcription of mPer and probably the 
Cryptochrome genes is initiated by heterodimerization of the  CLOCK and BMAL1 
proteins. The CRY proteins stabilize the mPER2 protein and they both enter into the 
nucleus where the CRY proteins shut off their synthesis and that of the mPer genes. 
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Although mPER2 activates transcription of Bmal1, the CKIε kinase may affect nuclear 
translocation and the halftime of the mPER proteins. BMAL1 availability is rate 
limiting for CLOCK/BMAL1 heterodimer formation and is critical for restarting the next 
cycle when the level of repressors has decreased. The functions of mPER1 and 
mPER3 remain to be determined in detail (Figure 6)(51,52). 
 
 
Figure 6: Mechanism of the mammalian clock. Positive limb of the feedback loop is dotted and the 
negative feedback loop is indicates by normal lines. Picture adapted from (51).  
 
1.3.3 The Circadian photoreceptor. 
Although we have some insight in the way light might act to reset the cellular clock, 
no consensus exists about the actual photoreceptive molecules involved. In 
mammals enucleation (removal of the eyes) eliminates light-induced phase shifting, 
indicating that the circadian photoreceptor must be located somewhere in the eye. 
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Action spectra for phase shifting are conserved through phylogeny, indicating that a 
carotenoid-based chromophore is used. Murine action spectra for phase shifting the 
clock appear to be consistent with two photopigments, an UV (±365 nm) and a green 
(±509 nm) sensitive pigment (53). This might suggest that the retinal-based visual 
photopigments could function as circadian photoreceptors. However studies with 
mouse models for retina degeneration (rd/rd, rdta/rdta and rdta/cl mice (54-56)) 
indicate otherwise. They present strong evidence that the visual photoreceptors are 
not directly required for photoentrainment and that most likely the primary circadian 
photoreceptor is not located within the photoreceptor cell layer of the retina. It should 
be noted, however, that in rdta/rdta mice that suffer from very early ablation of the rod 
photoreceptor, the amplitude of phase shift, the circadian period (τ) and the total 
duration of activity (α) is altered compared to +/+ and rd/rd mice (57). This could 
suggest that changes in early retina development, especially those stages related to 
rod photoreceptor development, may affect the properties of the circadian system. 
Basically, the conclusion seems justified, however, that the mammalian circadian 
system is not primarily mediated by one of the visual photoreceptors but by a novel 
as yet unidentified ocular photoreceptor.  
Although the search for the circadian photoreceptor has focused on opsin-like 
pigments, it has been proposed that a non-opsin terahydropyrrole photopigment such 
as hemoglobin or bilirubin could be involved (58). Direct evidence for such a 
mechanism is lacking, but a study reporting phase shifting of the human clock by light 
exposure to the back of the knees has transiently renewed interest in the concept of 
humoral photoreceptors (59). These results could not be reproduced in more recent 
work however (60-62). 
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One of the recently, very extensively studied family of photopigments is the 
cryptochrome (Cry) family. These flavin or pterin-based blue light photoreceptors are 
related to the photolyase family of DNA repair enzymes and are implicated in 
circadian entrainment in insects, higher plants and lower eukaryotes (63,64). Human 
homologues of the photolyase/blue-light photoreceptor family have also been cloned 
(hCry1 and hCry2). The hCRY1 and hCRY2 proteins would still be able to function as 
photoreceptors but lack photolyase activity (65). In mammals the two cryptochrome 
genes are expressed at varying levels throughout the body with relatively high 
expression in the SCN and the bipolar and ganglion cells of the retina. Analysis of the 
mouse homologues showed that only mCry1 is rhythmically expressed in the SCN 
with peak levels during the subjective day and that mCry2 is arhythmic (66). While 
functional circadian rhythms were retained after ablation of either single mCry gene, 
the mCry1 and mCry2 double knock-out mice were totally arrhythmic (67) but still can 
be photoentrained (66). This indicates that the mCRY proteins are central 
components of the clock’s output pathway. In addition, a light-dependent interaction 
of CRY with several proteins (dTIM, dPER, dCLOCK, dCYCLE etc.) in the pacemaker 
system was observed in Drosphophila whereas comparable interaction patterns in 
mouse were not light sensitive at all (68). Therefore we can conclude that the mCry 
genes encode essential components of the clock in mammals that do not function as 
circadian photoreceptors.  
At the moment two members of the opsin family, melanopsin (69) and vertebrate 
ancient opsin (VA-opsin)(70,71), are possible candidates to function as circadian 
photoreceptor pigments. However, VA-opsin is so far only detected in teleosts where 
it is located in the bipolar and amacrine cell layer of the retina (70,72).  Melanopsin, 
originally isolated from melanophores in Xenopus is also located in the iris and 
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bipolar region of the retina (69). In the mammalian retina melanopsin is expressed in 
a specific celtype, the intrinsically photosensitive retinal ganglion cells 
(ipRGC)(73,74) and recent studies indicate that melanopsin is photosensitive and 
functions rather like a invertebrate opsin than like a classical rod and cone opsin (75-
77). Apparently, in contrast to VA-opsin, melanopsin has been conserved throughout 
the phylogeny of species (73). Direct evidence identifying either of these opsins as a 
circadian pigment has not yet been produced. However, the melanopsin knock-out 
mouse model (78,79) displays a phenotype with deficiencies in circadian 
photoentrainment demonstrating that melanopsin contributes to, but is not solely 
responsible for the photic information that is received by the clock. Recent studies 
show that a triple knock-out mouse model, in which both the visual pigments of rods 
and cones and melanopsin are disabled, entirely fails to entrain to light/dark cycles. 
Thus it can be concluded that the rod and/or cone pigments and melanopsin 
photopigments together seem to provide all of the photic input for the circadian 
system (80,81). This is supported by a recent study in which it has been shown that 
the ipRGC also receive input from bipolar and multiple types of amacrine cells 
suggesting that rod and/or cone signals may be capable of activating and/or 
modifying the intrinsic light response of the ipRGC (82,83). 
 
1.3.4 Output disorders of circadian function. 
The main function of the circadian pacemaker is to integrate temporal information in 
order to regulate several physiological and behavioral processes. The most common 
feature is the regular cycle of sleep and waking. It is therefore not surprising that 
disordes of the circadian function are often characterized by sleep or waking 
disturbances (circadian rhythm sleep disorders; CRSD)(84).  
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A direct output mechanism of the circadian pacemaker is the synthesis and secretion 
of the pineal hormone, melatonin. Melatonin is exclusively produced during the dark 
phase of the cycle and its production is regulated by a negative feedback loop. 
Consequently, melatonin appears to be the ideal indicator and chronobiotic to assess 
and treat various sleep disturbances (85). 
One of the most common disorders of entrainment is the rapid time-zone change 
syndrome or jet lag (7,86,87). This is a typical disorder of modern life and is 
characterized by several typical symptoms like sleep disruption, fatigue, 
concentration difficulties, gastrointestinal distress, impaired psychomotor 
coordination, reduced cognitive skills and alterations in mood. Symptoms vary within 
different individuals, with the direction of travel and with the number of time zones 
crossed. Another disorder of modern life is the work-shift syndrome which is common 
in many occupations of industrialized countries (7,86,87).  Like jet lag there are 
numerous symptoms but the major symptom of work-shift disorder is impaired sleep. 
These disorders clearly result from a certain lifestyle. In delayed sleep phase 
syndrome (DSPS) and advanced sleep phase syndrome (ASPS)(86,87)  it is difficult 
to discern whether the disorder is caused by an entrainment defect or simply 
represents a certain lifestyle. People affected by DSPS have a persistent delayed 
phase shift in the sleep-wake cycle. Sleep onset is delayed until early morning with a 
consequent delay in rising. When lifestyle is not causing this disorder a defect in 
pacemaker sensitivity to light in the phase-advanced portion of the PRC is most likely 
responsible for these symptoms. This syndrome has a prevalence of  ~83,5% of all 
patients with CRSD (circadian rhythm sleep disorders) and is often found in elder 
people (88). ASPS is the mirror image of DSPS. Individuals with the ASPS have a 
persistent early onset of sleep and awakening which reflects a pacemaker sensitivity 
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defect in the phase-delayed portion of the PRC. Although ASPS is quite rare, a 
familial ASPS variant was identified in humans recently (89). Identifying the defective 
gene is a unique opportunity to study one of the multiple signal transduction 
pathways that influences the clock in a time-dependent manner. 
Individuals affected by a non-24-hour sleep-wake syndrome display a free running 
sleep-wake cycle. This indicates that in this entrainment disorder the circadian 
photoreceptor or essential components of the retinohypothalamic tract (RHT) are 
impaired. The irregular sleep-wake pattern syndrome (86,87) is a disorder associated 
with dysfunction in the downstream pacemaker and is manifested in an arrhythmic 
sleep-wake cycle. It is relatively uncommon and it sometimes occurs in people with 
evident hypothalamic pathology, such as a tumor or a hemorrhage. In a few cases 
where it manifests spontaneously it is most likely associated with a defect in an 
essential component of the molecular mechanism of the clock.  
 
1.4 Retinitis Pigmentosa. 
1.4.1 Histopathology.   
Retinal dystrophies are a heterogeneous group of diseases, in which the light 
sensitive layer of the retina degenerates, leading to either partial or complete loss of 
vision. A hereditary form, retinitis pigmentosa, causes primary degeneration of rod 
photoreceptors which starts with shortening of the outer segments and eventually 
results in the complete ablation of the photoreceptor cell. Ultimately, secondary 
degeneration of the cone photoreceptors, that display the same histopathological 
features, may lead to complete loss of vision (90). Cone cell death is believed to be 
triggered by toxic byproducts of rod cell degeneration (91) or the loss of rod-derived 
factors necessary for cone survival (92). The dysfunction of the rods starts in early 
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adolescence and causes night vision disturbances eventually followed by the loss of 
cones which begins in the mid periphery. The photoreceptor degeneration is 
progressive, and by adulthood the more central macular function may also be 
impaired. The loss of rods and cones is accompanied by changes in the RPE cells, 
which detach from the Bruch’s membrane and migrate to small retinal blood vessels. 
Hence the term ‘pigmentosa’ which refers to the black melanin deposits of RPE cells 
called ‘bone spicules’ characteristic for the advanced stages of the disease. Müller 
cells also undergo reactive gliosis in a variety of retinal degenerations (93). The 
gliotic changes in the Müller cells include cellular hypertrophy and migration of their 
enlarged nuclei from the inner nuclear layer to the outer retina. These reactive Müller 
cells contain increased amounts of glial fibrillary acid protein (GFAP), an intermediate 
filament protein found mainly in astrocytic glia cells. The inner nuclear layer displays 
very few signs of degenerative loss whereas ganglion cells reveal a significant 
reduction paralleled by the loss of photoreceptors (94).  
 
1.4.2 Ophthalmogenetics.  
Retinitis pigmentosa can be transmitted in an autosomal dominant (ADRP), 
autosomal recessive (ARRP), X-linked (XLRP) or digenic manner. The prevalence of 
RP is approximately 1/4000 making it one of the most common causes of hereditary 
visual impairment. The prevalence of the genetic subtypes is ~43% ADRP, ~20% 
ARRP and ~8% XLRP or digenic (95). Although RP is a genetic disease, 
approximately 23% of the patients have no family history and this type is called 
‘simplex’ or ‘isolated’ RP. The remaining 6% are still undetermined. Mutations in 
several photoreceptor cell genes have been identified to cause retinal degeneration. 
These can be classified into three groups according to there physiological function: 
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genes involved in (1) visual phototransduction, (2) outer segment morphogenesis and 
(3) retinol metabolism (96). A selection of the most well known inherited retinal 
diseases are listed in table 1. A complete overview can be found on the RedNet 
website ( http://www.sph.uth.tmc.edu/RetNet/ ). 
 
 
Protein   Localization  Disease 
 
Rhodopsin   Rods   ADRP (97), ARRP (98), CSNB (99) 
PDE (α,β)   Rods   ARRP (100), CSNB (101,102) 
cGMP-gated channel (α) Rods   ARRP (103) 
Arrestin   Rods   CSNB (Oguchi disease) (104) 
Rhodopsin kinase  Rods   CSNB (Oguchi disease) (105) 
Transducin   Rods   CSNB (Nougaret disease) (106) 
RetGC    Cones & Rods  LCA (107), CRD (108) 
GCAP1    Cones & Rods  Cone dystrophy (109,110) 
Peripherin/rds   Rods & Cones  ADRP (111), MD (112), 
 pattern dystrophy (113),  
 digenic ADRP (114) 
Rom-1    Rods & Cones   Digenic ADRP (114) 
ABCR/RIM   Rods & Cones  STGD (115), ARRP (116,117),  
CRD (117), AMD (118) 
CRX    Rods & Cones  LCA (119), CRD (120) 
RPRG    Rods   X-linked RP (RP3) (121-123)  
XLRS1    Extracellular  X-linked retinoschisis (124) 
 
RPE65    RPE   LCA (125,126), ARRP (126,127) 
CRALBP   RPE   ARRP (128) 
Bestrophin (VMD2)  RPE   Best’s macular dystrophy (129,130) 
 
TIMP3    Bruch’s membrane SFD (131) 
REP1     Choroid/RPE/retina CHM (132,133) 
Myosin VIIA   Rods/Cones/RPE Usher syndrome (134) 
Crb1    Extracellular  RP/LCA (135,136) 
 
ADRP, autosomal dominant retinitis pigmentosa; ARRP, autosomal recessive retinitis pigmentosa; 
CSNB, congenital stationary night blindness; X-linked RP, X-linked retinitis pigmentosa; MD, macular 
dystophy; AMD, age-related macular dystrophy; STGD, Stargardt’s macular dystrophy; CRD, cone-rod 
dystrophy; LCA, Leber’s congenital amaurosis; SFD, Sorby’s fundus dystrophy; CHM, chorioderemia. 
 
 
Table 1: Genes associated with various retinal degenerative diseases. 
 
A fourth group should be mentioned in which retinal degeneration is a component of 
a more complex disease. There are more than 30 complex syndromes, well-known 
e.g. is Usher syndrome (type 1, 2 and 3) which inflicts congenital deafness and RP. 
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In contrast to the above mentioned, the genes responsible for these complex 
syndromes are not retina-specific. 
The first identified retina-specific gene causing RP was the rhodopsin gene (97). At 
present over 100 different mutations in rhodopsin have been identified accounting for 
about 25% of ADRP and about 10% of all RP patients. The very heterogeneous 
nature of RP is already shown by the fact that different mutations in the same gene, 
rhodopsin, can cause a variety of symptoms (ADRP, ARRP and congenital stationary 
night blindness (CSNB)). CSNB only affects the function but not the integrity of the 
rod photoreceptor. 
Although the list of RP causing genes and mutations is rapidly expanding, little still is 
known about the mechanism of dysfunction and photoreceptor cell death. However, 
animal models for RP, like the rd (retinal degeneration) mouse, the rds (retinal 
degeneration slow) mouse (137,138) and many other animal models (139-141), 
indicate that the mechanism of photoreceptor cell death in many cases involves 
apoptosis.  RP-associated mutations (142,143) including the null mutation of the 
rhodopsin gene are also studied in transgenic mice (144,145). The transgenic mice 
with RP-associated mutations also display a shortening and disorganization of the 
outer segments, suggesting a mechanism of cell death similar to that observed in 
naturally occurring rd and rds mutants. In the rhodopsin knock-out mouse the rod 
outer segments can in fact not be assembled and the photoreceptors are lost within a 
very short period of time. We therefore can conclude that the genetic heterogeneity of 
RP implies multiple critical steps, all with their own “pace and constraints”, but 
ultimately all affecting photoreceptor viability and, in the end, retina integrity. 
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1.5 Aim and outline of this thesis. 
Rhodopsin is a multi-functional photopigment. It is the primary trigger in scotopic 
vision but has also been implicated to have a role in circadian photoentrainment and 
it is an important factor in maintaining the structural and functional integrity of the 
photoreceptor cell. This thesis aims at investigating the latter two aspects in more 
detail. 
To study the relationship between visual pigments and the circadian system we used 
the blind mole rat, Spalax ehrenbergi, as a natural animal model. Important elements 
of the visual system in this animal have regressed or are completely absent. The eye 
is strongly regressed and the lens starts to degenerate during early development.  In 
contrast, the retina is still fully preserved and immunohistochemical evidence 
indicates the presence of a rhodopsin-like pigment. Bilateral enucleation (removal of 
both eyes) has been shown to abolish photoentrainment and we therefore assumed 
that the photopigments remaining in the rudimentary eye could be involved in the 
regulation of the circadian system.  
Our objects were to clone and characterize photopigments from the Spalax retina 
and establish whether these pigments are functional photoreceptor proteins in vitro 
and in vivo. In chapter 2 the cloning and characterization of the major Spalax visual 
pigment is described which appeared highly homologous to the rod pigment of 
sighted animals. We present evidence that this pigment is fully functional as a 
photoreceptor protein in vitro as well as in vivo. Co-localization with the G-protein 
transducin in vivo suggests that this pigment sustains a classical phototransduction 
cascade.  
In addition to the rod-like pigment, we also cloned a green cone-like visual pigment 
from Spalax retina. In chapter 3 the functional characterization of this green cone 
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pigment is described. The green cone pigment appeared to be one of the most red-
shifted LWS pigments in rodents. A novel chloride-dependent spectral tuning 
mechanism is operative to adjust its spectral properties. Studies involving transgenic 
mice have generated evidence that the circadian system in sighted animals does 
entail rods or cones for photoentrainment (80,81). We hypothesize therefore that the 
visual pigments in Spalax, due to its subterranean lifestyle, have undergone an 
adaptive reorganization towards a major function in circadian photoreception.  
To study in vivo the effects of opsin mutations known in humans to cause the ocular 
disease retinitis pigmentosa and, subsequently, to study the role of opsin in 
maintaining the structural integrity of the rod photoreceptor cell, we set off to 
generate targeted rhodopsin knock-in mouse models. In chapter 4 we describe the 
generation of a mouse model in which the opsin gene has been replaced by a wild 
type bovine opsin cDNA. The resulting transgenic knock-in mice (KI/KI) produce a 
functional bovine rhodopsin but the exchange of a gene for a cDNA, altered 
transcription and/or translation in such a way that opsin expression levels are only 
approximately 10-15% of that observed in wild type control mice. Possible ways to 
overcome this reduced expression effect, to allow the generation of new models that 
carry retinitis pigmentosa mutations, are discussed. However, inadvertently the 
knock-in mouse model provided some very intriguing aspects that broadened our 
insight in the process of photoreceptor cell death. We established that the opsin 
concentration although only 15%, remains stable until the mice are 4 months of age, 
after which it rapidly decreases to 3% at 6 months. This is a strong indication for 
photoreceptor cell degeneration that nears completion at 6 months. Intriguingly, this 
retina degeneration in our homozygous KI/KI mice proceeds much slower than in the 
rhodopsin null mutant (KO/KO) which completes at 3 months. We therefore conclude 
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that a low expression level of rhodopsin does not suffice to rescue the degeneration 
prone phenotype, but it significantly reduces the rate of photoreceptor cell 
degeneration observed in these mice. 
Histochemical and immunohistochemical analysis of the eyes in the various mouse 
strains are described in chapter 5. These results display a progressive rod 
photoreceptor cell loss in KI/KI animals which nears completion at about 6 months. 
However, data from chapter 4 indicated that the opsin expression level remained 
stable during the first 4 months. Therefore we concluded that during the process of 
degeneration the retina tries to compensate for the loss of photoreceptor cells by 
upregulating opsin expression in the remaining photoreceptor cells. This upregulation 
of opsin expression to maintain a stable opsin concentration has never been 
observed before and represents an intriguing aspect in the process of retina 
degeneration.  
Crossbreeding of the rhodopsin knock-in with the rhodopsin null mutant mouse 
resulted in a hemizygous KI/KO mouse which also seems to slow the rate of 
photoreceptor cell degeneration of the homozygous knock-out model (KO/KO) and 
nears completion at 4 months. We therefore conclude that low expression levels of 
opsin can reduce the rate of degeneration but  also that the rate of photoreceptor cell 
degeneration seems to be inversely correlated to the opsin expression level. 
In chapter 6 the work presented in this thesis is summarized and discussed. We also 
speculate on the role of Spalax rhodopsin in photoentrainment and on the underlying 
mechanisms of photoreceptor cell death. 
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2.1 Summary. 
                                                                                                                                                                               
In the blind subterranean mole rat Spalax ehrenbergi superspecies complete ablation 
of the visual image forming capability has been accompanied by an expansion of the 
bilateral projection from the retina to the suprachiasmatic nucleus (SCN). We have 
cloned the open reading frame of a visual pigment from Spalax, that shows >90% 
homology with mammalian rod pigments. Baculovirus expression yields a membrane 
protein with all functional characteristics of a rod visual pigment (λmax = 497 ± 2 nm; 
pKa of meta I/meta II equilibrium = 6.5; rapid activation of transducin). We not only 
provide evidence that this Spalax rod pigment is fully functional in vitro, but also show 
that all requirements for a functional pigment are present in vivo. The physiological 
consequences of this unexpected finding are discussed. One attractive option is, that 
during adaptation to a subterranean lifestyle, the visual system of this mammal has 
undergone mosaic reorganization and the visual pigments have adapted to a major 
function in circadian photoreception. 
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2.2 Introduction.
Spalax represents an extreme model of a subterranean rodent, spending all its life in 
underground darkness with only a few occasional exits aboveground. Consequently, 
it displays a mosaic of reductional (regressions) and expansional (progressions) 
adaptation at all organizational levels. This mosaic evolution is most prominent in 
ocular and brain structures (1). Thirty  million years of adaptation to a subterranean 
environment and lifestyle has resulted in a natural degeneration of the visual system 
of mole rats (family Spalacidae). In this process, the eye of Spalax has been reduced 
to a very small size (≤ 1 mm) and regressed to a subcutaneous location, embedded 
in a hypertrophied Harderian gland. While the morphological development of the 
retina is normal, with a characteristic stratified organization, the anterior eye seg-
ments start to degenerate early in development (2). Neuronal components of the 
visual pathways are regressed or absent and anatomically no visual cortex can be 
identified (3). Likewise, electrophysiological measurements did not obtain any 
indication for functional visual pathways (1,4). In contrast, bilateral projections from 
the retina to the suprachiasmatic nucleus (SCN) have been expanded (5) and Spalax 
has preserved the ability to entrain its biological clock to environmental light cues 
(6)(Figure 1). Removal of the eyes abolishes circadian photoentrainment (7), 
demonstrating that the circadian photoreceptor system is located in the eye. Despite 
the degenerate nature of its visual system, Spalax has retained a well-organized 
retina that expresses both a rod-like and a cone-like visual pigment. A green cone-
like visual pigment was cloned from Spalax and spectrally identified via functional 
expression (6), but up to date only immunohistochemical evidence for the presence 
of a rod-like pigment has been presented (2,8). Here we present an extensive 
characterization of this pigment. Its sequence is characteristic for a rod visual 
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pigment and has retained very high homology with rod pigments of sighted mammals. 
Through functional expression with recombinant baculovirus we provide ample 
biochemical evidence that this pigment behaves like a fully functional rod pigment. 
Considering the absence of any visual ability, a possible novel function for the visual 
pigments of Spalax is discussed. 
 
Figure 1: Circadian locomoter behavior of Spalax ehrenbergi. Activity was recorded as described (9). 
Light was provided by Osram ‘cool white’ fluorescent lights (irradiance of approximately  
30 μW.cm2/110 lux). Following a 12:12 light dark cycle of 11 days (upper bar, white is light on), the 
animal was exposed to a daily 15 minute light pulse (lower bar). After a transitional period of 
approximately 12 days, stable entrainment to the new light regime was observed.  
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2.3 Experimental Procedures. 
2.3.1 Cloning of the Spalax rod pigment. 
Total RNA was isolated from Spalax eyes using Trizol reagent (GIBCO) and approxi-
mately 2 μg RNA was used to synthesize cDNA by means of reverse transcription 
(Superscript II reverse transcriptase, GIBCO-BRL). PCR amplification was performed 
using Pfu proofreading polymerase (Stratagene) in combination with degenerate 
nested and/or specific rod opsin primers. 
Degenerate primers. 
Forward : 5’-GTG-RTS-TGY-AAR-CCB-3’ (exon II) 
       5’-AAT-GTC-GAC-CAY-GCY-ATC-ATG-GTY-3’ (exon II nested) 
Reverse : 5’-RTA-RAT-SAY-VGG-RTT-3’ (exon IV) 
      5’-AAT-GTC-GAC-GCC-CTG-RTG-GGT-GAA-3’ (exon IV nested) 
Specific primers. 
Forward : 5’-ATG-AAC-GGC-ACA-GAG-GG-3’ (exon I) 
Reverse : 5’-CAT-CAC-CCA-GGA-GGT-TCT-TGC-3’ (exon V) 
5’ and 3’ RACE were performed using a 5’/3’ RACE kit (Boehringer Mannheim) in 
combination with an opsin specific reverse primer in exon I (5’-AAG-TTG-AGC-AGG-
ATG-TAG-3’) and the above mentioned forward nested degenerate rod opsin primer 
in exon II respectively. The obtained full length open reading frame (ORF) was 
checked on the genomic level by means of the expand long template PCR system 
(Boehringer Mannheim) using 500 ng genomic DNA and a rod opsin specific primer 
(5’-TCT-ACG-TGC-CCT-TCT-CCA-ACG-3’) in exon I in combination with the above 
mentioned specific rod opsin reverse primer in exon V. The obtained partial sequence 
was identical to the corresponding cDNA sequence. A forward primer with a BamHI 
site (5’- GGC-GGG-ATC-CAT-GAA-CGG-CA-3’) and an reverse primer containing a 
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Nar I site (5’-TTA-GGC-CGG-CGC-CAC-CTG-G-3’) were used in combination with 
the Pfu proofreading polymerase to clone the Spalax rod opsin cDNA in a baculovirus 
transfer vector modified from pFastbacdual (GIBCO-BRL). This modified transfer 
vector contains a BamHI site and a Nar I site in frame with the remaining 3’ part of 
the Spalax rod opsin sequence extended with an oligonucleotide coding for 6 
histidines (His-tag). 
 
2.3.2 Functional expression. 
The transfer vector containing the his-tagged Spalax rod opsin cDNA was used to 
generate recombinant baculovirus in a Spodoptera frugiperda derived cell line (IPLB-
Sf9) using the Bac-to-bac system (Life Technologies), according to manufacturer’s 
instructions. Generation and amplification of the recombinant baculovirus was 
performed in a monolayer of Sf9 cell, cultured in TNM-FH medium supplemented with 
10% (v/v) fetal calf serum, 50 U/ml penicillin and 50 μg/ml streptomycin (Life 
Technologies). For expression of recombinant protein (10) Sf9 cells were adapted to 
suspension culture in 250 ml spinner flasks (Bellco) in serum-free InsectXpress 
medium (BioWittaker), infected in mid log phase with a multiplicity of infection (MOI) 
of 0.1 and finally harvested 5 days post infection (dpi). 
 
2.3.3 Regeneration, Purification and Reconstitution of recombinant pigment. 
At 5 dpi the infected Sf9 cells were harvested by centrifugation (10 min, 1000xg at 
26°C) and resuspended at a concentration of 108 cells/ml in buffer A (6 mM Pipes, 10 
mM EDTA, pH 6.5), supplemented with 5 mM β-mercaptoethanol and 2 μg/ml 
leupeptin. The suspension was homogenized in a Potter Elvehjem homogenizer and 
centrifugated (10 min, 40,000xg at 4°C). The pellet containing the cellular 
                                                                          43
Chapter 2 
membranes was resuspended at a concentration equivalent to 108 cells/ml in buffer B 
(20 mM Pipes, 130 mM NaCl, 10 mM KCl, 3 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 
2 μg/ml leupeptin, pH 6.5). All subsequent manipulations are performed under deep 
red light (Schott R630 longpass filter). Regeneration of the recombinant Spalax opsin 
into rhodopsin was performed under argon by addition of a concentrated 11-cis 
retinal solution in dimethylformamide (DMF) to the membrane suspension in an 
amount of 10 nmoles/108 cells. The mixture was incubated under continuous rotation 
during 30 min at room temperature followed by 1 h at 4°C. To extract the rhodopsin 
from the membranes n-dodecyl-β-D-maltoside was added to a final concentration of 
1% (w/v) and the resulting mixture was incubated during 1 hr under argon with 
continuous rotation at 4°C. After centrifugation (30 min,  120,000xg at 4°C) the 
supernatant was diluted 1:1 with buffer C (20 mM bis-Tris propane, 0.5 M NaCl, 20% 
glycerol v/v, 5 mM β-mercaptoethanol, 1 mM histidine, 2 μg/ml leupeptin, 40 mM n-
nonyl-β-D-glucoside, pH 7.0).  
The solubilized pigment was purified by immobilized metal affinity chromatography 
(IMAC) over Ni2+ nitrilotriacetic acid (NTA) resin (Qiagen) in a slight modification from 
earlier described procedures (10,11). Prior to purification the pigment concentration in 
the extract was determined by UV/VIS difference-spectroscopy (11), and the pH was 
raised to 7.0-7.2 by addition of several aliquots of 200 mM unbuffered Bis-Tris 
propane solution. The Ni2+-NTA resin (25-30 μl resin /nmole pigment) was washed 
with 10 volumes of distilled water and buffer C, respectively. The protein extract was 
then applied to the column and washed with approximately 10 column volumes of 
buffer C followed by approximately 10 column volumes of a linear gradient prepared 
from buffer C and D (buffer D : buffer C with the histidine concentration raised to 5 
mM and containing 20 mM n-nonyl-β-D-glucoside). Elution was accomplished using 
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buffer E (20 mM bis-Tris propane, 140 mM NaCl, 20% glycerol v/v, 20 mM n-nonyl-β-
D-glucoside, 5 mM β-mercaptoethanol, 50 mM histidine, 2 μg/ml leupeptin, pH 6.5). 
Fractions were screened by UV/VIS-spectroscopy and those containing over 0.5 
nmol of rhodopsin/ml were combined.  
In order to reconstitute the purified pigment into a lipid membrane (proteoliposomes) 
a 100 fold molar excess of bovine retina lipids (RL) in buffer F (20 mM Pipes, 130 
mM NaCl, 10 mM KCl, 5 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 2 μg/ml 
leupeptin, pH 6.5) supplemented with 20 mM n-nonyl-β-D-glucoside and 1 mM DTE, 
was added to the combined rhodopsin fractions. Preparation of bovine RL and 
removal of the detergent through addition of β cyclodextrin to a final concentration of 
20 mM were performed as described before (12). Purification of the proteoliposomes 
containing the reconstituted pigment was accomplished on a discontinuous sucrose 
gradient (10%, 20% and 45% sucrose, w/w) in buffer F (12). After 16 h centrifugation 
at 120,000xg and 4°C the pigment containing proteoliposomes were isolated from the 
20-45% interface and diluted with 4 volumes of buffer B. The membranes were then 
pelleted (200,000xg, 30 min at 4°C) and stored at -80°C in light-tight containers.  
For spectral analysis of the pigment a Perkin Elmer Lambda 15 spectrophotometer 
was used with the cuvette house thermostrated at 10°C. Membrane samples were 
used for analysis of the slow photocascade transitions (rhodopsin → meta II → meta 
III) as described before (13). Absorbance spectra were measured after solubilization 
in buffer B containing 20 mM n-dodecyl-β-D-maltoside. The samples were 
supplemented with hydroxylamine to a final concentation of 20 mM and were 
measured before and after illumination with a 75 W light bulb. Difference spectra 
were obtained by subtraction of the “dark” from the “illuminated” spectrum. 
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2.3.4 Transducin Activation Assay. 
Activation of the bovine G-protein transducin (Gt) by the Spalax rod pigment was 
measured by the intrinsic fluorescence enhancement of the G-protein α subunit upon 
GTP binding (14). Native bovine rhodopsin or reconstituted pigment samples of 
recombinant his-tagged Spalax or bovine rhodopsin (final concentration of 5 nM) 
were added under illumination to a stirred cuvette containing, in a final volume of 2 
ml, 100 nM of bovine transducin, 100 mM NaCl, 2 mM MgCl2, 1 mM DTE, 0.01% 
(w/v) n-dodecyl-β-D-maltoside, 20 mM Hepps, pH 7.4. The sample fluorescence was 
measured using a Shimadzu RF-5301-PC spectrofluorometer with excitation at 295 
nm and emission at 337 nm, and after a stablization period of 200 s, GTP-γ-S 
(guanosine 5’-O-3’ thiotriphosphate) was added to a final concentration of 2.5 μM. 
The subsequent increase in relative fluorescence intensity represents pigment 
triggered activation of Gtα. The same assay in the absence of pigment was used as a 
negative control.  
 
2.3.5 Microspectrophotometry. 
Spalax eyes were isolated from dark adapted animals and the retina was excised and 
mounted between coverslips in the microscope and potential outer segment material 
identified under infra-red illumination. The spectral transmission of the photoreceptor 
outer segments was scanned using a 2 μm diameter beam of monochromatic light 
over the wavelength range 350 nm to 750 nm (15). This resulted in the dark 
spectrum. Following a 3 minute exposure to white light this procedure is repeated to 
establish whether the pigment is photosensitive. The dark spectrum was fitted with 
standard Dartnall templates for a vitamin A1 based visual pigment (15).  
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2.3.6 Immunohistological analysis. 
Polyclonal antibodies CERN886 against rhodopsin and CERN9412 against Gtα were 
described before (16). Monoclonal antibodies against rhodopsin (1D4) or against Gtα 
were obtained from R.S. Molday (17) and A.M. Spiegel (18), respectively. 
Spalax ocular tissue was fixed in 4% paraformaldehyde/PBS and mouse ocular 
tissue in Bouin fixative (3 volumes saturated picrine acid, 1 volume 37 % formalde-
hyde and 0.2 volume of acetic acid). Paraffin embedded 4 μm sections were used for 
antibody incubations and  hematoxylin/eosin staining. Spalax and mouse ocular 
tissue were incubated according to standard procedures with 1D4 or anti-Gtα 
(dilutions 1:50 and 1:100 in PBS/10% FCS respectively), and with CERN886 or 
CERN9412 (dilutions 1:100 and 1:500 in PBS/10% FCS respectively).  
Bound antibody was visualized by incubation with a fluorescent second antibody 
(FITC-RAM (DAKO) for 1D4 and anti-Gtα, FITC-GAR (DAKO) for CERN886 and 
CERN9412; dilutions 1:50 in PBS/10% FCS). Coverslips were mounted using a 
ProLong Anti-fade kit (Molecular Probes) according to manufacturer’s instructions. 
Fluorescence microscopy was performed on a Zeiss Axioskop microscope.  
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2.4 Results and discussion. 
2.4.1 Structural and functional characterization of the Spalax rod visual 
           pigment in vitro.
To clone the rod pigment from Spalax retina we conducted RT-PCR and 5’ and 3’ 
RACE on total ocular RNA using degenerate and rod opsin specific primers. The 
amino acid sequence deduced from the full length cDNA displays a very high 
similarity with other mammalian rhodopsins (91-95%), and all elements essential for a 
functional visual pigment are conserved (Figure 2).  
 
Figure 2: Multiple Sequence Alignment of the amino acid sequence of Spalax, rat and mouse  
rhodopsin. The nucleotide sequence of Spalax rhodopsin cDNA contains an open reading frame 
which codes for 348 amino acid protein and shares approximately 95% similarity with other rodent 
rhodopsins like rat and mouse. The amino acid substitutions in Spalax compared to rat (16 in total) 
and mouse (19 in total) rhodopsin are boxed. Note (arrows) the presence in Spalax of the over all 
vertebrate visual pigments fully conserved residues Lys-296 (11-cis retinal binding), Glu-113 (counter 
ion), and Cys-110 and Cys-187 (disulfide bridge). The third arrow indicates the Glu residue at position 
122, highly characteristic for rod visual pigments. 
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To establish whether the isolated cDNA encodes for a functional rod pigment we 
extended the cDNA C-terminally with a 6x his-tag to allow easy purification and 
expressed it using the baculovirus system. After regeneration with the chromophore, 
11-cis retinal, purification was accomplished using immobilized metal affinity 
chromatography (IMAC)(11). This yields a purified protein, which has an apparent 
molecular weight of 40 kD (Figure 3) and an absorbance spectrum with a peak 
spectral activity of 497 ± 2 nm (Figure 4).  
 
Figure 3: Western Blot analysis of rhodopsin preparations using CERN 886 anti-rod polyclonal 
antibody (dilution 1:1000). Left panel: Spalax eye extract (lane 1) and mouse eye extract (lane 2). 
Right panel: Sf9 cells expressing his-tagged Spalax rhodopsin (lane 3); n-dodecyl-β-D-maltoside 
extract of Sf9 cells (lane 4); purified and reconstituted his-tagged Spalax rhodopsin (lane 5); purified 
and reconstituted his-tagged bovine rhodopsin (lane 6). Note the apparent higher molecular weight of 
native Spalax rhodopsin (lane 1, 43 kD) relative to mouse (lane 2, 40 kD). 
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Figure 4: Spectral properties of purified reconstituted Spalax rhodopsin. The photopigment displays a 
peak spectral activity at 497 ± 2 nm. The A280/A500 ratio is approximately 3.5. This is higher then for 
purified rod pigments (1.7-2.0), due to the excess of lipid, which contributes to the UV-absorbance. 
Inset shows the difference spectrum, obtained by subtracting the dark spectrum from the spectrum 
after illumination. The spectra were measured in the presence of 20 mM hydroxylamine to convert the 
liberated all-trans retinal into all-trans retinoxime with an absorbance maximum at 365 nm. 
 
As expected, the spectral properties are very similar to those of rod pigments in 
sighted animals, since all known spectral tuning sites (19) have been conserved in 
Spalax. However, immunoblots of Spalax eye extracts suggest a higher molecular 
weight of ca. 43 kD (Figure 3). Since the protein component of the Spalax and bovine 
rod pigments are very similar (39 kD) and the recombinant pigments display the 
same molecular weight (Figure 3), most likely the native Spalax pigment contains 
larger oligosaccharide moieties on its two N-glycosylation sites, which will reduce its 
electrophoretic mobility. The very small Spalax eye only contains minute amounts of 
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rhodopsin (ca. 5 pmol;(8)), which so far has prohibited isolation and structural 
characterization of the native protein. 
To study the pigment’s photocascade and receptor activity in a native-like environ-
ment, we reconstituted the pigment into proteoliposomes of bovine retina lipids (12). 
The reconstituted Spalax rhodopsin displays typical rod pigment photochemical 
behavior (pKa of meta I/meta II equilibrium of 6.5; half-time of meta II decay of 15 ± 3 
min at 10º C). Spalax is very similar to the human rod pigment in this respect (20). 
Note that the decay of meta II is typically much faster in cone pigments (t½ < 3 min; 
(21)).The structural transitions accompanying receptor activation were probed by FT-
IR difference spectroscopy and were found to be almost identical to recombinant his-
tagged bovine rhodopsin (not shown). This already implies that the Spalax rod 
pigment should be able to activate the rod G-protein transducin. Indeed, in an in vitro 
assay (14) it achieves an activation rate very similar to that of native and of recom-
binant bovine rhodopsin (Figure 5). We therefore conclude that in vitro the Spalax rod 
photopigment behaves as a fully functional visual pigment.  
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Figure 5: Activation of bovine G-protein transducin (Gt) by the Spalax rod pigment. Intrinsic 
fluorescence enhancement of the G-protein α subunit upon GTP binding was used to monitor 
activation by either native bovine rhodopsin (trace 3), or recombinant his-tagged Spalax (trace 1) or 
bovine (trace 2) rhodopsin. As a negative control the activation rate in the absence of pigment was 
measured (trace 4). All pigments were present at the same concentration (5nM) and the reaction was 
initiated by the addition of GTPγS to 2.5 μM (arrow) 
 
2.4.2 Functional characterization of the Spalax rod pigment in vivo. 
Do we have evidence for a functional pigment in vivo? Both 11-cis retinal (8) and a 
functional interphotoreceptor retinoid binding protein (IRBP) (22), have been iden-
tified in Spalax retina, suggesting a functional visual cycle. Therefore, we attempted 
to identify a photopigment in vivo by means of microspectrophotometry (MSP). In 
spite of a much lower degree of organization of Spalax photoreceptor outer segments 
we managed to determine the spectral absorbance of several outer segments in 
retinas isolated from dark adapted animals (Figure 6). The corresponding pigment is 
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photosensitive and its absorbance curve obeys the Dartnall standard template for a 
vitamin A1 based visual pigment (15). The dashed curve (Figure 6) represents a 
template with a peak absorbance at 497 nm, as determined for the recombinant 
pigment. This template fit is not optimal, which could be due to the noise level in the 
spectral data or might indicate that in vivo the pigment’s absorbance is slightly shifted 
to the red. Such small discrepancies between spectral data of native and 
recombinant pigments have been observed before (19).  
 
Figure 6: Spectral absorbance data from four Spalax photoreceptor outer segments obtained by 
microspectrophotometry (MSP). Open squares were measured before illumination, solid squares after 
3 min illumination with white light. The dashed curve represents a visual template (17) with a λmax of 
497 nm. This yields a reasonable fit, but better fits are exhibited by 500 to 505 nm templates. The 505 
nm template is given by the solid curve. 
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Nevertheless, the close agreement of the in vivo spectrum with our in vitro data 
strongly argues, that the Spalax retina contains a photoactive rod pigment.  
A functional visual pigment requires co-localization with the rod G-protein transducin 
(Gt). To address that question, we performed immunohistochemical analysis of 
Spalax retina with anti-rhodopsin and anti-Gtα antibodies. We observed abundant 
expression of rod pigment in Spalax photoreceptor outer segments and clear staining 
of inner segments and outer nuclear layer (Figure 7 C). This is similar to the picture 
obtained for mice (Figure 7 D). Gtα expression was observed in Spalax, but only in 
the outer segment layer (Figure 7 E) in contrast to mouse where Gtα is detected 
throughout the entire photoreceptor cell (Figure 7 F). This suggests, that in Spalax  
the expression level of Gtα relative to rhodopsin is lower as compared to mouse. This 
might be related to the subterranean environment of the mole-rat. For instance, in 
order to guarantee maximal photon capture under the very low light intensities experi-
enced by Spalax, the high expression level of visual pigment, typical for sighted 
animals, should be maintained. Nevertheless, the level of activated pigment will be 
very low and signal transduction should be able to operate with much lower Gt levels 
than in sighted animals. Considering our in vitro data (spectral properties, full 
activation of Gt) and the in vivo evidence for the same photosensitive pigment co-
localized with Gtα, we conclude that the Spalax rod visual pigment is functional in 
vivo and uses the same photocascade as sighted animals.  
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Figure 7: Rhodopsin and Gtα localization in Spalax and mouse retina.   
Figures A&B display the retina morphology of Spalax and C57BL6 mouse using a HE-staining. 
Figures C&D and E&F display immunohistological analysis of Spalax and mouse retina incubated with 
the monoclonal anti-rhodopsin antibody 1D4 (C&D) and with the polyclonal anti-Gt antibody 
CERN9412 (E&F) respectively. Results identical to C&D were obtained with the polyclonal anti-
rhodopsin antibody CERN886 and to E&F with a monoclonal anti-Gtα antibody. 
RPE, retina pigment epithelium; OS, outer segments; IS, inner segments; ONL, outer nuclear layer; 
OPL, outer plexiform layer; INL, inner nuclear layer, IPL, inner plexiform layer; GCL, ganglion cell 
layer. Bar represents 60 µm for all panels. 
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2.4.1 A functional photopigment in a blind mammal: rudiment or mosaic 
reorganization ? 
Although visual pigments have been identified before in blind animals like the cave 
fish Astyanax (23) and crayfish (24), we here report the first extensive functional 
characterization of a visual pigment in a blind mammal. In other blind animals loss of 
sight seems to be accompanied by deficiencies in gene expression or pigment 
functionality (23-25). In contrast, the rod visual pigment of the blind mole-rat, we have 
cloned, is highly conserved and exhibits full functionality.  
A major question then is, why a blind mammal, in spite of mosaic reorganization of 
visual structures to an auditory function (1,3,5), has retained a fully functional visual 
pigment ? The subcutaneous location of the eye and the complete degeneration of 
the lens (2) already abolish any capacity of the retina to transfer image-information. 
In fact, all available evidence, based upon anatomical, electrophysiological and 
behavioral studies, convincingly shows, that the visual pathways in Spalax have 
almost fully regressed and do not retain any detectable function (1,3-5,7). Ocular 
regression to a subcutaneous embedded atrophic eye and degeneration of the visual 
system is a logical consequence of adaptation to a subterranean environment where 
visual cues are reduced. However, negative selection upon the neuronal components 
of the visual system was accompanied by positive selection pressures resulting in 
maintenance of retinal morphology and expansion of bilateral projections to the 
suprachiasmatic nucleus (SCN). This pathway is responsible for mediating circadian 
photoentrainment (1,4,5), and, similar to sighted mammals, removal of the eyes 
completely abolishes photoentrainment in Spalax. 
In sighted mammals there still is no agreement about which photopigments mediate 
photoregulation of the circadian system. Data obtained from mouse models like rd/rd 
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and rdta/rdta (9,26,27) suggest that neither rods nor cones are directly required for 
photoentrainment, but that the mouse retina contains a novel type of circadian photo-
receptor(s), not located in the photoreceptor layer. It has been demonstrated, that the 
mammalian retina contains novel types of photosensitive proteins which are not 
located in the photoreceptor cell layer but in the inner neuronal retina. One of the 
novel types of photopigments are the blue light receptors, Cry1 and Cry2 but from 
recent data it can be concluded that these proteins are components of the molecular 
clock rather than circadian photoreceptors (28-31). A novel opsin-based 
photopigment, melanopsin (32,33) is the most likely candidate for circadian 
photoreceptor and is expressed in the membrane of a specific type of retinal ganglion 
cells called the intrinsically photosensitive retinal ganglion cells (ipRGC). Mice with an 
ablation of melanopsin still entrain to photic stimuli but the magnitude of the 
responses to strong stimuli is reduced to 40% compared to wild type mice (30,34) 
indicating that melanopsin is involved but not solely responsible for the photic 
information that is received by the clock. Triple knock-out mice studies with an 
ablation of rods, cones and melanopsin entirely fail to entrain to light/dark cycles. 
Thus it can be concluded that the rod and/or cone pigments and melanopsin 
photopigments together seem to provide all of the photic input for the circadian 
system (35,36). The presence of melanopsin in the retinal ganglion cells of Spalax 
(37)  strongly suggests that  similar to sighted animals, melanopsin has a function in 
photoentrainment. However, the circadian system in sighted animals is not very 
photosensitive (38,39) and may not function properly in combination with a 
subterranean lifestyle.  We propose that Spalax did maintain a photoreceptor cell 
layer and functional visual photopigments basically to preserve circadian 
photoreception. In fact, in blind animals like Spalax, maintenance of visual 
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photoreceptors without any physiological importance would go with high metabolic 
costs and appear to contradict evolutionary laws (1). 
Considering such, admittedly circumstantial, evidence we propose that Spalax, in its 
adaptation to a blind subterranean life, has rewired its retinal circuitry to maintain 
circadian photoentrainment under conditions where light cues are sparse and of low 
intensity. In this view, extensive deprivation of light due to a subterranean ecotope 
and the subcutaneous location of the eyes have expanded mosaic reorganization in 
Spalax to divert the much more abundant and much more sensitive visual 
photoreceptor system from its original function and devote it fully to circadian 
photoentrainment. This demanded that the full integrity of the retinal morphology be 
maintained, but without the need for an optical focusing system (cornea, lens). Direct 
evidence for this hypothesis unfortunately is very hard to provide. The Spalax 
underground ecotope cannot very well be mimicked and animals do not breed very 
well in captivity. Hence, recombinant DNA technology that could lead to identification 
of circadian pigment(s) (e.g. mutagenic screens, gene targeting), is not currently 
available for Spalax. Determination of sufficiently accurate action spectra for the 
circadian photoresponses in Spalax to provide unequivocal evidence for the 
involvement of visual pigments is not a feasible task, either (6). 
However, another circumstantial argument can be put forward. The degenerate eye 
of Spalax shares several characteristics with the pineal organ of non-mammalian 
vertebrates. Both lack a focusing lens, are located subcutaneous and exhibit a much 
lower degree of organization of the outer segments of the photoreceptor cells, than 
observed for visual photoreceptors (38,40-42). The pineal photoreceptors also 
contain rod-like as well as cone-like photopigments (41,43) and have unequivocally 
been shown to function as photo-detectors mediating photoperiodic information in 
                                                                        58
Rod visual pigment in Spalax  
 
non-mammalian vertebrates (38,42,44,45) 
 
2.5 Conclusion. 
We present the first extensive characterization of a visual pigment cloned from a blind 
animal, the mole-rat Spalax ehrenbergi. In view of its high homology to rod pigments 
of sighted animals and the functional properties of the corresponding recombinant 
protein, this pigment represents the rod visual pigment of Spalax. We provide 
evidence, that the rod photoreceptor cell of Spalax, in spite of the strongly regressed 
state of the eye, still contains the primary elements required for a role as a functional 
photoreceptor. In view of the striking evolutionary conservation and the in vitro and in 
vivo functionality of the Spalax rod visual pigment we propose that, during evolu-
tionary adaptation to a predominantly subterranean lifestyle, the visual photoreceptor 
system in this blind mammal has been reprogrammed to play a major role in photo-
periodic entrainment. Extrapolating this to sighted animals, one could argue, that this 
might imply a role for the visual system in circadian photoentrainment in general. This 
is in line with recent studies of a triple knock-out mice of rods, cones and melanopsin 
(35,36), and might for instance explain, why early ablation of photoreceptors during 
retinal development changes the photosensitivity of the circadian system (27). 
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Spalax green cone pigment 
3.1 Summary. 
The degenerate subcutaneous eye of the blind mole rat belonging to the Spalax 
ehrenbergi superspecies has been shown to contain a long wavelength sensitive 
(LWS) cone pigment. Baculovirus expression of this LWS pigment and subsequent 
IMAC purification yields a photosensitive protein, that according to absorbance 
maximum (530 ± 2 nm), kinetics of late phototransitions, and transducin activation, 
has all characteristics of a functional green cone pigment. However, the evidence we 
present indicates that this Spalax LWS cone pigment has developed an 
unconventional spectral tuning mechanism. The absorbance spectrum of the Spalax 
pigment is strongly red-shifted relative to the very homologous mouse, rabbit and rat 
green cone pigments (508 –510 nm) and exhibits, in spite of the absence of a typical 
anion-binding site (Tyr instead of His at the critical position 197), a 12 nm blue-shift 
upon removal of chloride ions. The spectral properties of the Meta I 
photointermediate differ significantly from that of the human green cone pigment, 
also indicative for a novel spectral tuning variant in the Spalax pigment. The possible 
relevance of these findings for the evolutionary adaptation of Spalax to a 
subterranean ecotope is discussed. 
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3.2 Introduction. 
The blind mole rat, belonging to the Spalax ehrenbergi superspecies or Spalacids, is 
a unique rodent that spends most of its lifetime underground in total darkness. 
Spalacids exhibit natural degeneration of its visual system accompanying thirty 
million years of adaptation to a subterranean lifestyle (1). The eyes have been 
reduced to a very minute size (< 1mm) and are located in the hypertrophied 
Harderian gland, covered by skin and fur. The anterior eye segments, lens and 
cornea, start to degenerate early in development (2). The neuronal components of 
the visual system are regressed or completely absent (3-5). In contrast, bilateral 
projections from the retina to the suprachiasmatic nucleus (SCN) have been 
expanded in comparison to sighted rodents (3). Recently, two visual pigments, a 
green cone-like (6) and a rod-like (7), have been cloned from Spalax eye. All 
available evidence indicates that Spalax is visually blind, and that the corresponding 
photoreceptor cells cannot serve their original function in image formation. 
Nevertheless, the rod visual pigment was shown to be fully functional (7). The LWS 
(green cone-like) pigment was only spectrally characterized (6). Here we present an 
extensive biochemical characterization of the LWS pigment. The recombinant protein 
shows the characteristics of a functional cone pigment (photosensitive, rapid decay 
of Meta II, activation of the downstream effector transducin). However, its 
absorbance band (λ max: 530 ± 2 nm) is markedly red-shifted from the green cone 
pigments of other rodents (508-510 nm) and this shift cannot be fully explained by 
changes in critical amino acids. Even more surprisingly, removal of chloride ions 
results in a 12 nm blue shift, despite the absence of a typical LWS anion-binding site 
(see below). Spectral tuning in this Spalax LWS pigment seems to have developed 
novel features. 
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3.3  Experimental Procedures. 
3.3.1 Generation of recombinant baculovirus and production of recombinant 
protein. 
cDNA encoding the green sensitive cone pigment was isolated from Spalax eye 
(chromosomal  species 2n=60, Anza population, Samaria Mountains, Israel) as 
described (6). A sense primer with a BamHI overhang (5' cgc gga tcc agg gag agt gtc 
ttc cag a 3') and an antisense primer containing a BamHI overhang and a 10 x 
histidine tag (5' cgc gga tcc tta atg gtg atg gtg atg gtg atg gtg atg gtg tgc agg tga cac 
tga 3') were used to extend the cDNA by means of PCR. The cloned PCR product 
was sequenced single stranded to ascertain that no Taq polymerase errors had 
occurred. The PCR product was then ligated into the BamHI site of the baculovirus 
transfer plasmid pFastbacdual (Life Technologies) under transcriptional control of the 
polyhedrin promoter. The resulting transfer plasmid pFastbacdual-SGH (Spalax 
green his-tagged) was used to generate recombinant baculoviruses with help of the 
Bac-to-Bac system (Life Technologies), according to manufacturer’s instructions. A 
Spodoptera frugiperda derived cell line (IPLB-Sf9) served to amplify recombinant 
baculovirus and to express recombinant protein (8,9). The Sf9 cells were cultured as 
a monolayer in TNM-FH medium supplemented with 10% (v/v) fetal calf serum (Life 
Technologies), 50 U/ml penicillin and 50 μg/ml streptomycin (Life Technologies). For 
small scale production of recombinant protein the cells were grown in 250 ml spinner 
flasks (Bellco) using 100 ml protein-free Insect-Xpress medium (BioWhittaker) 
supplemented with 50 U/ml penicillin and 50 μg/ml streptomycin. For large scale 
production a bioreactor (Applikon) and volumes up to 5 liter were used. Cells were 
infected with recombinant baculovirus at mid-log phase (2-3.106 cells/ml) with a 
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multiplicity of infection (moi) of 0.1. The cells were harvested 4 days post infection 
(dpi). 
 
3.3.2 Regeneration of the recombinant green opsin into photosensitive 
pigment and purification.  
Infected Sf9 cells were harvested by centrifugation (10 min 1000xg at room 
temperature) and resuspended in buffer A (6 mM Pipes, 10 mM EDTA, pH 6.5) 
supplemented with 5 mM β-mercaptoethanol and 2 μg/ml leupeptin. 
The suspension was homogenized in a Potter-Elvehjem homogenizer, centrifuged 
(10 min, 40,000xg at 4°C), and the pellet was resuspended in buffer B (20 mM Pipes, 
130 mM NaCl, 10 mM KCl, 3 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 2 μg/ml 
leupeptin, pH 6.5) at a concentration equivalent to 1.108 cells/ml. The pigment was 
regenerated by incubation with its ligand, 11-cis retinal. All subsequent manipulations 
were performed in the dark or under dim deep red light (Schott RG650 long-pass 
filter). Approximately 10 nmoles of 11-cis retinal were dissolved in about 10 μl 
hexane for every 108 cells harvested. The hexane was evaporated in a stream of 
argon and the residue dissolved in an equal amount dimethylformamide (DMF) and 
added to the membrane suspension under thorough mixing. The mixture was 
incubated under continuous rotation during 30 min at room temperature, followed by 
1 h at 4°C. To solubilize the resulting pigment, CHAPS (3-[(3 cholamidopropyl)- 
dimethylammonio]-propanesulfonate, Anatrace) was added to a final concentration of 
1% w/v. After 1 h the suspension was centrifuged (30 min, 120,000xg at 4°C) and the 
supernatant carefully removed and diluted with an equal volume of buffer C (20 mM 
bis-Tris propane, 0.5 M NaCl, 20% glycerol v/v, 5 mM β-mercaptoethanol, 1 mM 
histidine, 2 μg/ml leupeptin, 1% n-dodecyl-β-1-D-maltoside (DoM; Anatrace), pH 7.0). 
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The pigment was purified by immobilized metal affinity chromatography (IMAC) over 
Ni2+ nitriloacetic acid (NTA) resin (Qiagen), using 0.6% (w/v) CHAPS as detergent as 
described before for the human green cone pigment (8). 
 
3.3.3 UV/VIS spectroscopy. 
Samples supplemented with hydroxylamine to a final concentration of 10 mM were 
measured on a Perkin Elmer Lambda 15 spectrophotometer with a thermostatted 
cuvette house (10°C). Spectra were taken before and after 3 min illumination with a 
75 W light bulb equipped with a 450 nm long-pass filter (Schott). Difference spectra 
were obtained by subtracting the dark spectrum from the spectrum taken after 
illumination. 
 
3.3.4 Anion Exchange.  
Purified SGH was applied to a  Sephadex G25 PD 10 column (Pharmacia) 
equilibrated with buffer D (20 mM Pipes, 140 mM NaNO3, 20% glycerol v/v, 1% 
CHAPS w/v, 2 μg/ml leupeptin, pH 6.5). The column was eluted with buffer D and 
fractions of approximately 1 ml were analyzed by UV/VIS spectroscopy. Fractions 
containing the SGH pigment were pooled and submitted a second time to the same 
procedure to ensure complete depletion of chloride ions. 
 
3.3.5 Reconstitution of the purified green pigment into proteoliposomes.  
An approximately 100 fold molar excess of bovine retina lipids (RL) in buffer E (20 
mM Pipes, 130 mM NaCl, 5 mM KCl, 2 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 2 
μg/ml leupeptin, pH 6.5) was added to reconstitute the purified pigment in a lipid 
membrane. Extraction of detergents DoM and CHAPS was accomplished by addition 
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of solid β and γ cyclodextrin in a final concentration of 5 mM and 20 mM (10). To 
isolate the proteoliposomes the mixture was applied to a sucrose step gradient (10% 
sucrose w/w containing 5 mM γ-cyclodextrin and 10%, 20% and 45% sucrose w/w in 
buffer E) and centrifuged for 16 h, 200,000xg at 4°C. The proteoliposome band 
containing reconstituted SGH was isolated from the 20-45% interface, diluted with 4 
volumes of buffer B, pelleted at 200,000xg for 30 min at 4°C and stored at -80°C in 
light-tight containers. The membrane samples were used to analyze the slow 
photocascade transitions and the Gt activation of the pigment.  
 
3.3.6 Analysis of slow photocascade transitions. 
These analyses were performed on approximately 0.5 nmole SGH in 0.5 ml 
proteoliposome suspension in the thermostatted cuvette house of a PE lambda 15 
spectrophotometer at 0, 4 and 10°C. Photolysis was initiated by a 10 s illumination 
with a 75 W light bulb using a 530 nm long-pass filter (GG530, Schott). 
Subsequently, spectra were recorded every 60 s up to ca 60 min.  
 
3.3.7 Transducin activation assay.  
Activation of the bovine rod G-protein transducin (Gt) by SGH was measured through 
the fluorescence enhancement of an intrinsic tryptophane residue in the α-subunit 
(Gtα) upon GTP binding (11). Reconstituted pigment samples were added at a final 
concentration of 5 nM under illumination to a stirred cuvette containing 100 nM 
bovine transducin, 100 mM NaCl, 2 mM MgCl2, 1 mM DTE, 0.01% DoM w/v, 20 mM 
Hepps, pH 7.4. A hypotonic extract of bovine rod outer segments served as a source 
for bovine transducin in this assay (12). The fluorescence of the sample was 
measured using a Shimadzu RF-5301-PC spectrofluorometer with excitation at 295 
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nm and emission at 337 nm. The emission intensity was allowed to stabilize for about 
200 s and then GTPγS (guanosine 5’-O-3’ thiotriphosphate; Boehringer) was added 
to a final concentration of 2.5 μM. The subsequent increase in relative fluorescence 
intensity represents pigment triggered activation of Gt involving GDP/GTP exchange. 
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3.4 Results and Discussion.  
3.4.1 Functional properties of the Spalax green cone pigment. 
The Spalax green cone photopigment extended with a 10x his-tag was expressed in 
Sf9 infected cells using a recombinant baculovirus. The recombinant protein was 
regenerated with 11-cis retinal into a photosensitive pigment and purified by means 
of immobilized metal affinity chromatography (IMAC). The purified pigment displays a 
maximum absorbance at 530 ± 2 nm (n=18) and an A280/A530 ratio of 3.3 (Figure 1).  
This λ max is slightly blue-shifted from that previously reported (534 ± 3 nm) which was 
based on partially purified pigment (6).  
                 
 
Figure 1: UV/VIS absorbance spectrum of purified reconstituted Spalax green cone pigment. Inset 
shows a difference spectrum, which has been obtained by subtracting the spectrum obtained after 
illumination from the dark spectrum. Illumination was performed in the presence of 10 mM 
hydroxylamine, which generates the all-trans retinoxime with an absorbance maximum of 365 nm. 
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This difference is not significant, however, and does not effect conclusions drawn in 
earlier papers (6,13). The A280/A530 ratio is indicative for the purity of the pigment and 
the value of 3.3 is in the same range as those reported before for LSW 
photopigments and indicates an at least 80% pure pigment (8). This has been 
confirmed by SDS/PAGE and Western blotting (not shown). The signaling activity of 
the recombinant pigment was measured in a transducin (Gt) activation assay and 
compared with that of bovine rhodopsin and the human green cone pigment. Very 
similar initial activation rates were observed for the Spalax and the human green 
cone pigment (Figure 2).  
          
Figure 2: Activation of the bovine rod G-protein transducin by recombinant Spalax and human green 
cone pigments and recombinant bovine rod rhodopsin. The increase in intrinsic tryptophan 
fluorescence of the G-protein transducin α subunit upon GTP binding was used to monitor activation 
by recombinant his-tagged bovine rhodopsin (trace 1) and recombinant his-tagged human (trace 2) 
and Spalax (trace 3) green cone pigment. Negative controls are presented by the activation rate with 
recombinant his-tagged bovine opsin (trace 4) or without any proteins added (trace 5). 
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This indicates that the Spalax green cone pigment can activate this downstream 
effector to the same extent as its counterpart in a sighted mammal. The lower activity 
of these cone pigments relative to the bovine rod pigment rhodopsin is to be 
expected since the rod transducin has a lower affinity for cone pigments and the 
active state, Meta II, decays about 10 fold faster in cone pigments than in bovine 
rhodopsin (see below and (8)). We conclude, that the Spalax green cone pigment 
behaves like a fully functional cone pigment. 
 
3.4.2 Spectral tuning in LWS visual pigments.  
Spectral tuning of the visual system is an evolutionary adaptation to a particular 
habitat and lifestyle. Animals have adapted to diverse photic environments by 
modifying their photoreceptor elements in order to maximize sensitivities to a 
desirable spectral range of light. This can be accomplished on a morphological level 
by altering the position of the rods and cones (14) or by changing the rod-cone ratio 
in the retina (15,16) or on a ligand level by using modified chromophores like 11-cis-
3-hydroxyretinal (insects) (17) or 11-cis-3,4-dehydroretinal (certain fish, amphibians 
and reptilians) (18;19) instead of the more commonly used 11-cis retinal (mammals).  
The subtlest approach to alter the spectral properties of a photopigment is by 
changing certain amino acids at critical sites. There are two ways, in which amino 
acid substitutions are thought to regulate the spectral properties. On the one hand, 
substitutions may affect the energy levels of the ground and excited state of the 
chromophore by a direct electrostatic interaction. On the other hand they may 
execute an indirect effect by changing the tertiary structure of the chromophore 
binding pocket, thereby altering the interaction of the chromophore with its 
microenvironment.  
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To elucidate the mechanisms underlying spectral tuning of LWS photopigments, 
physiological and electrophysiological studies in combination with molecular 
characterization (20) and site directed mutagenesis studies have been conducted 
(21,22). These results show that amino acid substitutions at five critical sites 
determine the difference in absorbance of red and green LWS pigments: S180A 
(SÆA at position 180 using the amino acid numbering of the human LWS pigment), 
H197Y, Y277F, T285A and A308S (the `five site rule´). The substitutions as indicated 
blue-shift the λ max value in an additive manner with approximately 7, 28, 7, 15 and 16 
nm (23). All discrepancies between experimental and calculated λmax values can be 
traced to methodological variation except for the dolphin (Tursiops truncatus) LWS 
pigment (24). The maximum absorbance of the dolphin LWS protein is 524 nm which 
is 13 nm blue-shifted compared to its predicted λ max (Table1). Mutagenesis  studies 
reveal that the reverse amino acid substitution S308A in the dolphin LWS cone 
pigment results in a 28 nm red-shift (25) instead of the 16 nm expected according to 
the ‘five-site rule’. This suggests that that the dolphin LWS pigment still abide by the 
‘five-site rule’ but that it has altered the importance of the amino acid at position 308 
in its spectral tuning mechanism. This has resulted in a more extensive blue shift, 
possibly necessary for this mammal to adapt to its aquatic environment. In spite of 
this exception, the `five site rule´ still provides the most general molecular 
mechanism to account for the spectral variation in LWS photopigments.  
With the human red cone pigment the Spalax green cone pigment shares three of the 
five amino acids important in spectral tuning (Y277, T285 and A308) but differs at 
positions 180 and 197 (S180A and H197Y). This would predict a 7 and a 28 nm blue 
shift respectively (23) compared to the human LWS pigment and therefore in a λmax of 
525 nm (Table I).  
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λmax     Position 
            Measured #      Predicted *          180   197   277   285   308 
Human Red   560  560   S      H      Y       T      A 
Goldfish Red   559  560  S      H      Y       T      A 
Cat Red   553  553  A      H      Y       T      A 
Dog Red   555  553  A      H      Y       T      A 
Goat Red   553  553  A      H      Y       T      A 
Horse Red   545  546  A      H      F       T      A  
Human Green  530  531  A      H      F       A      A  
Dolphin Green  524  537  A      H      Y       T      S 
Deer Green   531  531  A      H      F       A      A  
Guinea pig Green  516   517  S      Y      Y       A      A 
Squirrel Green  532  532  S      Y      Y       T      A 
Rabbit Green      509  509  A      Y      Y       T      S 
Mouse Green  508  509  A      Y      Y       T      S 
Rat Green   509  509  A      Y      Y       T      S 
Spalax Green   530  525  A      Y      Y       T      A 
 
Table I: The amino acid composition of mammalian red and green LWS pigments at the five sites most 
relevant for spectral tuning. The amino acid substitutions, S180A, H197Y, Y277F, T285A and A308S 
blue shift the absorbance of LWS pigments by about 7, 28, 7, 15 and 16 nm respectively (23). In  
almost all pigments the predicted λmax was verified by means of heterologous expression studies  
(measured λmax). The pigments where the predicted λmax significantly deviates from the measured λmax  
are printed in bold. 
#  recombinant pigments;  * ‘five-site rule’  
 
The predicted λmax deviates from our recombinant data by approximately 5 nm. 
Although this discrepancy is not very large it is significantly more than observed for 
most of the other mammalian LWS pigments (1 à 2 nm, Table I). Only the dolphin 
LWS pigment exhibits an even larger deviation (24). To explain the 30 nm shift 
between human red and green pigment, minor contributions from other amino acids 
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substitutions like S116Y, I230T, A233S and Y309F are assumed (21). Spalax 
contains two of these four amino acid substitutions (S116Y and A233S) (13) which 
could effectuate a small red shift. However, the subsequent evidence we present 
below, indicates that an additional spectral tuning mechanism is involved.  
 
3.4.3 Spectral tuning involving anion binding. 
The spectral properties of many LWS pigments have been shown to be influenced by 
binding of anions like chloride to a specific site (26). The binding of anions like 
chloride or bromide usually shifts the absorbance band to longer wavelengths (red-
shift) and nitrate and thiocyanate usually effectuate a blue-shift, and fluoride and 
sulfate display very little effect (26). However, since chloride is the ion to bind under 
physiological conditions, this site is usually referred to as the chloride binding site. 
Studies using site-directed mutagenesis studies have established that two positively 
charged amino acids, H197 and K200 (using the LWS pigment numbering), are the 
major determinants of this anion binding site (26). This is consistent with the 
observation that pigments, in which H197 has been changed to a tyrosine (H197Y), 
like the rod pigments and the mouse green cone pigment (Table I), do not show a 
spectral change upon chloride replacement (22). Similar to other rodents, Spalax 
also carries the H197Y substitution, and hence lacks the typical anion binding site 
(Table I). Nevertheless, in view of the discrepancy with the ‘five-site rule’, we tested 
the effect of chloride-depletion. Surprisingly, the Spalax green cone pigment displays 
a significant blue shift of 12 nm upon substitution of chloride for nitrate (Figure 3). 
The absorbance maximum shifts to about 518 nm, and this shift is reversed upon 
repletion with chloride ions.  
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Figure 3: Difference spectra of the Spalax green cone pigment under chloride-saturated and nitrate-
saturated conditions. Difference spectra were obtained by subtracting spectra after illumination from 
the ‘dark’ spectrum. The Spalax green cone pigment recorded under chloride-saturated displays a λmax 
of 530 ± 2 nm and displays under nitrate-saturated conditions a λmax of 518 ±  3 nm. The 
corresponding  blue shift of 12 ± 2 nm is reproducibly observed (n=3). The difference spectra were 
obtained under identical conditions as in figure 1. Spectra were normalized to the same OD at the 
positive maximum. 
 
The stability of the chloride-depleted pigment is quite low however in the detergent-
solubilized state, and we were not able to obtain a reliable estimate for the chloride 
affinity constant by means of titration experiments. This blue shift of 12 nm upon 
chloride-nitrate exchange is smaller than that observed for the human green pigment 
(19-25 nm; (8,26)). The presence of a tyrosine residue at position 197 in the Spalax 
green cone pigment was confirmed at the genome level. Hence, the available 
evidence suggests that Spalax has a chloride binding site different from the one 
described for the other mammalian LWS pigments. The substitution H197Y indicates 
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that Spalax, as a rodent, first lost the classical anion binding site like other rodents, 
but that adaptation to a subterranean habitat imposed a red-shift back to longer 
wavelengths. Since only a small repertoire of tuning sites seems to have evolved 
(13,23) the reverse substitution Y197H would have seemed most logical. Why this 
was not selected is a matter of speculation. According to the ‘five-site rule’ this would 
red shift the λmax as far as 546 nm, which could be unfavorable (13). Instead Spalax 
developed an alternative anion binding mechanism. It should be noted that in the 
absence of chloride, the absorbance maximum is at 518 nm, i.e. significantly lower 
than the 525 nm predicted by the ‘five-site rule’. Clearly, other sites must be involved 
in spectral tuning of the Spalax green cone pigment as well. This is also suggested 
by the significant anion-independent red shift of the Meta I intermediate relative to 
that of the human green pigment (see below). Comparison of the Spalax and the 
mouse green cone pigment sequence yields differences at only 34 positions (13). 
None of these substitutions results in an acquisition of a positively charged protein 
residue in the Spalax pigment. Hence, there is no obvious candidate site for a novel 
anion binding location. Possibly, certain amino acid substitutions serve to generate a 
binding site involving K200 that induces a smaller red shift than the classical one. To 
establish which residues are essential for this anion binding generating 
mouse/Spalax green cone hybrid pigments and performing site directed mutagenesis 
of the Spalax LWS pigment would be an option. 
 
3.4.4 Characteristics of photointermediate states. 
The slow photocascade transitions of the reconstituted Spalax green cone pigment 
(Meta I ÆMeta IIÆMeta III) were analyzed at 0, 4 and 10°C and compared to the 
human green cone pigment (8). The suspension was illuminated for 10 s and spectra 
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were recorded at regular time intervals of 60 s (Figure 4). Illumination results in a loss 
of the original pigment absorbance and an increase in absorbance below 440 nm 
(Figure 4).  
                  
Figure 4: Slow photoreactions of the purified and reconstituted Spalax green cone pigment at 0°C. 
Spectra were measured before illumination (curve 1) and at regular time intervals of 1 minute after 
illumination (curve 2Æ60). Evident is the ‘bleaching’ of the pigment and formation and decay of slow 
photointermediates.  
 
The spectral changes following illumination (spectrum 1Æ2) are better resolved in 
difference spectra. Subtraction of the dark spectrum (curve1) from the first spectrum 
after illumination (curve 2) clearly shows the transition of the Spalax (left panel) and 
human (right panel) green cone pigment to their Meta II (Meta-rhodopsin II) 
photointermediate state at 375 ± 3 nm (Figure 5). By subtracting the first spectrum 
after illumination from the last spectrum the subsequent slow photocascade 
transitions become apparent. In the human green cone pigment these changes are 
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dominated by the decay of Meta II and formation of Meta III (440 ± 3 nm) (8,27,28). 
Remarkably, however the Spalax green cone pigment displays significant amounts of 
the Meta I photointermediate (508 ± 5 nm) at 0 and 4°C (Figure 5).  
            
Figure 5: Difference spectra showing the slow photocascade transitions Meta I Æ Meta II Æ Meta III of 
the Spalax and human green cone pigment at 0, 4 and 10°C. Difference spectra (2-1) were obtained 
by subtracting the spectrum before illumination from the first spectrum after illumination and show the 
transition from the pigment into mainly Meta II (375 nm). The other difference spectra (60-2) were 
obtained by subtracting the first spectrum after illumination from the last spectrum and show the decay 
of Meta II (375 nm) and the formation of Meta III (440 nm). At 0 and 4°C this spectrum for Spalax 
clearly displays a Meta I photointermediate at 508 nm whereas no significant amount of Meta I is 
observed for the human green pigment.  
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The decay of Spalax green Meta I and Meta II could be fitted with first order kinetics. 
The decay rate of human and Spalax green Meta II are comparable (Table II) and in 
the range typical for cone pigments (8). The Meta I component in the Spalax green 
photocascade has a half life at 0°C of 5 ± 2 min i.e. in the same range as the decay 
of Meta II and several orders of magnitude slower than the decay of Meta I reported 
for other cone pigments (27,28). This slow decay pertains to only part of the 
illuminated pigment and this fraction becomes much smaller at higher temperature, 
disappearing at 10°C. Therefore, we assign this to a temperature-dependent Meta I 
<->Meta II equilibrium. The Meta I fraction in this equilibrium will decay with about the 
same rate as the Meta II -fraction, since the latter decay now is rate determining for 
the Meta I -fraction as well. This assumes for simplicity that the green pigment 
photocascade contains a single Meta I -> Meta II pathway; in any case, a pH 
dependence, that complicates this transition in rod pigments (29,30), has not been 
detected in cone pigments yet (8,27). Since the human green cone pigment does not 
generate a significant fraction of Meta I even at 0°C, the temperature dependence of 
the Meta I <–>Meta II equilibrium must be quite different for these two green 
pigments.  
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        Human                                       Spalax 
Cl-                   NO3 -            Cl-                 NO3 -
λmax 
          Pigment    527 ± 2 nm        508 ± 2 nm        530 ± 2 nm        518 ± 3 nm 
          Meta I     490 ± 2 nm        463 ± 5 nm        508 ± 5 nm        508 ± 5 nm 
          Meta II              375 ± 3 nm        376 ± 3 nm        375 ± 3 nm        375 ± 3 nm 
          Meta III             440 ± 3 nm        437 ± 3 nm        440 ± 3 nm        440 ± 3 nm 
  
t ½ 
          Meta II §    3.5 ± 0.7 min            nd                4.7 ± 0.5 min          nd 
  
 
Table II: Characteristics of the Spalax and human green cone pigment and 
corresponding photointermediates. The data present the absorbance maximum, with its anion 
dependence, as well as the half-life of the Meta II intermediate. The number of experiments varies 
between 3 and 5. All data were obtained at 10°C. 
nd = not determined. 
 
Another interesting difference between the Spalax and human green cone pigment 
pertains the λmax of the Meta I intermediate (Table II). While the Meta I intermediate 
of the human pigment has a λmax of 490 nm, that is anion-dependent (8) as has also 
been observed for the chicken cone pigment (31), the Meta I intermediate of the 
Spalax pigment displays an anion-independent λmax of 508 nm. We take this as 
independent support for our conclusion that Spalax green has developed novel 
spectral tuning mechanisms, including an altered anion binding mechanism. The 
latter affects the λmax of the pigment, but in contrast to human green, has no effect on 
the spectral properties of the Meta I photointermediate. This could indicate, that the 
anion binding site in Spalax is a modification of the classical site and the 
conformational changes accompanying Meta I formation strongly reduce its affinity 
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for chloride ions (31). On the other hand, the anion site in Spalax green might be 
located in another part of the protein and the conformational changes leading to Meta 
I remove it away from the chromophore. Structural analysis of the conformational 
changes that occur in these pigments after illumination by means of FT-IR 
spectroscopy might elucidate some of these aspects. 
The Meta II and Meta III photointermediates of Spalax display spectral properties 
similar to those of human green (Table II) as well as other cone pigments (28,32) 
indicating that spectral tuning mechanisms are no longer effective at this stage. 
 
3.5 Conclusion. 
We present the first extensive characterization of a cone visual pigment of a blind 
animal. The green cone visual pigment of the blind mole rat Spalax ehrenbergi has 
all characteristics of a functional cone pigment. Remarkably however, it has 
developed some novel features in spectral tuning, in order to red shift its absorbance 
band. The ‘five-site rule’ does not fully apply and another mechanism to induce a 
chloride-dependent red shift is operative. In addition, the Meta I photointermediate is 
quite red-shifted relative to that of other visual pigments. The fact, that Spalax has 
put in so much effort to red shift its green pigment suggests that this pigment should 
still have a physiological function. Due to the degenerate nature of the Spalax eye 
and the regression of the entire visual system, it seems highly unlikely that the 
photoreceptor cells still serve to produce a visual image. Rather, considering that the 
circadian physiology of Spalax is still under photo-control, we assume, as we have 
argued in detail before (6,7,13), that the visual photoreceptors have been adapted to 
a major function in circadian photoregulation (Chapter 2). Remains the intriguing 
question, why Spalax in this evolutionary adaptation process needed to red shift its 
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green cone pigment. One option, discussed elsewhere (13), is that it had to 
compensate for the subcutaneous regression of the eyes and the concomitant light-
filter effect of the tissue surrounding the eye. Evidently, however, much more study is 
required to understand the remarkable photobiology of this blind mammal. 
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4.1 Summary. 
Retinal degeneration is not only the end result of a large variety of mutations within 
the rhodopsin gene, but can also be caused by overexpression as well as complete 
disruption of the gene. This indicates that rhodopsin expression levels play a critical 
role in the maintenance of the structural integrity of the photoreceptor. As a means to 
study the physiological role of rhodopsin in the morphology of the retina and the 
mechanisms underlying photoreceptor cell death, we have generated a bovine 
rhodopsin knock-in (KI) mouse model and compared the retinal consequences in 
these mice with those of rhodopsin deficient (KO/KO) and wild type control mice. 
Homozygous knock-in (KI/KI) mice produce only 10-15% functional rhodopsin 
compared to wild type animals. Opsin levels in KI/KI mice remain constant until 4 
months of age, after which they decrease to some 3% at 6 months of age. In 
contrast, in KO/KO mice photoreceptor cell degeneration proceeds much faster, 
nearing completion around 3 months of age. We conclude that low levels of bovine 
rhodopsin cannot fully rescue, but do considerably delay the photoreceptor cell 
degeneration phenotype observed in rhodopsin deficient mice. 
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4.2 Introduction.  
Retinitis pigmentosa (RP) is the most common hereditary retinal dystrophy with a 
prevalence of approximately 1/4000. RP patients experience night blindness followed 
by a progressive loss of vision. This is caused by the gradual death of the rod 
photoreceptor cells, which ultimately leads to impairment and death of the cone 
photoreceptors as well. Mutations in the rhodopsin gene, coding for the visual 
pigment of the rod photoreceptors, account for approximately 10% of all inherited 
human retinal dystrophies. Nowadays, almost 100 different mutations in the human 
rhodopsin gene causing retina degeneration have been identified (1). However, the 
mechanisms by which these mutations lead to photoreceptor cell death are not very 
well understood. Therefore, studies to reveal the pathways of retinal degeneration 
have focused mainly on natural and transgenic mouse models. 
Natural mouse models like retinal degeneration (rd/rd) and retinal degeneration slow 
(rds/rds) display a retinal degeneration phenotype, which is not caused by mutations 
in the visual pigment rhodopsin itself. In rd/rd mice the cause of degeneration is a 
defective downstream effector protein of the rhodopsin signal transduction 
machinery, the β subunit of cGMP phosphodiesterase (β-PDE) (2,3). The underlying 
mechanism causing photoreceptor cell death is believed to be metabolic overload 
due to elevated cGMP levels, resulting in an excessive influx of Na+ and Ca2+ through 
cGMP-gated cation channels. Subsequently, increased intracellular Ca2+ levels can 
stimulate apoptosis (4). After identification of the defective gene in rd/rd mice also 
mutations in the human PDE6B gene which cause recessive retinitis pigmentosa 
(RP) or dominant congenital stationary night blindness (CSNB) have been identified 
in several families (5,6).  In rds/rds mice degeneration is caused by a defective 
RDS/peripherin gene, which is believed to play an important role in stabilizing the 
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sharp membrane folds at the edges of the outer segment discs. The lack of 
peripherin disrupts proper membrane folding and therefore also proper disc 
formation. Thus, the degeneration in rds/rds mice is not due to metabolic overload as 
in rd/rd mice but most likely to faulty disk morphogenesis (7,8). Following 
identification of the defect in rds/rds mice, mutations in the RDS gene were also 
found in humans where they result in autosomal retinitis pigmentosa (adRP) (9-11) 
and dominant macular dystrophies (12,13). 
In addition, designer animal models like knock-out and transgenic mice have been 
generated in which respectively disruption (14,15) or overexpression (16) of the 
rhodopsin gene also results in retina degeneration. The underlying mechanism 
causing rod photoreceptor cell death in these mice is most likely also impaired disc 
morphogenesis as reflected by misrouting of disc components and subsequent 
disrupted outer segment formation (17). This indicates that both rhodopsin 
expression levels and mutations have direct bearing on photoreceptor cell 
homeostasis (18-21). In classical transgenic mice expressing rhodopsin variants, the 
severity of degeneration that is observed is therefore not only caused by the mutation 
introduced but also by gene dosage effects. To separate these contributions an 
alternative strategy is required. One strategy would be to produce mice with a null 
background and crossbreed the transgenic mice with this model to obtain more 
appropriate mutant rhodopsin expression levels. However, this strategy critically 
depends on the availability of transgenic mice that display an expression level of the 
mutant rhodopsin that is very close to that of the endogenous protein (22,23).  
We therefore plan to study the role of rhodopsin in normal retinal morphology and in 
the pathogenesis of retina degeneration using an alternative strategy that consists of 
the generation of targeted knock-in mouse models in which the mouse opsin gene is 
 88
Generation of a knock-in mouse model 
replaced by mutant rhodopsin cDNAs. Here we describe the generation and initial 
characterization of a mutant mouse strain in which the rhodopsin gene has been 
replaced by a bicistronic DNA construct containing the wild type bovine rhodopsin 
open reading frame followed by an internal ribosomal entry site (IRES) and the β-
galactosidase coding sequence from the LacZ gene as a marker. However, when 
analyzed for opsin and β-galactosidase content the homozygous knock-in (KI/KI) 
mice were found to produce only 10-15% of the expected, wild type rhodopsin levels 
during the first 4 months of age. At 6 months of age opsin levels have even 
decreased to 3% of normal, in line with progressive rod photoreceptor cell 
degeneration and supporting the notion that rod photoreceptor integrity strongly 
depends on the expression level of rhodopsin. 
 
4.3 Experimental Procedures. 
4.3.1 Construction of the targeting vector. 
An EcoRI fragment of the bovine rhodopsin cDNA (24) was used as a probe to 
isolate a genomic clone from a mouse strain 129 cosmid library (Figure 1). A ±11 kbp 
BamHI fragment containing the rhodopsin gene was subcloned into the pBluescript II 
SK(+) vector . Also an overlapping ± 10 kbp HindIII fragment, consisting of a ± 7 kbp 
genomic segment containing exons 2-5 and 3’ flanking sequences and a ± 3 kbp 
cosmid vector part, was subcloned into pBluescript II SK(+). A 3.5 kbp KpnI/XhoI 
fragment was excised from the BamHI subclone and used as 5’ homology region in 
the targeting construct. The XhoI site is located approximately 15 bp upstream of the 
transcription initiation site. A similar-sized EcoRI/SphI fragment was obtained from 
the HindIII subclone and served as 3’ homology region. In between these fragments 
a 3 kbp loxP-flanked Neo/HSV-tk cassette (courtesy of Dr P.Krimpenfort, Amsterdam, 
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The Netherlands) was cloned using pBluescript II SK(+) as cloning vector. The entire 
coding region of the rhodopsin gene was replaced by a rabbit β-globin intron II, a 
bovine rhodopsin cDNA, IRES (internal ribosome entry site) and a lacZ reporter 
respectively (Figure 1). The rabbit β-globin intron II was obtained from pSG5 
(Stratagene) using PCR and primers β-GLO-F (5’-ATA-CTC-GAG-GAT-CCT-GAG-
AAC-TTC-3’) and β-GLO-R (5’-ATA-GTC-GAC-TGC-CAA-AAT-GAT-GAT-GAG-A-3’)  
with a XhoI and SalI restriction site respectively. The bovine rhodopsin cDNA was 
cloned as a BamHI fragment in the BglII site of pGT1.8IRESβgeo kindly provided by 
dr. Mountford (25). A SstI fragment containing the bovine rhodopsin cDNA, the IRES 
and partial sequence of the lacZ reporter was excised from pGT1.8IRESβgeo. The 
remaining 3’ part of the lacZ reporter was taken as a SstI/BamHI fragment from pSV-
β-galactosidase (Promega). Both parts were cloned in a pGEM-4 plasmid (Promega) 
in which the EcoRI site has been replaced for a XhoI site and in which the XhoI – SalI 
PCR product from the rabbit β-globin intron II was already cloned. The insert 
containing the rabbit β-globin intron II, the bovine rhodopsin cDNA, the IRES and the 
complete lacZ reporter was excised as a XhoI-SalI fragment and cloned into the XhoI 
site  which is located 15 bp upstream of the transcription initiation site of a  
pBluescript SK(+) vector containing the 5’ flanking region, the loxP-flanked Neo/HSV-
tk cassette and the 3’ flanking region. If splicing would occur as expected the 
transcription initiation site is located in the bovine rhodopsin cDNA. The sequence of 
the bovine rhodopsin cDNA, loxP sites and the splice donor and acceptor sites of the 
rabbit β-globin intron II were verified by sequence analysis. Every subsequent cloning 
step was checked by means of comprehensive restriction analysis. 
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4.3.2 Tissue culture and electroporation. 
E14 ES cells were cultured on irradiated SNLH9 feeder cells (STO cells stably 
transfected with Neomycin phosphotransferase, Leukemia inhibitory factor and 
Hygromycin phosphotransferase expression constructs) (26) in high-glucose 
Dulbecco´s Modified Eagle Medium (DMEM, Life Technologies) supplemented with 
15% fetal calf serum, 2 mM L-glutamine, 110 mg/L  sodiumpyruvate and 14.3 µM  
β-mercaptoethanol. ES cells were transfected by electroporation (26) using targeting 
vector DNA that had been linearized with SalI. For each electroporation, 8x106 cells 
were harvested by trypsinization, washed twice with PBS, and resuspended in 200 μl 
PBS. 4.5 μg of linearized DNA was added and electroporation was performed on a 
Biorad Gene Pulser using a voltage setting of 0.25 kV and a capacitance of 500 μF.  
Cells were reseeded onto feeder layers and allowed to recover in normal medium for 
24 hours, after which the positive selection was started with medium containing 0.3 
mg/ml G418 (Life Technologies) to enrich for stably transfected clones. After 8 days 
of selection, individual clones were picked, trypsinized and transferred to 96 well 
plates coated with irradiated feeder cells, and cultured under selective conditions until 
the wells were 70% confluent. Approximately ¾ of the cells from a well was frozen in 
medium containing 10% DMSO and kept for further use in liquid nitrogen. The 
remaining quarter was transferred to gelatin-coated 96 well plates, cultured until 
confluency and used to extract DNA for southern blot analysis. Cells were washed 
two times with PBS and incubated over night at 60°C  using a lysis buffer containing 
10 mM Tris pH 7.5, 10 mM EDTA, 10 mM NaCl, 0.5% SDS and 1 mg/ml proteinase 
K. DNA was precipitated with ice cold ethanol and 0.75 M NaCl and washed 3 times 
with 70% ethanol before used for restriction enzym digestion. 
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4.3.3 Southern blot analysis. 
DNA from the ES cell clones was resuspended in a total volume of 40 μl containing  
digestion buffer, 1 mM spermidine, 100 μg/ml BSA, 50 μg/ml RNase and 10 U of 
restriction enzyme per well and incubated overnight at 37°C.  At first a BamHI digest 
was performed and the digested DNA was run overnight on a 0.5% agarose gel. 
According to standard procedures the DNA was blotted overnight (27) onto Hybond-
N nylon membrane (Amersham) using 20x SCC as transfer buffer.  An approximately 
900 bp BamHI/KpnI fragment, isolated from the previously described 11 kbp BamHI 
genomic subclone, was used as a 5’ flanking probe to analyze the obtained ES 
clones. Likewise, an approximately 650 bp SphI/SalI fragment, obtained from the 
HindIII genomic subclone, was exploited as 3’ flanking probe to check on proper 
homologous recombination of 5’ positive ES clones digested with HindIII. Probes 
were labeled with α32P-dCTP using the random primer labeling method (27) and 
purified on a Sephadex G50 colomn. Hybridisation was according to Church and 
Gilbert  (28) and washing were performed with 2XSCC/0.1% SDS at 65°C depending 
on signal to noise ratios as judged with a monitor. Exposure of photographic film 
(Kodac) using two screens was at least overnight at -70°C.  
 
4.3.4 Karyotype analysis. 
Cells were cultured in 6 well plates until they were 80% confluent. Colcemid  (Serva 
Electrophoresis) was added to the culture medium at a final concentration of 20 μg/ml 
and the cells were incubated for 2 hours at 37°C.  After trypsinization the cells were 
incubated for 10 minutes with 3 ml pre-warmed 0.075 M KCl at 37°C. Then 3 drops of 
fixative (3:1 methanol/acetic acid) was added and the cells were pelleted.  After at 
least 2 washings with fixative the cells were resuspended in 10 drops of fixative. Two 
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drops of cells were spotted from a 20-30 cm distance onto a cold coverslip de-fatted 
in alcohol. The metaphase chromosomes were stained in 10% Giemsa solution in 
0.014 M phosphate buffer, pH 7.0. Approximately 25 metaphase spreads were 
microscopically examined for the presence of 40 chromosomes.  
 
4.3.5 Excision of the selection cassette by Cre expression. 
Individual ES clones were cultured and transiently transfected with vector pOG231, 
containing the coding sequence of the Cre recombinase under the control of a CMV 
promoter (generously provided by Dr. P Groenen, Department of Cell Biology, 
Nijmegen). Electroporation settings were as described above with the exception that 
now 3.5x106 cells and 1 μg of circular DNA in 200 μl PBS were used. After 48 hours 
of recuperation the cells were trypsinized and reseeded onto feeder cells at a density 
of  105 cells/60 cm2 plate. On day five after transfection 0.2 mM FIAU (1-[2-deoxy, 2-
fluoro-β-D-arabinofuranosyl] was added to the medium to select for excision of HSV-
TK selection cassette. After 3 to 4 days of selection approximately 50 subclones per 
transfected ES clone were picked, expanded, frozen in liquid nitrogen, and used for 
DNA extraction as described above (4.3.2). For Southern blot analysis a genomic 
300 bp PstI/BamHI probe just downstream of the mouse rhodopsin gene (Figure 1) 
was used. Clones in which the selection cassette had been properly excised were 
subjected to karyotype analysis as described above (4.3.4). 
 
4.3.6 Generation of chimaeric mice. 
ES cell lines were microinjected into C57BL/6 blastocysts, which after recovery were 
reimplanted into pseudopregnant CBA foster females. Chimaeric male offspring was 
mated with C57BL/6 females to test for the generation of ES cell-derived offspring on 
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the basis of the dominant agouti coat color. Agouti offspring that were tested 
heterozygous for the targeted allele, were then used in breeding programs with 
C57BL/6 animals to establish the transgenic line. Their heterozygous offspring were 
used to generate mice of all three genotypes. For biochemical studies mice were 
sacrificed by gentle suffocation with CO2  followed by cervical dislocation to ensure 
that the mice will not recover consciousness. Eyes were collected under deep red 
light (Schott R630 longpass filter) and directly used for analysis or kept at –80°C in 
light-tight containers. 
 
4.3.7 Genotype assignment. 
Genotyping of mutant offspring was done by PCR. Since bovine and mouse opsin 
are highly homologous (~90%) it is impossible to generate a bovine or murine 
specific primer set. Forward primer OPS-F5 (5’-CTG-AGC-TCG-CCA-GGC-AGC-CT-
3’) in the 5’ UTR of the opsin gene and reverse primer OPS-R5 (5’-GTT-GAG-CAG-
GAT-GTA-GTT-GAG-G-3’) in exon I of bovine  and mouse opsin were used in the 
PCR reaction. The expected PCR products are 250 bp for the wild type allele and 
750 bp for the mutant allele. The smaller wild type allele is preferably amplified 
compared to the larger knock-in allele. Therefore we used besides the OPS-R5 
primer a second reverse primer, the rabbit β-globin intron II (β-glo-R; 5’-ATA-GTC-
GAC-TGC-CAA-AAT-GAT-GAG-A-3’) in combination with the described forward 
primer. The latter should generate a PCR product of approximately 600 bp in the 
targeted allele only (Figure 2).  
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Figure 2: Schematic representation of the primer location in the wild type (A)  
and the targeted allele (B).  
 
The DNA used in the reaction was extracted from ± 0.5 cm mouse-tails. The tails 
were put in a mix of 50 mM Tris/HCl pH 8.0, 100 mM EDTA, 0.5% SDS and 500 
μg/ml proteinase K and dissolved overnight at 55°C. After at least two 
phenol/chloroform extractions the DNA was precipitated and washed with 70% 
alcohol according to standard procedures. The pellet was dissolved in 100 μl 10 mM 
Tris/HCl pH 8.0 and heated approximately 10 min at 65°C. In the PCR reaction, 1 μl 
of DNA together with 0.6-0.8 μM of each primer, 400 μM of each dNTP and 2.0 mM 
MgCl2 in a reaction buffer supplied with 2.5 units Taq polymerase (Promega) were 
used. PCR was performed on a PTC-200 Peltier Thermal Cycler (MJ Research) 
using the following cycle conditions: 2 min 94°C followed by 30 cycles of 10 sec 
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94°C, 30 sec 63°C and 2 min 72°C with an elongation of 20 s/cycle in the last 20 
cycles. Targeted PCR products were analyzed on an 0.7% agarose gel.  
 
4.3.8 Ocular extracts. 
One mouse eye was put in 1 ml of PBS and cut to small pieces. The material was 
pelleted for 1 minute in a microcentrifuge at 13000 rpm and dissolved in 100 μl of 2% 
Ammonyx-LO in PBS (ALO) (29). Extraction was performed under continuous 
rotation at room temperature for at least 30 minutes. The material was again pelleted 
in an eppendorf microcentrifuge and the supernant was used for Western blotting and 
ELISA. 
 
4.3.9 Western Blotting and detection with ECL. 
Equal amounts of ocular extracts were loaded in each lane of a 12% (w/v) 
polyacrylamide mini-gel (Biorad) and, following electrophoresis, proteins were blotted 
onto nitrocellulose (S&S). The blot was blocked with 5% BSA (w/v)/ 0.1% PBST (PBS 
containing 0.1% Tween-20) and incubated overnight at room temperature with 
primary anti-rhodopsin antibody CERN 886 (30) diluted 1:10,000 in 0.05% PBST  
(PBS containing 0.05% Tween-20). After at least 3 washings with 0.05% PBST, the 
blot was incubated with 1: 500 diluted peroxidase-labeled swine anti-rabbit antibody 
(DAKO) for 1 hour at room temperature. Again the blot was washed at least 3 times 
with 0.05% PBST and subsequently peroxidase-labeled bands were visualized with 
chemiluminescent substrate (Super Signal; Pierce) on photographic film (Kodak) 
according to manufacturer’s instructions.  
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4.3.10 RNA isolation and RT-PCR. 
Total RNA was isolated from freshly prepared or frozen stored eyes using TRIzol 
reagent (GIBCO-BRL). For RT-PCR analysis cDNA was synthesized with 
approximately 2 μg of random hexamer primers (Boehringer Mannheim) and 
Superscript II Rnase H- Reverse Transcriptase (GIBCO-BRL) according to the 
manufacturer’s protocol.  
For PCR analysis three different primer pairs were used, one to detect opsin (OPS-F: 
5’-AAT-GTC-GAC-CAY-GCY-ATC-ATG-GGY-3’ and OPS-R: 5’-AAT-GTC-GAC-
GCC-CTG-RTG-GGT-GAA-3’), one for rabbit β-globin intron II (β-GLO-F: 5’-ATA-
CTC-GAG-GAT-CCT-GAG-AAC-TTC-3’ and β-GLO-R: 5’-ATA-GTC-GAC-TGC-CAA-
AAT-GAT-GAG-A-3’), and for actin (ACT-F: 5’-ATG-GGT-CAG-AAG-GAC-TCC-TA -
3’ and ACT-R: 5’-TTG-ATG-TCA-CGC-ACG-ATT-TC -3’) as a control.. The reaction 
contained 10% of the first strand reaction, 400 μM of each dNTP, 2.0 mM MgCl2, 0.6-
0.8 μM of both primers and 2.5 units of Taq polymerase (Promega) and was carried 
out in the buffer supplied with the polymerase on a PTC-200 Peltier Thermal Cycler 
(MJ Research). The protocol conditions were: 4’ 94°C followed by 30 cycles of 1’ 
94°C, 2’ 50°C and 2’ 72°C. The RT-PCR products were analyzed on a 0.7% agarose 
gel. 
 
4.3.11 Rhodopsin assay by UV/VIS spectroscopy. 
One mouse eye was homogenized in 2 ml buffer A (20 mM Pipes, 130 mM NaCl, 10 
mM KCl, 3 mM MgCl2, 2 mM CaCl2, 0.1 mM EDTA, 2 μg/ml leupeptin, pH 6.5) in a 
Potter Elvehjem homogenizer and centrifugated (20 min, 20,000xg at 4°C).  
To extract the rhodopsin from the membrane pellet a 1% solution of reduced Triton 
X-100 (Sigma) in buffer A was added and the resulting mixture was incubated for 30 
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min under argon with continuous rotation at 4°C.  After centrifugation (30 min, 
120,000xg at 4°C) 1 M hydroxylamine was added to the supernatant to a final 
concentration of 10 mM and a spectrum was recorded from 700 to 250 nm before 
and after illumination.  Rhodopsin levels were calculated from the Δ A500 using a 
molar absorption coefficient of 40,600 ODM-1cm-1 (31).  
 
4.3.12 Opsin analysis by enzyme-linked immunosorbent assay (ELISA). 
Two polystyrene microtiterplates I and II (Greiner; medium binding) were coated 
overnight at 4°C with either buffer A (2% BSA in PBS) or buffer B (25 nM rhodopsin 
in 0.01% Ammonyx-LO (ALO, Fluka Chemie) in PBS). The microtiter plate I is 
washed with buffer C (0.1% BSA/0.01% ALO in PBS) and used to preincubate the 
antigen/antibody mixtures (29). In all wells with exception of row 3, 60 μl buffer D 
(0.2% ALO in PBS) was added. In row 3 120 μl of eye extract diluted 10 times in PBS 
was added and 1:1 further diluted to row 12. Rows 2-12 were filled with 60 μl of 
primary antibody in buffer C (CERN 886, anti bovine rhodopsin, dilution 1:6000) 
whereas row 1 was filled with only 60 μl of buffer C and serves as negative control. 
The plate was incubated for 1 hour at room temperature.  
Microtiter plate II was washed with buffer C and wells were incubated for 1 hour at 
room temperature with the corresponding antigen/antibody solution of plate I. After at 
least 5 washings with buffer C the plate was incubated for 1 hour at room 
temperature with a 1:2000 SARPO (DAKO) dilution in buffer C. Subsequently the 
plates were washed with buffer C and incubated with 100 μl/well substrate (25 mM 
citric acid, 50 mM Na2HPO4, 0.012% H2O2, 2.2 mM O-phenylene diamine) for 20-30 
minutes in the dark. The reaction was stopped by adding 100 μl 4 M H2SO4 per well. 
Absorption at 492 nm was measured using an ELISA reader (CERVIS UV900C; Bio-
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Tek Instruments Inc.). Calibration curves were constructed by a semi-log plot of the 
percentage of maximal absorbance versus the amount of opsin added. Wild type 
mouse and bovine ocular extracts, which were quantified by means of UV/VIS 
spectroscopy, were used as standards. The amount of opsin in the extract samples 
was calculated from the measured absorbance using the linear part of the sigmoid 
calibration curve. All absorbance values were corrected for non-specific binding. 
 
4.3.13 β-Galactosidase assay. 
Determination of β-galactosidase activity was performed by means of an ONPG (0-
nitrophenyl-β-D-galactopyranoside; Sigma) assay (27). In this assay β-galactosidase 
catalyses the following hydrolytic reaction: 
 
O-nitrophenyl-β-D-galactopyranoside (ONPG) +H2O Æ galactose + O-nitrophenol 
 
The β-galactosidase mediated conversion of the O-nitrophenolate ion can be 
quantified by means of a spectroscopic assay since the product, O-nitrophenol can 
be measured in the 405-420 nm range.  
One mouse eye was homogenized in 0.5 ml PBS in a Potter Elvehjem homogenizer 
and briefly centrifugated (10 min, 18,000xg at 4°C). The supernatant, containing the 
β-galactosidase, was carefully aspirated from the pellet and total amount of protein in 
the ocular extracts was determined by means of a colorimetric protein assay (Biorad). 
An aliquot containing 100 μg of eye protein was added to 100 μl buffer A  
(100 mM Na-phospate buffer pH 8.0; 10 mM KCl, 1mM Mg2Cl; 50 mM β-
mercaptoethanol) and a serial 1:1 dilution of the sample in buffer A was made in a 96 
well plate. The reaction was started by the addition of 20 μl of buffer B (100 mM Na-
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phosphate buffer pH 8.0; 2 mg/ml ONPG). The samples were incubated for 30 
minutes at 37°C and the reaction was stopped with 50 μl 1M Na2CO3 . The extinction 
at 405 nm was recorded in an ELISA reader (CERVIS UV900C; Bio-Tek Instruments 
Inc.).  
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4.4 Results and Discussion. 
4.4.1 Generation of a bovine rhodopsin knock-in mouse model. 
To better understand the role of rhodopsin in normal retinal morphology and in the 
pathogenesis of retina degeneration, we generated a targeting construct with the 
purpose of replacing some 5 kbp of the mouse rhodopsin gene (an XhoI-EcoRI 
fragment comprising the last 15 bp of the 5’ non-coding region, all coding sequences 
and a large part of the 3’ untranslated region) by a bovine rhodopsin cDNA (Figure 
1). Since both rhodopsin and transducin are highly homologous in mouse and bovine, 
downstream signaling consequences are not to be expected.  
In order to ensure rapid nuclear processing of the resulting knock-in (KI) primary 
transcript, the rabbit β-globin intron II  was cloned in front of the bovine rhodopsin 
cDNA. Furthermore, to allow the monitoring of rhodopsin promoter activity, a lacZ 
reporter construct headed by an IRES (internal ribosome entry site) element (25) was 
cloned downstream of the bovine rhodopsin cDNA (Figure 1). This will yield a 
bicistronic messenger encoding two separate protein products: bovine rhodopsin and 
β-galactosidase. Lastly, a neomycin phosphotransferase – thymidine kinase fusion 
protein selection cassette was added to the targeting vector to enable selection of 
stably transfected cells. In this fusion cassette the Neor-HSV/TK expression construct 
is flanked by two lox P sequences (32), allowing excision of the sequence in between 
from the targeted locus later on following transient expression of Cre recombinase 
(33), thereby minimizing perturbation of transcription regulation within the mouse 
rhodopsin locus.  Neomycin selection is used to screen for integration and 
subsequently FIAU selection is used to screen against HSV-TK activity, thus for 
excision of the selection cassette.  
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There are two disadvantages in using this selection cassette. Usually one or more 
HSV-TK selection cassettes that flank the actual targeting constructs are exploited to 
counterselect clones that result from random integration events, and thus to 
specifically enrich for clones resulting from correct homologous recombination. In our 
targeting strategy we cannot use such a combined positive-negative selection / 
homologous recombination enrichment scenario, and consequently many individual 
clones will have to be screened. Additionally, failure of removing the cassette from 
the locus would render all male offspring infertile (34-36).  
The resulting targeting vector (Figure 1) was isolated as a linearized 15 kbp KpnI-
SphI fragment and electroporated into E14 ES cells. Following G418 selection, four 
hundred individual clones were inspected for homologous recombination by Southern 
blot analysis. Upon proper homologous recombination, the endogenous 11 kbp 
BamHI fragment is reduced in the targeted allele to approximately 5 kbp (Figure 1). 
Using a 5’ BamHI-KpnI diagnostic probe, only in four (1%) clones proper targeting by 
homologous recombination had occurred (Figure 3). These 5’-positive clones were 
subsequently tested with a 3’ SphI-SalI probe which reduced the endogeneous 10kbp 
HindIII fragment to approximately 7 kbp (Figure 1 and 3). Two of these clones 
displayed improper growth behavior or had an aberrant karyotype and were 
discarded. The two remaining clones (1C10 and 5A3) were then transiently 
transfected with a Cre expression construct and subjected to a negative selection 
screen to enrich for excision of the selection cassette from the locus. 
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Figure 3: Southern blot analysis of E14 embryonic stem cell clones. Hybridization with a BamHI-KpnI 
probe results in a signal at approximately 11 kbp and 5 kbp in a BamHI genomic DNA digest for the 
wild type and the knock-in allele, respectively. Homologous recombination at the 3’ region of the 
construct is verified using a SpHI-SalI probe which results in a hybridization signal at approximately 10 
kbp and 7 kbp in a HindIII genomic DNA digest for respectively the wild type and the knock-in allele. 
 
This step is essential, since failure of removing the cassette from the locus would 
render all male offspring infertile (34-36). Multiple FIAU-resistant clones were 
obtained for each clone and proper excision was checked by Southern blot analysis 
(Figure 4). The endogenous BamHI fragment of 11 kb, which in the targeted allele is 
reduced to approximately 4 kb, was further reduced to approximately 1 kb upon 
selection cassette excision (Figure 1 and 4). 
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Figure 4: Southern blot analysis. Excision of the loxed selection cassette is verified using a 
PstI-BamHI probe on BamHI-digested ES cell genomic DNA. This results in hybridization signals of 
approximately 10 kbp, 4 kbp and 1 kbp fragments for the wild type allele, the knock- in allele before 
and the knock-in allele after Cre recombinase –mediated excision, respectively. 
 
After karyotype analysis three different clones (1C10-B9, 5A3-B10, 1C10-A12) were 
selected for injection into day-3 C57BL/6 blastocysts that were subsequently 
transferred into pseudopregnant foster mice and allowed to mature to term. The coat 
color of the resulting chimaeric offspring was used to estimate the relative 
contribution of the injected E14-derived ES cells to the embryo proper. Cell line 
1C10-B9 resulted in only black-haired offspring, indicating that a contribution by this 
ES clone is not manifest because this would have resulted in agouti-colored skin 
patches. Injection of cell line 5A3-B10 resulted in one male chimaera that was 70% 
agouti, and 5 chimaeric females. Finally, clone 1C10-A12 produced three chimaeric 
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males and four females. One male displayed a chimaerism of approximately 20%, 
and the other two were 60-70% chimaeric. The four chimaeric males were mated with 
C57BL/6 females to test for germ line transmission of the mouse strain 129 ES cell-
derived genotype. Since the agouti coat coloring of 129 mice is dominant over the 
black C57BL/6 color, the coat color of resulting offspring can be used as read-out for 
germ line competence. Only one of the high chimaeric 1C10-A12 male mice 
produced an agouti colored offspring that carried the targeted allele. This founder 
heterozygote was crossed with C57BL/6 mice and obtained heterozygous offsprings 
were intercrossed to produce litters with all three genotypes.  
To discriminate between the wild type (+/+), heterozygous (KI/+) and homozygous 
knock-in (KI/KI) genotype at the targeted locus in a facile way, we developed a rapid 
PCR assay addressing the globin and/or opsin sequences (Figure 5). Opsin 
sequence primers, OPS-F5 and OPS-R5 were used to detect the wild type mouse 
allele (~250 bp) whereas the opsin forward primer, OPS-F5 in combination with the β-
glo-R primer were used to detect the mutant allele (~600 bp). To generate a mouse 
model on a stable C57BL/6 genetic background heterozygous mice (KI/+) were bred 
with C57/BL6 mice. Subsequently agouti coat color can no longer be used to 
discriminate between genotypes. When homozygous mice (KI/KI) were required 
heterozygous mice (KI/+) were bred and litters were obtained consisting of 
approximately 50% heterozygous mice and 25% wild type and 25% homozygous 
mice according to Mendelian law. The heterozygous mice (KI/+) and wild type mice 
were used in subsequent experiments as litter controls because a stable genetic 
background was not yet achieved. For each experiment litters from the same 
generation were used whereas mice used in different experiments were offspring 
from different generations. 
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Figure 5: Genotype analysis on genomic DNA from wild type (+/+), heterozygous (KI/+) and 
homozygous knock-in (KI/KI) mice using the primers OPS-F5, OPS-R5 and β-glo-R. Fragment sizes 
obtained for the KI and wild type (WT) allele-specific amplification reaction are indicated on the left. 
 
4.4.2 Splicing and functional expression of the transgenic mRNA. 
Correct splicing of the rabbit β-globin intron that is present in the knock-in bicistronic 
primary transcript was examined by RT-PCR.  We used 5-month-old wild type and 
heterozygous (KI/+) mice to isolate total ocular RNA. Equal amounts of eye mRNA 
from wild type and heterozygous mice, as determined by spectrophotometric 
analysis, were used in a reverse transcription reaction. To verify the proper 
production of cDNA, an amplification reaction exploiting an actin-specific primer pair 
was performed (Figure 6, lanes 9-10).  Although not a quantitative method, the 
intensity of amplification products generated by this PCR is in line with the use of 
equal amounts of RNA in the RT reactions. Likewise, by using an opsin-specific 
primer set, the amounts of RT-PCR product generated from opsin mRNA in wild type 
+/+ and heterozygous KI/+ material appear more or less the same. When the 
presence of rabbit β-globin intron II sequences derived from the knock-in allele was 
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tested in the respective cDNA materials, only a weak and very small, probably 
aspecific, signal was obtained in the case of KI/+. 
 
Figure 6: RT-PCR analysis of the presence of transgene intron sequences in mouse ocular mRNA. 
RNA isolated from the eyes of wild type (lanes 1, 5 and 9) and heterozygous KI/+  (lanes 2, 6 and 10) 
animals at 5 months of age was reverse transcribed and the resulting cDNA was used in PCR 
reactions exploiting a β-globin intron-specific  primer set (lanes 1-4), a mouse opsin primer pair (lanes 
5-8), or actin-specific primers (as a control for the RT reaction; lanes 9-10). As a negative control 
(lanes 3 and 7) no cDNA was added, and plasmid DNA of the targeting construct served as positive 
control (lanes 4 and 8)  for the respective primer pairs. 
 
Importantly, an appropriately-sized β-globin intron amplification product was only 
detectable when using the targeting vector plasmid DNA as positive control (Figure 6, 
lane 4), firmly establishing proper splicing of the bovine opsin-encoding transcript that 
is produced from the knock-in allele.  
To assess whether the properly-spliced bicistronic knock-in transcript is also leading 
to the desired protein products, protein extracts were prepared from eyes of 1-month-
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old wild type, heterozygous and homozygous knock-in animals. Western blot analysis 
using anti-rhodopsin antiserum CERN 886 revealed an opsin band of approximately 
40 kDa for all three genotypes (Figure 7). Importantly, no additional, aberrant opsin 
product was formed in eyes from animals carrying the knock-in allele. Unfortunately, 
the immunoblot signal intensities clearly indicate that the bovine rhodopsin level in 1-
month-old homozygous knock-in mice is considerably lower than that of mouse 
rhodopsin in wild type littermates. The difference cannot be attributed to species 
preference of the polyclonal antiserum (CERN 886) used in this analysis since this 
was raised against the C-terminus of bovine rhodopsin and, as a matter of fact, 
furthermore, demonstrates equal affinity for bovine and mouse rhodopsin (data not 
shown).  
 
Figure 7: Western blot analysis of rhodopsin levels in eye extracts of 1-month-old mice. Equal amounts 
of protein extracts, prepared from eyes of wildtype (+/+), heterozygous (KI/+)  and homozygous (KI/KI) 
knock-in animals at the age of 1 month, were separated on SDS gels, blotted onto nitrocellulose 
membranes and immunostained with anti-rhodopsin antiserum CERN 886 (1:10,000). Upper bands in 
the first two lanes represent artificial rhodopsin dimers. Molecular weight markers are depicted on the 
right. 
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The obvious reduction in rhodopsin expression levels observed in the KI/KI mice as 
compared to wild types is surprising. Mouse and bovine rhodopsin are highly 
homologous (~90%), making it rather unlikely that differences in protein synthesis 
rate, processing or stability may explain the severe reduction in rhodopsin levels. 
Furthermore, by including an intron sequence within the knock-in bovine rhodopsin 
mini-gene and through the Cre-mediated excision of the positive/negative selection 
cassette together with its promoter-enhancer elements, impairment of transcriptional 
activity and post-transcriptional processing was kept to a minimum. We cannot 
exclude that transcription of the knock-in mini-gene may be compromised because 
genuine rhodopsin introns contribute regulatory elements for gene transcription. 
However, this assumption is not supported by available literature data on opsin gene 
regulation. Alternatively, the bicistronic mRNA encoded by the knock-in mini-gene 
may be less stable than the wild type mouse rhodopsin (Figure 6). The reason for the 
reduction in protein expression level, therefore, may reflect alterations in mRNA 
translation efficiency. The construction of the targeting vector (Figure 1) led to some 
changes preceding the rhodopsin translation start site (gcagccATG Æ ggatccATG) 
which might render the site less attractive for initiation of translation. In addition, the 
presence of an IRES sequence further on in the bicistronic transcript may have 
introduced an internal competitor for attracting the translation initiation complex. In 
conclusion, in designing future knock-in constructs for rhodopsin mutant studies the 
kinetics of transcription and translation will have to be re-evaluated. 
To establish whether the expressed bovine rhodopsin was functional we prepared 
ocular extracts from wild type and knock-in mice and assayed rhodopsin levels by 
difference UV/VIS spectroscopy. We tested several littermates from 1 and 2 months 
of age. The difference spectra of homozygous knock-in mice were consistent with a 
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functional 11-cis retinal-based bovine rhodopsin with a λmax at approximately 500 nm 
(Figure 8). The heterozygous and wild type littermates also displayed a λmax at 
approximately 500 nm (Figure 8). Mouse and bovine rhodopsin are highly 
homologous and both have a peak spectral activity near 500 nm, which makes it 
impossible to distinguish their separate contribution in the heterozygous difference 
spectrum.  
 
                       
 
Figure 8: UV/VIS absorbance difference spectra of ocular extracts. Ocular extracts were prepared from 
wild type (+/+), heterozygous (KI/+) and homozygous (KI/KI) knock-in mice and assayed for rhodopsin 
levels by difference UV/VIS spectroscopy. Difference spectra were obtained by subtracting the 
spectrum obtained after illumination from the dark spectrum. The spectra were measured in the 
presence of 10 mM hydroxylamine to convert the all-trans retinal liberated upon illumination into all-
trans retinoxime with an absorbance maximum at 365 nm. 
 
These analyses indicate, in agreement with the Western blot data, that the rhodopsin 
expression level in 1 and 2-month-old homozygous knock-in mice is strongly 
reduced, to approximately 10-15% of that encountered in wild type littermates (Figure 
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8).  It must be noted that the rhodopsin levels in the homozygous transgenic mice 
were close to the detection limit of our UV/VIS spectrophotometer and do not allow a 
more precise spectral estimation of the amount of rhodopsin present.  
The level of rhodopsin in heterozygous knock-in littermates was found to be around 
60-70% of that in wild type controls. For comparison, in heterozygous rhodopsin 
knock-out mice stable rhodopsin levels at approximately 50% of that of wild type 
levels were observed during the first 24 weeks (15). We therefore conclude that the 
rhodopsin level in the heterozygous knock-in mice is largely contributed by mouse 
rhodopsin, encoded by the wild type allele, with only a small contribution from the 
targeted knock-in allele.  
 
4.4.3 Opsin levels. 
We turned to an enzyme-linked immunosorbent competition assay that is much more 
sensitive than the spectral assay to quantitate the expressed opsin levels more 
reliably. In this assay purified bovine rhodopsin was coated to the microtiter plates 
and incubated with mouse or bovine ocular extracts and a polyclonal antiserum, 
CERN 886, raised against bovine rhodopsin. We observed no difference whether we 
used bovine or mouse ocular extracts for calibration, indicating that the affinity of the 
anti-rhodopsin antiserum for mouse and bovine opsin protein is identical. Opsin 
levels in ocular extracts of all three genotypes were determined at 1, 2, 3, 4 and 6 
months of age. In wild type (+/+) mice the opsin levels were found to remain constant 
over time, at an average level of 612 ± 28 pmole/eye (Table 1).  
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Genotype/ 
        age 
+/+ KI/+ KI/KI 
1 moa 0.60 ± 0.01 0.41 ± 0.01 (67%) 0.08 ± 0.02 (14%) 
2 moa 0.65 0.43 ± 0.04 (69%) 0.12 ± 0.04 (19%) 
3 moa nd 0.38 ± 0.04 (61%) 0.09 ± 0.02 (15%) 
4 moa nd 0.44 ± 0.09 (71%) 0.09 ± 0.01 (14%) 
5 moa 0.60 nd nd 
6 moa nd 0.38 ± 0.07 (62%) 0.02 ± 0.00 ( 3%) 
 
Table 1: Determination of opsin levels in ocular extracts using a competitive ELISA. Protein extracts of 
single eyes from wild type (+/+), heterozygous (KI/+) and homozygous (KI/KI) knock-in mice of various 
ages (indicated in months of age; moa) were used in an enzyme-linked immunosorbent competitive 
assay to determine opsin amounts in nmole per eye. Percentages relative to wild type levels are 
indicated between brackets. Results are the mean ± S.E.M. of two experiments with eyes from two 
age-matched mice, with the exception of the values for 2 and 5 month old wild type mice. Nd, not 
determined. 
 
This average wild type level agrees well with earlier data (29) and was used to 
calculate the percentage of opsin present in heterozygous and homozygous knock-in 
mice. The heterozygous mice have stable opsin levels of 66 ± 8% relative to wild 
type, throughout the investigated time period (up to and including 6 months of age). 
This basically agrees with the spectral rhodopsin analysis (Figure 8). The finding that 
at 6 months of age the amount of opsin in heterozygous animals was not significantly 
reduced when compared to that at younger ages parallels the data obtained in 
heterozygous KO/+ animals (data not shown). 
The quantitative ELISA is sufficiently sensitive to measure very low opsin levels. At 
one month of age an opsin concentration of about 14% relative to wild type levels 
was measured in the homozygous knock-in animals, which is in good agreement with 
the UV/VIS results. This suggests that almost all opsin will be present in its activated 
form, covalently linked to its ligand 11-cis retinal, and that regeneration is not 
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impaired. Opsin levels remained stable, at 15 ± 3% of that of wild type, until 4 months 
of age. However, at 6 months of age a rapid decrease in opsin content, to about 3% 
of wild type levels, was observed in the homozygous knock-in mouse eye,  a putative 
indicator for ongoing retinal degeneration. 
These results were substantiated by Western blot analysis of the ocular extracts 
exploiting antiserum CERN 886 (Figure 9). Opsin signal intensities on the 
immunoblots were independent of age for wild type and heterozygous knock-in mice 
(data not show), but revealed a clear decline over time in adult homozygous knock-in 
animals.    
 
Figure 9: Immunoblot analysis of opsin protein levels in mouse ocular extracts. Protein extracts of eyes 
from homozygous knock-in mice at 1, 2, 3, 4 and 6 months of age (indicated in months above the 
lanes) were size-separated by SDS-PAGE, blotted onto nitrocellulose membranes and immunostained 
with the anti-rhodopsin antiserum CERN 886 (1:10,000). Molecular weights of marker proteins are 
indicated (in kDa) on the left. 
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4.4.4 Expression of β-Galactosidase. 
In order to determine whether the IRES-lacZ reporter part in the knock-in construct is 
functional, and thus could be exploited in histological experiments, we measured β-
galactosidase activity in ocular material. In contrast to rhodopsin, β-galactosidase is a 
cytoplasmic protein that will be present in the supernatant after lysis of cells. We 
therefore prepared protein lysates, using a single eye from 2-months-old wild type, 
heterozygous and homozygous knock-in mice, and performed a colorometric ONPG 
assay (27) (Figure 10). 
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Figure 10:  β-Galactosidase activity in mouse ocular lysates. Protein lysates of single eyes, from wild 
type (+/+), heterozygous (KI/+) and homozygous (KI/KI) knock-in mice at 2 months of age, were tested 
for β-galactosidase activity using 0-nitrophenyl-β-D-galactopyranoside as a substrate. Serial 1:1 
dilutions of 100 μg of eye protein were tested in a microtiter plate format. After 30 minutes incubation 
at 37°C in ONPG assay buffer the reaction was stopped and extinction was recorded at 405 nm using 
an ELISA plate reader.  
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These results demonstrate that the E.coli  β-galactosidase is functionally expressed 
in heterozygous (KI/+) and homozygous (KI/KI) knock-in mice. Wild type mice 
revealed low levels of endogenous β-galactosidase activity. Surprisingly, 
heterozygous knock-in (KI/+) mice display much higher β-galactosidase levels than 
homozygous knock-in (KI/KI) mice. In fact, if loss of photoreceptor cells in the KI/KI 
mice is not taken into account, a twofold higher β-galactosidase levels in the retina of 
homozygous knock-in mice than in that of age-matched heterozygous animals is 
expected. Thus, contradictory to our previous results these data suggest that at 2 
months of age degeneration of the rod photoreceptors is already ongoing in KI/KI 
animals, urging for a detailed histological analysis in these mice (Chapter 5).   
In conclusion, the bicistronic knock-in construct is functional and results in the 
production of active rhodopsin and β-galactosidase. The low rhodopsin levels in the 
homozygous knock-in mice, however, most likely trigger a progressive cellular 
degeneration process, which could explain the reduced level of β-galactosidase 
activity in eyes of KI/KI mice as compared to that in heterozygous littermates. 
 
4.5 Conclusions. 
We have generated a targeted knock-in mouse model for bovine rhodopsin. The 
homozygous knock-in (KI/KI) mice express functional bovine rhodopsin at 10-15% of 
the wild type level. Our data reveal that opsin and rhodopsin levels in these mice are 
very close, indicating that the opsin is correctly processed and expressed in a 
functional state. Opsin levels remain stable in these mice for about 4 months. At 6 
months of age, however, amounts drop to 3% of the wild type levels.  This is highly 
suggestive for progressive retina degeneration, and urges for a detailed histological 
analysis to reveal the time course of events (Chapter 5). 
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There are several factors that could cause or contribute to the relatively low opsin 
expression produced by the knock-in mini-gene. Transcription could be affected due 
to the replacement of almost the complete mouse opsin transcription unit, which 
includes four introns, by a bovine opsin cDNA. We cannot exclude the inadvertent 
removal of regulatory elements present within these introns, or in the partially excised 
3’ untranslated region, that could be important for transcription. However, there are 
no indications in literature that crucial elements for transcription regulation of the 
opsin gene might be touched upon by the present strategy (37-41). To allow the 
bicistronic messenger a default processing in and routing out of the nucleus, a small 
intronic sequence derived from the rabbit β-globin gene was incorporated in the 
knock-in construct. RT-PCR analysis clearly demonstrated that this intron is spliced 
out correctly, resulting in the generation of the expected bicistronic mRNA. Whether 
the production level or the stability of the bicistronic mRNA encoded by the knock-in 
mini-gene is identical to that of the normal wild type opsin mRNA still needs to be 
investigated. A simple Northern analysis would not have been sufficient to establish 
this. At the translational level, small sequence differences around the AUG start 
codon in the mouse and bovine species may be causing lower expression levels of 
the bovine protein in mice. Alternatively, the presence of an IRES sequence as a 
competitor to attract translation initiation complexes could also affect the translation 
rate of the opsin open reading frame in bicistronic messenger produced by the mini-
gene. In vitro translation studies using this mRNA with and without the IRES might 
give an answer to these questions. Finally, with respect to the gradual reduction in 
opsin levels reminiscent of retinal degeneration, it should be mentioned that formally 
speaking not only reduced opsin expression but also β-galactosidase overexpression 
could contribute to the destruction of the photoreceptor cell. However, ample 
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evidence has been raised that, despite its size and tetramerization behaviour, β-
galactosidase is a rather inert type of reporter, also at high dosages in the retina (e.g. 
42).  
For future studies it will be relevant to understand what factors contribute to the low 
opsin expression levels from the mini-gene. Meanwhile, the current study already 
provides some clues on how to fine-tune the knock-in targeting vector to ensure the 
creation of novel mouse models that express opsin variants at wild type levels, 
eliminating expression level-related retinal degeneration. Since the targeting strategy 
resulted in proper tissue-specific expression, a future construct could do without the 
IRES-LacZ part, eliminating possible problems at the translational level. Also, the 
sequences preceding the AUG start codon within the rhodopsin cDNA that will be 
introduced could be optimized for translation purposes using the mouse rhodopsin 5’ 
untranslated part as template.  
Irrespective, the current knock-in mouse model is already highly intriguing on its own, 
because it serves to study the cellular processes that are triggered by reduced opsin 
levels and eventually result in the death of the photoreceptor cell.  
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Chapter 5 
5.1 Summary. 
Rod photoreceptor cell degeneration has been observed in animal models in which 
the opsin protein is completely ablated, strongly overexpressed or specifically 
mutated at certain positions. We have generated a bovine rhodopsin knock-in (KI/KI) 
mouse model that produces opsin levels which are seven-fold lower than in normal 
animals and that eventually displays signs of retinal degeneration. To learn more 
about the processes underlying photoreceptor degeneration an extensive histological 
and immunohistochemical characterization of this mouse model was performed. 
Although opsin levels in homozygous KI/KI mice remain constant during the first 4 
months, a progressive photoreceptor cell loss that nears completion around 6 
months of age was observed. This rate of photoreceptor cell loss is much slower 
than that observed in rhodopsin knock-out (KO/KO) mice, where degeneration is 
completed within 3 months. Intercrossing both models yielded hemizygous KI/KO 
mice that displayed intermediate rates of photoreceptor cell degeneration, nearing 
completion around 4 months of age. We conclude that the rate of photoreceptor cell 
degeneration seems inversely correlated with opsin expression levels. Furthermore, 
it appears that during the process of degeneration in the bovine rhodopsin knock-in 
mice, the retina tries to compensate for the photoreceptor cell loss by up-regulating 
opsin expression levels in the remaining photoreceptor cells. This suggests a retinal 
compensation mechanism, aimed at ensuring minimal opsin levels to escape or 
delay the process of retina degeneration, that is of interest for the fields of ocular 
developmental biology and ophthalmology. 
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5.2 Introduction.  
The ocular disease retinitis pigmentosa (RP) usually adversely affects the metabolic 
integrity of the rod photoreceptor cells in the retina, resulting in cell death and 
degeneration of the photoreceptor layer with severe loss of vision. Mutations in the 
rod visual pigment rhodopsin represent a large segment of the autosomal dominant 
form of this disease (ADRP). Several of these mutations have been tested in 
transgenic animals and again provoke retinal degeneration with loss of vision (1-12). 
The general explanation so far is, that these mutations inflict misrouting of opsin and 
subsequently cause impaired morphogenesis of the outer segment, that eventually 
results in activation of apoptotic pathways (13). Intriguingly, in rhodopsin null mutant 
mice the complete absence of the opsin protein also appears to provoke rod 
photoreceptor cell death, and it does so with a relatively rapid pace leading to 
completion of retina degeneration within 3 months. Heterozygous animals (KO/+) 
apparently do not enter this degenerative pathway (14,15): whereas the absence of 
opsin prevents formation of rod outer segments, a 50% reduction in the total amount 
of opsin still allows proper disk morphogenesis and does not lead to apoptosis. The 
mechanisms by which lack or misrouting of opsin leads to faulty or even failure of 
disk morphogenesis and ultimately to apoptosis of the photoreceptor cell still needs 
to be investigated. 
We have generated a targeted bovine rhodopsin knock-in mouse model, which 
produces approximately 15% of opsin as compared to wild type animals (Chapter 4). 
The opsin levels remain stable during the first 4 months, but then the opsin 
concentration rapidly declines to approximately 3% of wild type levels at 6 months 
(Chapter 4), suggesting the occurrence of photoreceptor cell degeneration at these 
later time points. In this chapter we demonstrate, by means of histological analyses, 
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that in fact loss of photoreceptor cells in homozygous knock-in mice (KI/KI) is 
initiated and already progressing during the first 4 months and nears completion at 
about 6 months.  
Analysis of various mouse models resulting from crosses between rhodopsin knock-
in and knock-out strains demonstrated that the rate of photoreceptor cell 
degeneration is inversely correlated with the opsin expression level. Hence, 
intriguingly, the number of photoreceptor nuclei in homozygous knock-in (KI/KI) mice 
strongly decreases over the first 4 months, but the opsin levels remain quite stable in 
this period. This suggests that during degeneration the retina tries to compensate for 
the photoreceptor loss by up-regulating opsin expression levels in the remaining rod 
photoreceptor cells.  
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5.3 Experimental Procedures. 
5.3.1 Mouse strains. 
Rhodopsin knock-out mice (14) were kindly provided by Prof. P. Humphries, Trinity 
College Dublin. The generation and initial analysis of the bovine rhodopsin knock-in 
mouse strain has been described (Chapter 4). By cross-breeding wild type (+/+), 
rhodopsin knock-out (KO/KO) and rhodopsin knock-in (KI/KI) mouse strains, 
transgenic lines with increasing rhodopsin levels were generated: KO/KO, KI/KO, 
KI/KI, KO/+, KI/+, and +/+ animals. No significant difference between the various 
genotypes was noted with respect to fertility and litter size. All mice were treated in 
accordance with National guidelines for Animal treatment and were kept under 
standard 12:12 hours light/dark conditions, while food and water was given ad 
libitum. Mice used for histological or biochemical analyses were sacrificed with CO2 
and cervical dislocation. 
Genotyping of mouse offspring was done by means of PCR screening assays as 
described (Chapter 4, paragraph 3.7, and (14)).  
 
5.3.2 Immunohistochemistry. 
Wild type and transgenic mice were sacrificed with CO2 and cervical dislocation. 
Eyes were removed and the ocular tissue was fixed in Bouin fixative (3 volumes 
saturated picric acid, 1 volume 37 % formaldehyde and 0.2 volume of acetic acid) for 
a maximum of 2 hours. Then the eyes were washed several times with 70% ethanol, 
the lens was extracted and the remaining ocular tissue was embedded in paraffin 
(Paraplast Plus, Sherwood). Sections (5 μm) were deparaffinized in xylol, rehydrated 
in alcohol and washed with PBS before being used for antibody incubations or 
hematoxylin/eosin (16) staining. Primary and secondary antibody dilutions (1:50 
 125
Chapter 5 
SAR-FITC; DAKO) were prepared in 20% FCS/PBS and 10% FCS/PBS, 
respectively. The primary antibody dilutions used are: 1:500 CERN 886 (anti-bovine 
opsin rabbit polyclonal), 1:800 anti-β-galactosidase rabbit polyclonal (Biotrend), 
1:250 CERN 956 (anti human red-green cone visual pigment rabbit polyclonal) or 
1:50  anti-GFAP rabbit polyclonal (generously provided by dr. G.J. Bosman). 
Incubation time with primary antibody dilutions was 1 hour at room temperature. 
Before and after each incubation the sections were washed extensively in PBS and 
were mounted using a ProLong Anti-fade kit (Molecular Probes) according to 
manufacturer’s instructions. Fluorescence microscopy was performed on a Zeiss 
Axioskop microscope.  
 
5.3.3 Immunocytochemistry. 
For analysis at the EM level eyes were fixed in a phosphate-buffered (0.1 M, pH 7.3) 
3% paraformaldehyde/1% glutaraldehyde solution for 3 hrs at 4°C, washed in 
distilled water, dehydrated in ethanol and embedded in LRWhite resin (London Resin 
Company). Ultra thin (about 70 nm thick) middle-cross sections of the eyes were 
obtained in a Reichert-Jung ULTRACUT S ultramicrotome, using a diamond knife, 
and mounted on nickel grids. The anti-rhodopsin antiserum CERNJS858 was used 
as primary antibody at a final dilution of 1:500. Afterwards, grids were processed 
following a standard immunogold protocol (17) using 10 nm gold-conjugated rabbit 
IgG as secondary antibody. Subsequently, the sections were counterstained with 
uranylacetate and lead citrate, and examined and recorded on film in a JEOL 1010 
electron microscope. The negative film images were digitalized using a Polaroid 
SprintScan 35/LE scanner.  
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5.4 Results and Discussion. 
5.4.1 Retinal Morphology. 
As a means to study the physiological role of rhodopsin in the morphology of the 
retina and the mechanisms underlying photoreceptor cell death, we previously 
constructed a bovine rhodopsin knock-in (KI) mouse model, in which the protein 
coding part of the mouse rhodopsin gene was replaced by a bicistronic sequence 
encompassing the bovine rhodopsin cDNA, an IRES element and the β-
galactosidase open reading frame. Homozygous knock-in (KI/KI) mice were found to 
produce only 10-15% functional rhodopsin as compared to wild type animals, and 
after 4 months of age this level gradually drops to some 3% at 6 months of age. To 
investigate this phenotype at the morphological level, a histological analysis of the 
retina from homozygous (KI/KI), and heterozygous (KI/+) knock-in mice and their 
age-matched wild type littermates (+/+) at 1, 2, 3, 4 and 6 months of age was 
performed. For each time point and each genotype, mice from at least two different 
litters were analyzed. The mouse retina is composed of 95% rods and only 5% 
cones. Therefore we used the established approach of taking the number of rows of 
nuclei in the outer nuclear layer (ONL) as a good estimate for the relative number of 
rod photoreceptors (Figure 1). A decline in this number of rows is commonly used as 
a measure of the extent of photoreceptor loss (14,15). For wild type animals it has 
been reported that they display approximately 10-12 rows of photoreceptor nuclei 
throughout their first year of age (14,15). At the age of 1 month the retina 
morphology of +/+, KI/+ and KI/KI mice was almost identical, with outer nuclear 
layers (ONL) showing the normal 10-12 rows of nuclei. In the homozygous (KI/KI) 
mice there were indications that the outer segment layer was slightly thinner. 
However, the not well defined transition between the outer and inner segment layer 
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(OS and IS) makes it difficult to discern between the two layers. Electron microscopy 
confirms the presence of photoreceptor outer segments in homozygous KI/KI mice of 
2 weeks of age (Figure 2A). Although these outer segments show a lower degree of 
structural organization (Fig. 2B) than those of wild type animals, they are much 
larger and better organized compared to the rudimentary outer segments seen in 
completely rhodopsin-deficient (KO/KO; knock-out) animals (data not shown). The 
outer segments in the homozygous knock-in retinas are usually still composed of 
stacked cisternae, but these are organized in small groups, that often are misaligned  
(Figure 2B). Nevertheless, similar to wild type the outer segments derive from a 
ciliary base (Figure 2A) and are in close proximity to the retina pigment epithelium 
(RPE). 
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Figure 1: Histochemical analysis  of wild type (+/+), heterozygous (KI/+) and homozygous (KI/KI) 
knock-in retinas at the age of 1 (A), 2 (B), 3 (C), 4 (D) and 6 months (E), respectively. While wild type 
(+/+) and heterozygous (KI/+) mice display a normal structural integrity of the retina (left and middle 
column) upon haematoxylin / eosin staining, it is obvious that retina degeneration is an ongoing 
process in homozygous (KI/KI) mice at 2 months and nears completion at 6 months of age (right 
column). 
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Figure 2: Electron microscopy of homozygous (KI/KI) knock-in mice at the age of  2 weeks.  An outer 
segment is shown in close proximity to the RPE and with its ciliary connection to the inner segment 
as indicated by a large arrow (A). In detail it can be observed that the outer  
segments display a disorganization of small groups of cisternae. Cross sections of incorrectly stacked 
cisternae are indicated by an arrow (B). 
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At two months of age the ONL in the retina of the KI/KI mice had only approximately 
6 rows of nuclei left and the outer and inner segment layers were significantly 
reduced. The disorganization was especially obvious in the outer segment layer, 
which now appeared much shorter and had lost its stratified character.  
In the subsequent months, the degeneration process continues in the KI/KI retina but 
at a reduced pace as compared to that in the second month after birth. At three 
months the ONL of homozygous mice was slightly reduced, having 4-5 rows of 
nuclei left, and by the age of 4 months the ONL was further reduced to 3-4 rows of 
nuclei. Importantly, the length of the inner and outer segments had not significantly 
changed over these periods. At 6 months of age, however, the homozygous knock-in 
(KI/KI) mice had only 1 row of nuclei left, and almost no outer and inner segment 
layer (OS/IS) could be observed.  
From this we can conclude that the photoreceptor degeneration essentially nears 
completion at approximately 6 months. This is much slower than that observed in the 
rhodopsin knock-out mouse, that completely lacks rhodopsin protein from the earliest 
time points on, where the retinal degeneration process is completed within the first 3 
months (14,15). Sharply contrasting with the material from KI/KI mice, the rhodopsin 
knock-out retina already reveals the loss of approximately 2 rows of ONL nuclei 
within the first month. Based upon the results from Humphries et al. (14) and Lem et 
al.(15), the onset of receptor cell death must occur between postnatal day 15 and 24. 
Hence, the onset of photoreceptor cell death in the rhodopsin knock-out is initiated at 
about the age of three weeks, which is several weeks earlier then in the KI/KI animal. 
Although these two transgenic lines have different genetic backgrounds, which may 
influence for instance susceptibility to apoptosis, preliminary data indicate that 
mouse strain differences cannot account for the large difference in onset of 
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degeneration. The rhodopsin deficient mouse displays the highest photoreceptor 
loss, 4-5 rows of nuclei (±40-50%) in the second month after birth, which is followed 
by a complete loss of remaining nuclei within the third month. In the rhodopsin 
knock-in model we observe a similar phenomenon. A ±40-50% decrease in ONL 
nuclei is apparent in the second month after birth, but the degeneration then 
proceeds much slower during the subsequent months (Figure 1). Apparently, a 
rhodopsin level as low as 10-15% of that encountered in normal retina serves to 
significantly delay photoreceptor loss, and particularly in the mature animal.  This is 
also reflected in the number of apoptotic nuclei within the retina that peaks in the first 
month of rhodopsin deficient mutants but does so only in the second and third month 
in KI/KI mice (not shown). 
Heterozygous knock-in (KI/+) animals display a relatively normal retinal morphology 
over the first 3 month of age. At 4 months a slight reduction in outer segment length 
may be noted, and at 6 months it appears that there might be a minor loss of ONL 
nuclei and a reduction in the outer segment layer (Figure 1). However, preliminary 
studies on retinas from older heterozygotes (KI/+), including animals from 14 up to 
21 months of age, indicate that there is no significant reduction in outer segments or 
loss of photoreceptor nuclei relative to wild-type animals (data not shown). We 
conclude, therefore, that there is no conspicuous morphological difference between 
the retina of heterozygous (KI/+) and wild-type (+/+) mice. Taken together, the above 
results clearly suggest that the rate of photoreceptor cell degeneration is dependent 
on the rhodopsin level. Lem et al. concluded from their data, that the lower limit to 
prevent photoreceptor cell death must be close to 50% of normal rhodopsin levels 
because the heterozygous KO/+ animals display a minor reduction in outer segment 
length and loss of 1-2 rows of ONL nuclei after 3 months. Considering our results 
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with the heterozygous knock-in mice we can now refine this estimate and state that 
rhodopsin levels in mouse must be in the order of 60% of the normal level to prevent 
significant loss of photoreceptor cells.  
 
Hemizygous KI/KO. 
We also crossed rhodopsin knock-out animals with the bovine rhodopsin knock-in 
mouse model to obtain mice that are compound heterozygous for the knock-out (KO) 
and knock-in (KI) allele and should have opsin levels somewhere between 5 and 8% 
as compared to wild type. Retina morphology of the hemizygous KI/KO mice was 
examined at 1,2,3 and 4 months of age (Figure 3) and compared to that of wild type, 
KO/KO and KI/KI control specimen (Figure 1 and data not shown). 
 
Figure 3: Histochemical analysis of the retina from hemizygous (KI/KO) mice. Haematoxylin / eosin 
staining of retinal sections from hemizygous (KI/KO) mice at the age of approximately 1 (PN30), 2 
(PN60), 3 (PN90) and 4 (PN120) months of age revealed a rapid loss of photoreceptors that nears 
completion around 4 months of age. For comparison a retina of a wild type mouse (+/+) is shown on 
the left. 
 
At one month of age the retina displays the normal number of 10-12 photoreceptor 
nuclei, but the outer segment layer already has a thinner appearance compared to 
wild type and KO/+ mice. At two months the ONL in KI/KO mice was reduced to 
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approximately 4-5 nuclei and it was difficult to discern the OS and IS transition. At 
three months the ONL was reduced to approximately 2 nuclei and it was impossible 
to discern between OS and IS. At four months there is only one photoreceptor cell 
layer left in the hemizygous retina samples, demonstrating that retina degeneration 
has almost reached completion. 
Since in homozygous knock-out (KO/KO) mice already within three months of age 
just a single layer of photoreceptor nuclei is left, it appears that the single KI allele, 
responsible for the production of about 7% of the wild type rhodopsin level, is able to 
delay the process of photoreceptor cell loss. Therefore, the data obtained from the 
hemizygous KI/KO, the heterozygous KI/+, and the homozygous KI/KI and KO/KO 
mice agree on a general trend, that the rate of retina degeneration is inversely 
correlated to the level of opsin expression. 
 
5.4.2 Immunohistochemistry: Expression of opsin. 
 
Immunohistochemical analysis of various homozygous KI/KI and hemizygous KI/KO 
age groups with antibody CERN 886 shows that bovine opsin is correctly targeted to 
the outer segment layer and fully confirms the histological data of the retina 
degeneration process (Figure 4). At the age of one month the retina derived from 
mice with genotypes +/+, KO/+, KI/KI and KI/KO show the same pattern of opsin 
expression. Strong labeling of the outer segment layer is observed. Strong labeling is 
obvious as well in the basal part of the inner segment, and the intermediate labeling 
around the nuclei reflects the sites of rhodopsin biosynthesis. While in +/+ and KO/+ 
animals the outer segment (OS) layer has reached its maximal size by two months of 
age, it is clearly reduced by 30-40% in KI/KI transgenic mice of that age. The outer 
nuclear layer (ONL) shows a reduction in line with the histological data. In 
 134
Characterization of the Knock-in mouse model  
subsequent months a gradual further reduction of the outer segment, inner segment 
(IS) and outer nuclear layers (ONL) are obvious in KI/KI animals. At six months there 
is a substantial disorganization of the photoreceptor cell layer and the outer or inner 
segment layer can no longer be identified. This also fully complies with the 
histological observations. The remaining scattered photoreceptor cells in the 
homozygous KI/KI mice still express opsin at the age of 6 months (Figure 4) which 
most likely accounts for the 3% opsin that was detected by means of the quantitative 
ELISA (Chapter 4).  The KI/KO mice show a similar progressive reduction of the 
outer segment, inner segment and outer nuclear layers, but since at 4 months of age 
the outer segment is no longer discernable this occurs with an accelerated pace as 
compared to the homozygous KI/KI mice. 
It is quite remarkable that, while the number of photoreceptor nuclei in the outer 
nuclear layer (ONL) of homozygous KI/KI mice strongly decreases in the first four 
months (Figures 1 and 5), the opsin level remains fairly stable over this period, at 
about 15% as established by quantitative ELISA (chapter 4). A possible explanation 
might be that only a subset of relatively stable rod photoreceptor cells, that will 
survive until the later stages, is responsible for the production of the majority of the 
opsin present. Their eventual loss during the fifth and sixth month after birth then 
would explain the rapid decrease in opsin levels over this period. However, this 
suggestion is not supported by the immunohistochemical data that reveal a rather 
homogeneous expression of opsin over the entire photoreceptor layer in KI/KI as 
well as KI/KO animals and display no evidence for high-expressing or low-
expressing foci. A more appealing possibility comes from the observation that the 
outer segment layer in homozygous knock-in mice, although slightly declining, is 
clearly persisting between 2 and 4 months of age. This suggests that the retina is 
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compensating for the photoreceptor loss and corresponding reduction in signal 
output by up-regulating opsin expression levels in the remaining photoreceptors. 
Such an up-regulation mechanism has also been noted in rats maintained in 
complete darkness (18). The mechanism responsible for this up-regulatory process 
and its possible link with photoreceptor cell death are as yet unclear. 
 
 
 
Figure 4: Immunohistochemical analysis of the retina from homozygous knock-in (KI/KI) and 
hemizygous knock-in knock-out (KI/KO) mice with anti-opsin antibody CERN 886. Retinal sections 
from wild type (+/+), hemizygous (KI/KO), heterozygous knock-out (KO/+) and homozygous knock-in 
(KI/KI) mice were immunostained with CERN 886. At one month of age (PN30) the wild type and 
heterozygous knock-out retinas are indistinguishable, whereas the homozygous knock-in retina 
reveals a slightly disorganized pattern of opsin staining. At approximately 2 months of age (PN60) 
hemizygous mice display a more severe retina degeneration than homozygous KI/KI mice of the 
same age. At 4 months (PN120) hemizygous mice have only a few opsin-expressing nuclei and no 
outer segments left. A comparable stage of retina degeneration is reached in the homozygous KI/KI 
mice at approximately 6 months of age (PN180). The heterozygous KO/+ , KI/+ (data not shown) and 
the wild type littermates display a normal retina. 
 136
Characterization of the Knock-in mouse model  
 
0
2
4
6
8
10
12
0 30 60 90 120 150 180
days [PN]
nu
m
be
r o
f l
ay
er
s 
in
 O
N
L
0
5
10
15
20
25
%
 opsin
KO/KO
KI/KI
KI/KO
% opsin in
KI/KI
% opsin in
KI/KI
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Correlation between the photoreceptor cell number and the opsin level in the retina  
of homozygous knock-in (KI/KI) mice during the first 6 months of age. The number of outer 
nuclear layers (vertical left axis) was taken as a measure for the total amount of photoreceptor  
cells within the retina. Opsin protein levels, expressed in percentages of wild type levels  
(vertical right axis) are given for homozygous knock-in (KI/KI) mice only. The number of ONL  
layers in the retina from hemizygous KI/KO mice and homozygous knock-out (KO/KO) mice  
during the first 6 months (age in postnatal days, at horizontal axis) are also shown to 
demonstrate the significant difference in the rate of photoreceptor loss between these three 
genotypes.  
 
Obviously, after 4 months a further up-regulation can no longer be achieved in the 
KI/KI retina and the ongoing loss of photoreceptor cells thus causes a rapid decline 
of opsin levels over this period. At 6 months of age only scattered opsin-positive cells 
can still be observed, and a stratified outer segment layer is entirely absent.  
 
 
 137
Chapter 5 
5.4.3 Immunohistochemistry: Expression of β-galactosidase. 
In mice carrying the bovine rhodopsin knock-in allele the β-galactosidase levels in 
the retina could be used as an independent reporter of the mini-gene expression 
levels. Therefore, we examined by means of immunohistochemistry β-galactosidase 
expression levels in retina derived from homozygous KI/KI and hemizygous KI/KO 
mice at various ages (Figure 6). A polyclonal antibody against E. coli β-galactosidase 
on wild type retina sections revealed that it does not cross-react with endogenous 
mouse proteins. The KI/KI and KI/KO mice display a β-galactosidase staining which 
is confined to the photoreceptor cell layer and is distributed over the entire 
photoreceptor cell. 
Opsin is a membrane protein that is rapidly targeted to the outer segment 
membranes. Therefore most of the opsin staining was observed in the outer 
segment layer (OS) with only minor staining in the inner segment layer (IS) and outer 
nuclear layer (ONL) and no staining in the synaptic region of the photoreceptor cell 
or outer plexiform layer (OPL) of the retina.  β-galactosidase, however, is a 
tetrameric protein that despite its considerable size is able to migrate throughout the 
cytoplasm of the entire photoreceptor cell, which results in the uniform staining of the 
inner and outer segment layer, outer nuclear layer and outer plexiform layer of the 
retina. On the other hand, unlabeled photoreceptor cells can also be discerned in the 
inner and outer segment layers, especially in the 2, 3 and 4 months samples. These 
cells most likely represent cone photoreceptors, since expression of the knock-in 
mini-gene should be restricted to the rod photoreceptor cells only. Indeed, 
immunohistochemical analysis of retinas from homozygous KI/KI mice of 1, 2 and 3 
months of age with the anti-green cone pigment CERN 956 resulted in a regular 
staining of outer segments, that partly complemented the β-galactosidase staining 
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pattern (Figure 6). The presence of a fully functional population of cone 
photoreceptors in 3 months old homozygous KI/KI mice could indeed be confirmed 
by means of electrophysiological ERG measurements (data not shown). Importantly, 
the age-dependent trend in the β-galactosidase expression levels as observable in 
the KI/KI retina corroborate the findings for opsin, i.e. that initially the degenerating 
retina is compensating for the loss of photoreceptors by up-regulating expression 
levels in the remaining rods (compare figure inserts PN60 and PN90 time points for 
KI/KI retina in Figure 6).  
 
 
Figure 6: Opsin expression levels are nicely paralleled by β-galactosidase staining patterns in retinal 
sections from mice carrying the knock-in allele. Immunofluorescence analysis of the retina from wild 
type (+/+), homozygous knock-in (KI/KI) and hemizygous (KI/KO) mice conducted with a rabbit 
polyclonal antibody generated against bacterial E. coli β-galactosidase. In the retina of homozygous 
KI/KI mice at postnatal day 30, 60, 90, 120 and 180 an obvious diminishing β-galactosidase staining 
in line with the retina degeneration can be observed. The same is seen in the retina of the 
hemizygous KI/KO mice at postnatal day 60, 90 and 120. Unlabeled cells (indicated by an arrow in 
the PN60 panel of KI/KI) probably represent cone photoreceptors. The presence of cone 
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photoreceptors in the retina of a homozygous KI/KI mouse of approximately 3 months of age (PN90) 
was confirmed using a rabbit polyclonal antibody CERN956 generated against the mammalian 
red-green cone visual pigment (most upper right panel). 
 
5.4.4 Immunohistochemistry: Expression of glial fibrillary acidic protein 
(GFAP). 
In Müller cells the expression of GFAP (glial fibrillary acidic protein) is enhanced 
following a wide variety of pathological stress-conditions including retinal 
degeneration, neuronal injury, ischemia and trauma. The stressed Müller cell 
displays GFAP staining throughout the entire cell, which can be taken as a reliable 
indicator for neuro-retinal injury (19). To investigate the stress-response of Müller 
cells upon photoreceptor degeneration as observed in our transgenic mice, we 
performed an immunohistological survey exploiting an antibody against GFAP. 
GFAP is an intermediate filament protein that in the retina is expressed 
predominantly by mature astrocytes and Müller cells. Müller cells are glial cells, 
which have their nuclei in the inner nuclear layer (INL) and span the entire retina up 
to the outer limiting membrane (OLM). In wild type retina GFAP expression in Müller 
cells is restricted to their end-feet that locate in the ganglion cell layer (GCL) (Figure 
7). However, in homozygous KI/KI and hemizygous KI/KO mice an abundance of 
activated Müller cells is observed at 1 month of age in the periphery (data not 
shown), but not the central part (Figure 7), of the retina. In contrast, homozygous 
rhodopsin knock-out (KO/KO) mice at 1 month of age do contain activated Müller 
cells throughout the retina, including the central part. In the second month the 
number of activated Müller cells strongly increases in the central retina of 
homozygous KO/KO animals (Figure 7). At that age, the central retina of hemizygous 
KI/KO animals just starts to contain a few activated Müller cells, whereas the 
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homozygous KI/KI mice still do not display any activated Müller cells in the central 
retina (Figure 7). In the third month the GFAP staining in the central retina of 
hemizygous KI/KO mice resembles that observed in homozygous KO/KO animals at 
2 months of age. In homozygous KI/KI mice still only a few activated Müller cells can 
be observed (Figure 7). It is only after four months that the number of activated 
Müller cells in the central retina of homozygous KI/KI mice clearly begins to increase 
(Figure 7). Evidently, there is a correlation between the onset of Müller cell activation 
and the progression of photoreceptor cell degeneration. During this process of retina 
degeneration loss of photoreceptor cells starts in the periphery at the ora serata and 
progresses towards the central retina. Müller cell activation displays the same 
pattern. Within the retina, Müller cells and photoreceptors are in close proximity and 
seem to be metabolically coupled. Targeted disruption of Müller cell metabolism 
adversely affects the photoreceptor cell causing a disorganization of the outer 
segments (20). Vice versa, our data show, that photoreceptor cell damage leads to a 
vigorous reaction of the Müller cells (21,22).  Why there is a certain delay between 
the first signs of photoreceptor cell loss and the first observable activation of Müller 
cells in the central retina of homozygous KI/KI mice remains elusive. Most likely the 
Müller cell is indirectly involved in phagocytosis of photoreceptor cell remnants 
(23,24). The gradual loss of photoreceptor cell integrity will evoke a stress reaction in 
the Müller cells, and only when this situation persists, the sustained response of the 
Müller cells may manifest itself in up-regulation of GFAP expression. The Müller cells 
maintain their up-regulated GFAP expression level until photoreceptor cell 
degeneration is complete. Subsequently, GFAP expression returns to normal levels 
(data not shown).   
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Figure 7: Stress-induced GFAP up-regulation in Müller cells within the degenerating central retina. 
Immunofluorescence analysis of the central retina from wild type (+/+), homozygous knock-in (KI/KI) , 
hemizygous (KI/KO), and homozygous knock-out (KO/KO) mice conducted with a rabbit polyclonal 
antibody generated against glial fibrillary acidic protein (GFAP). GFAP expression in the central retina 
of a homozygous KO/KO mouse is seen at postnatal day 60 (PN60) whereas this develops much later 
in hemizygous (KI/KO at postnatal day 90 (PN90)) and in homozygous (KI/KI at postnatal day 120 
(PN120)) animals. At postnatal day 30 (PN30) GFAP expression in KI/KI retina is identical to that in 
wild type specimen. 
 
5.5 Conclusions. 
The histological and immunohistochemical data in this chapter fully support our 
earlier conclusion that homozygous knock-in (KI/KI) mice display a degenerative 
process that is close to completion at the age of 6 months. This is considerably 
slower than the photoreceptor cell loss in homozygous rhodopsin knock-out (KO/KO) 
animals (completed within 3 months) and hemizygous (KI/KO) animals (completed 
around 4 months). Still, this is clearly faster than the degeneration process in 
heterozygous (KO/+) animals, where the first signs of gradual photoreceptor loss are 
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only observed at the age of 5-6 months (15). These data clearly indicate that there is 
an inverse correlation between the rate of rod photoreceptor cell loss and their visual 
pigment level. Intriguingly, in the heterozygous KI/+ mouse we did not detect any 
obvious indication for abnormal photoreceptor loss up to the age of  21 months, 
implying that opsin levels exceeding some 60% of that in the wild type retina are 
sufficient to warrant retinal homeostasis.  
During the degenerative process not only the number of photoreceptor cells declines 
but there is also a gradual reduction in the width of the outer segment layer. At 6 
months of age an intact outer segment layer is no longer observed in the KI/KI 
animals and the amount of opsin has dropped to about 3% of wild-type mice. 
Remarkably, the amount of opsin in KI/KI mice remains fairly stable during the first 
four months whereas the number of photoreceptor cells declines with circa 70% over 
that very same period. This suggests a compensatory mechanism resulting in up-
regulated opsin expression levels in the remaining rod photoreceptor cells. This is an 
intriguing observation and the first indication for such a compensatory process in an 
animal model for retina degeneration. In normal animals it was shown that the rate of 
absorption of photons by photoreceptor cells is kept nearly constant regardless of 
light intensity. This process is called photostasis and can be regulated by the rod cell 
count, the length of the rod outer segments, the rhodopsin concentration and 
regeneration constants. When an animal is moved from high to low light intensities 
rhodopsin is up-regulated, outer segments are lengthened and rhodopsin 
concentration and regeneration rate are increased with the aim of maintaining a 
constant rate of photon absorption (18). KI/KI animals with reduced opsin levels 
could resemble animals constantly kept under very dim light conditions. To ensure a  
constant photon catch, the surviving photoreceptors are signaled to up-regulate 
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opsin expression level. The signaling pathway underlying up-regulation of opsin in 
the remaining photoreceptor cells during retina degeneration in KI/KI mice may 
therefore be the same or connected to that of photostasis in the healthy retina.  
The localization of bovine opsin in mouse rod cells shows the normal pattern: it is 
restricted to the outer segment layer (OS), with minor expression near the sites of 
biosynthesis in the inner segment layer (IS) and in the outer nuclear layer (ONL). As 
anticipated, the homology between bovine and mouse rhodopsin is sufficiently high 
to ensure that the bovine protein is properly processed by the murine translocation, 
transport and targeting machinery. 
In contrast, β-galactosidase was localized over the entire photoreceptor cell layers 
including the outer plexiform layer (OPL). This agrees with the fact that β-galacto-
sidase is a cytosolic protein which can diffuse through the entire photoreceptor cell. 
A small number of photoreceptor cells do not express β-galactosidase and these 
likely represent cone photoreceptor cells. The cones represent the vast majority of 
photoreceptor cells surviving at 6 months of age. This agrees with ERG 
measurements showing that at this age there is still a strong cone response (not 
shown). 
Pericellular GFAP expression in Müller cells is a reliable indicator for neuro-retinal 
injury and/or retina degeneration (19). In homozygous KI/KI and hemizygous KI/KO 
mice Müller cell activation and GFAP expression starts in the periphery of the retina 
already in the first month of age and can still be seen at 6 months when 
degeneration is complete. However, in the central retina more than half of the 
photoreceptor cells were lost before a profound Müller cell activation was 
observable. At 6 months there are still signs of up-regulated GFAP expression 
levels, indicating that the stress-response of the Müller cells only slowly subsides 
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after elimination of the photoreceptor cells. It is tempting to speculate, that the 
stress-response of the Müller cells not only serves to remove photoreceptor debris, 
but also plays a role in up-regulating opsin expression in the still surviving photo-
receptor cells. Vice versa, targeted disruption of Müller cell metabolism adversely 
effects photoreceptor outer segment membrane assembly causing faulty disk 
morphogenesis suggesting that signals for proper membrane folding of the 
photoreceptor disks can be influenced by Müller cells (20). This is indirect evidence, 
that the communication between Müller and photoreceptor cells may include mutual 
regulation of gene expression. The bovine opsin knock-in mouse strain will provide a 
valuable addition to the series of graded retina degeneration mouse models, as well 
as present a suitable system to study the fascinating interplay between Müller and 
photoreceptor cells. 
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One of the five senses, which we use to gather detailed information about our 
environment, is vision. The eye is the sensory organ that enables us to detect light 
and, in concert with the brain, to generate an image of our environment. Chapter 1 
gives an introduction of the structure and functions of the light-sensitive tissue, the 
retina and its highly specialized rod and cone photoreceptor cells. These cells are 
able to absorb light by means of light sensitive membrane proteins (visual pigments), 
and translate light energy into an electrochemical signal that is processed and 
eventually transmitted by neuronal cells to the visual cortex. Light is not only the 
primary trigger for vision but also it is necessary to regulate our biological rhythms. 
  
6.1 Circadian Regulation. 
Photopigments convert light into a signal to entrain the circadian pacemaker that 
resides in the suprachiasmatic nucleus (SCN) of the brain. 
In mammals bilateral removal of the eyes completely abolishes the ability to photo-
entrain the circadian system. Therefore it was concluded that the circadian 
photoreceptors must reside in the eye. In search for circadian photopigments we 
studied a unique subterranean rodent, Spalax ehrenbergi. Approximately thirty 
million years of adaptation to a subterranean environment and lifestyle resulted in a 
natural degeneration of the visual system of Spalax (1). The Spalax eye has a 
subcutaneous location and the anterior eye segments start to degenerate shortly 
after embryonic development. However, morphological development of the retina 
with its classical stratified organization is relatively normal (2). On the other hand, 
neuronal components of the visual pathways are regressed or absent and neither 
anatomically nor electrophysiologically a visual cortex can be identified (3,4). In 
contrast, bilateral projections from the retina to the suprachiasmatic nucleus (SCN) 
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have been expanded (5) and, surprisingly, Spalax has preserved the ability to entrain 
its biological clock to environmental light cues (6). Removal of both eyes completely 
abolishes photoentrainment, demonstrating that the circadian photoreceptor system 
is located in the eye (7). Despite the degenerate nature of its visual processing 
systems, Spalax has retained a relatively well-structured retina that expresses both a 
rod-like and green cone-like visual pigment (6,8,9). 
In chapter 2 we present an extensive characterization of the rod-like visual pigment 
of Spalax. The open reading frame of the rod-like visual pigment has more than 90% 
homology with the mammalian rod pigments. In vitro expression and regeneration of 
this protein resulted in a photopigment with a peak absorbance at 497 ± 2 nm and all 
functional characteristics of a rod visual pigment, including the ability to activate its 
downstream effector, the G-protein transducin (Gtα) (10,11). We also identified this 
functional system in vivo by means of immunohistochemical analysis of Spalax retina 
with anti-rhodopsin (12) and anti-Gtα antibodies (13). We observed abundant 
expression of rod visual pigment in Spalax photoreceptor outer segments (OS) and 
outer nuclear layer (ONL). Gtα expression was also observed in Spalax but only in 
the outer segment layer in contrast to mouse where Gtα is detected throughout the 
entire photoreceptor cell. Our present explanation is, that in order to guarantee 
maximal photon capture under very low light intensities Spalax has to maintain high 
expression levels of visual pigment. However, the level of activated pigment will be 
very low and therefore signal transduction could be established with much lower Gtα 
levels than in sighted animals. By means of microspectrophotometry (MSP) we also 
established functionality of the pigment in vivo. MSP analysis resulted in a vitamin 
A1-based spectrum (14) with a peak spectral absorbance in the range 500-505 nm, 
which is not significantly different from the recombinant protein. 
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In chapter 3 we describe an extensive biochemical characterization of the green 
cone-like visual pigment of Spalax ehrenbergi. The recombinant protein shows the 
characteristics of a functional cone pigment and a peak spectral absorbance at 530 ± 
2 nm. This is remarkably red-shifted from green cone pigments of other rodents. A 
possible explanation for this phenomenon is that Spalax needs to red shift its green 
cone pigment to compensate for the subcutaneous regression of the eyes and the 
concomitant light-filtering effect of the surrounding tissue (15).  This may also explain 
why in Spalax no functional blue-cone-like pigment could be detected (16). The 
subcutaneous positioning of the eye made a functional blue cone-like pigment 
obsolete. Furthermore, the green cone-like visual pigment has the ability to activate 
a downstream effector, the G-protein transducin (Gtα), to the same extent as the 
human green cone pigment.  Upon illumination the green cone pigment proceeds 
through a sequel of photointermediate states with characteristic biochemical 
properties. Meta II is the photointermediate that is able to bind to the G-protein 
transducin. The decay rate of human and Spalax green Meta II is comparable and in 
the range of typical green cone pigments (17). However, the Meta I to Meta II 
transition of the Spalax pigment displays a temperature dependence that differs from 
that of the human green cone pigment. This difference, however, is only apparent 
below 10°C, so will be without functional consequences.   
The spectral properties of green cone pigments can be influenced by binding of 
anions like chloride to a specific site referred to as anion or chloride binding site. The 
binding of chloride usually effectuates a red shift, which can be reversed by 
replacement with other anions like nitrate (18). The major determinants of the 
chloride binding site, histidine at position 197 (H197) and lysine at position 200 
(K200) have been identified in many mammalian species (19,20). Rodents, however, 
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have a tyrosine at position 197 (Y197) and do not show any spectral change upon 
chloride substitution (21). Similar to other rodents, Spalax green cone pigment also 
carries the H197Y substitution but it still displays a 12 nm blue shift upon exchange 
of chloride for nitrate. This blue shift, however, is much smaller than that observed 
for the human green cone pigment with the classical H197 site which displays a blue 
shift of 19-25 nm under similar conditions (17,20). 
Apparently Spalax was under evolutionary pressure to red-shift its green cone 
pigment. Why this constraint did not result in a simple back-mutation of Y197 into H 
remains in the dark, although eventually bioinformatics studies on cone pigment 
sequences from a larger collection of species may shed light on this matter.  
This leaves us with the intriguing question why a blind mammal, in spite of the 
regression of its visual pathways, has retained fully functional visual pigments? Most 
likely, adaptation to a subterranean environment resulted in a negative (or at best 
neutral) selective pressure regarding most components of the visual system. This 
would exclude those elements necessary to maintain basal retinal morphology and 
bilateral projections to the suprachiasmatic nucleus (SCN) in order to ensure 
maintenance of photoperiodic regulation, as was already suggested by Hendriks et 
al. (22). In sighted mammals the photoreceptors that mediate photoregulation of the 
circadian system are now finally being identified (23,24). Data obtained from animal 
models which display photoreceptor cell degeneration did suggest that neither rods 
nor cones are absolutely required for photoentrainment and that the major circadian 
photoreceptor must be located in the inner nuclear layer or ganglion cell layer of the 
retina (25,26). It has been demonstrated, that the mammalian retina contains novel 
types of photosensitive proteins which are not located in the photoreceptor cell layer 
but in the inner neuronal retina. One of the novel types of photopigments are the 
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blue light receptors, Cry1 and Cry2. From recent data it can be concluded that these 
proteins do not function as photopigments but rather as components of the molecular 
clock (27-30). Another, and very strong candidate at the moment is a novel opsin-
based photopigment, melanopsin (31,32). Melanopsin is expressed in the plasma 
membrane of a specific type of retinal ganglion cells called the intrinsically 
photosensitive retinal ganglion cells (ipRGC) that also express pituitary adenylate 
cyclase-activating polypeptide (PACAP), a neurotransmitter of the 
retinohypothalamic tract (RHT) (33,34). Retrograde labeling of the SCN indeed 
confirms that the ipRGC, via the RHT, are in direct contact with the SCN (35). Mice 
with an ablation of the melanopsin gene still entrain to photic stimuli, but in particular 
the magnitude of the responses to weak stimuli is strongly reduced compared to wild 
type mice (29,36). This indicates that melanopsin is not solely responsible for the 
photic information that is received by the clock. Recent studies show that triple 
knock-out mice, with disabled rod and cone phototransduction mechanisms and 
complete loss of functional melanopsin, entirely fail to entrain to light/dark cycles. 
Thus it can be concluded that the rod and/or cone pigments and melanopsin 
photopigments together seem to provide all photic input required for the circadian 
system (23,24). Recently, it has been shown that the ipRGC also receive input from 
bipolar cells and multiple types of amacrine cells, suggesting that rod and/or cone 
signals may be capable of activating and/or modifying the intrinsic light response of 
the ipRGC (37). This cooperative effect of three photoreceptor classes and the 
adaptation of the system to gene targeting of one or two components will most likely 
be subject of further intensive studies. How the ipRGC integrate the signals from the 
rod/cone photoreceptors and their intrinsic light response also needs to be 
investigated further.  
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The circadian system of sighted animals requires twilight intensities for sustained 
periods of time and thus may not function adequately in a subterranean environment 
with very low light intensities and sparse light exposure (38,39). Although 
melanopsin still is detected in the retinal ganglion cells of Spalax after 30 millions 
years of adaptation to a subterranean environment (40) it is questionable whether, 
under the given conditions, it still can have a function in photoentrainment. 
Considering that evolutionary principles would argue against maintaining a 
photoreceptor layer and functional visual pigments at high metabolic costs without 
physiological importance, we propose that Spalax, in its adaptation to a blind 
subterranean lifestyle, has rewired its retinal circuitry to maintain circadian 
photoentrainment under conditions of low light intensity. For that purpose, Spalax 
may have reorganized its non-visual photoreceptor circadian system to allow a 
strong input from the much more abundant and more sensitive visual photoreceptor 
system, which could be diverted from its original function because vision itself lost its 
relevance. This demanded that the photoreceptor cell layer and both rod and cone 
photopigment remained functional.  Whether both pigments, rod- and cone opsin, in 
Spalax play a crucial role in photoentrainment needs to be investigated in more 
detail. The location of the green-cone-like opsin has not been established yet. 
Morphologically, no evidence could be found for the presence of cone cells in the 
Spalax retina indicating that the green-cone-like opsin need not to reside in cone 
cells themselves (41). To what extent the circadian system in Spalax differs from that 
in sighted mammals is not clear. Our morphological data indicate that the visual 
photoreceptors in Spalax have adopted features similar to the pineal of non-
mammalian vertebrates suggesting a circadian function different from that in sighted 
mammals (41). A comparison between sighted rodents and Spalax can only be 
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made with transgenic Spalax models in which the melanopsin and the rod and/or 
cone photopigments have been rendered nonfunctional. However, from a technical 
point of view the generation of transgenic Spalax models is not an option. In 
conclusion, evolution resulted in Spalax in a negative selection pressure involving 
most components of the eye with the exception of those elements required for 
embryonic eye development to ensure a basal retina morphology and bilateral 
projections to the suprachiasmatic nucleus (SCN) in order to maintain photoperiodic 
regulation (22). Furthermore, we argue on basis of the presented indirect evidence 
that very low light intensities in the subterranean habitat of Spalax have requested 
an enhanced role for the visual photoreceptors in the process of photoentrainment 
and an identical or even less important role for melanopsin than in sighted mammals. 
 
6.2 Photoreceptor Degeneration. 
In sighted mammals, next to its role in vision, rhodopsin also contributes in 
preserving the structural integrity of the photoreceptor cell. Impairment of rhodopsin 
biosynthesis or impaired targeting as described in patients with autosomal dominant 
retinitis pigmentosa (ADRP) (42) or complete ablation of rhodopsin (43,44) 
compromise the metabolic and structural integrity of the photoreceptor cell and may 
eventually lead to photoreceptor cell death and degeneration of the outer retina. To 
better understand the role of rhodopsin in normal retinal morphology and in the 
pathogenesis of retina degeneration, targeted knock-in mouse models in which a 
mutated gene replaces the wild type murine opsin gene would be highly desirable. In 
chapter 4 we describe, as a first step in this direction, the generation and 
characterization of a wild type bovine rhodopsin knock-in mouse model. The 
designed knock-in construct contained, in the given order, a rabbit β-globin intron, 
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the wild type bovine rhodopsin open reading frame, an IRES (internal ribosome entry 
site) and the lacZ marker gene. Using only the opsin and lacZ coding sequences 
would result in a minigene without any introns. This may reduce the processing 
efficiency of the resulting RNA, and we therefore inserted the small globin intron 
upstream of the start codon. To allow independent monitoring of successful 
transcription / translation from the knock-in allele, we introduced the lacZ reporter, 
headed by an IRES sequence, downstream of the bovine rhodopsin coding part. The 
knock-in mini-gene thus would render a bicistronic messenger, encoding bovine 
rhodopsin as well as β-galactosidase. Since rhodopsin and transducin are highly 
homologous in mouse and bovine, downstream functional signaling consequences 
should be minimal. The resulting targeted knock-in mice have been analyzed for 
opsin and β-galactosidase expression. The bicistronic messenger indeed resulted in 
two separate, appropriately sized proteins. Tissue-specific expression of the mutant 
allele was verified by immunohistochemical analysis as described in chapter 5, that 
showed normal opsin localization in the outer segment (OS) and outer nuclear layer 
(ONL), with minor expression in the inner segments (IS). In contrast, β-galactosidase 
was localized over the entire photoreceptor cell layer including the outer plexiform 
layer (OPL). This is not surprising, since β-galactosidase is a cytosolic protein, which 
can diffuse throughout the entire photoreceptor cell. There also are a small number 
of photoreceptor cells that do not express β-galactosidase and most likely represent 
cone photoreceptor cells. The levels of opsin and rhodopsin are very similar 
indicating that the bovine opsin is expressed in a functional state; i.e. that it is 
correctly processed and activated. This did not come as a surprise, since the 
homology between murine and bovine opsin is so high that processing of the bovine 
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protein should be properly performed by the murine translocation, transport and 
targeting machinery. 
Unexpectedly, only 10-15% of normal opsin levels are produced in the homozygous 
knock-in mouse (KI/KI). In view of future studies involving mutant rhodopsin animal 
models it will be relevant to know what factors contribute to this decreased opsin 
expression. Presently, we can only speculate why the mini-gene replacement leads 
to reduced levels of opsin. Perhaps the use of a bicistronic messenger may have a 
negative effect on translation efficiency. To test this, an animal model could be 
generated that lacks the IRES sequence and the LacZ reporter. If this indeed 
improves opsin expression and retina degeneration remains absent we can start 
generating animal models with mutated opsin coding sequences in order to serve in 
the study of mutation-dependent degeneration. Otherwise, replacement with a 
genomic DNA segment instead of a cDNA carrying the desired mutation should be 
considered. 
In the knock-in mouse model we generated, the opsin level remained stable at about 
15% of the wild type level for about 4 months. At the age of 6 months, however, it 
has strongly decreased to 3% of the wild type level. This is a clear indication that 
retina degeneration is proceeding and that at this stage almost no photoreceptor 
cells are left. In sharp contrast, the histological data display a progressive 
photoreceptor degeneration during the first 4 months, which nears completion at 6 
months. Previous studies indicate that both targeted disruption of the opsin gene and 
overexpression of opsin in transgenic mice lead to photoreceptor degeneration (43-
45). The rate of photoreceptor cell degeneration in homozygous rhodopsin knock-out 
(KO/KO) animals proceeds much faster and is completed within 3 months.  
Crossbreeding both models resulted in hemizygous KI/KO mice in which the rate of 
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photoreceptor cell degeneration is slowed, since it nears completion only after 4 
months.  Heterozygotes, KI/+ and KO/+, display a slight reduction in outer segment 
length at 4 months and a minor reduction of photoreceptor nuclei at 6 months 
(43,44). However, preliminary studies with older heterozygous KI/+ mice from 14 up 
to 21 months of age indicate that there is no significant reduction in outer segments 
or loss of photoreceptor nuclei relative to wild-type animals . Hence, whether the KI/+ 
mouse deviates significantly from wild type has to be examined in more detail.  
Very recently a knock-in mouse model was presented where the murine gene was 
replaced by a human rhodopsin gene construct coding for a rhodopsin-EGFP fusion 
protein (46). This model shows correct targeting of the fusion protein as well as 
reduced expression levels and progressing photoreceptor degeneration, a 
phenotype similar to the one we report, in spite of the fact that the complete gene 
was inserted. In this case, however, the phenotype maybe due to expression of a 
fusion protein, which could present a compromising factor at several levels 
(transcription, translation, targeting, disc assembly or structure, and excitation and/or 
desensitization) and therefore cannot be easily compared with the current model.  
Our data present novel evidence that photoreceptor integrity strongly depends on the 
expression level of rhodopsin. In fact, the rate of photoreceptor cell degeneration 
seems to be inversely correlated with the opsin expression level. The level of opsin 
that suffices for a photoreceptor cell to maintain metabolic integrity and to prevent 
apoptosis remains to be determined precisely, but considering the results from our 
heterozygous KI/+ mice and from the heterozygous KO/+ mice (43,44) we can state 
that the lower limit of opsin levels must be in the order of 60% of the normal wild type 
level to prevent significant loss of photoreceptor cells.  
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It is quite remarkable that the number of photoreceptor cells in homozygous knock-in 
mice strongly decreases in the first 4 months while the opsin level remains stable at 
approximately 15%. These data suggest a novel and intriguing mechanism in which 
the retina, during degeneration, tries to compensate for photoreceptor loss by up-
regulating opsin expression in the remaining rod photoreceptor cells. The 
mechanism by which photoreceptor cells up-regulate their opsin expression would 
present an interesting subject for further studies, including proteomic approaches. 
Unfortunately, very little is known about the cellular processes underlying 
photoreceptor cell degeneration. A clear morphological phenotype in our KI/KI mice 
is the severe disruption of the outer segment organization. Transgenic mouse 
models in which opsin expression is blocked or opsin targeting is compromised 
display impaired disk morphogenesis or even complete lack of outer segments 
(43,44,47-50). How disk morphogenesis can be influenced by the amount of opsin is 
unknown. This may reflect a simple mass imbalance, but one could also speculate 
that low opsin expression levels inflict changes in the polarized opsin distribution 
across the connecting cilium and outer segments, reminiscent of what was noted in 
Rpgr knock-out mice (51). There, unequal opsin distribution resulted in shorter and 
disorganized outer segments. Increasing opsin levels may also serve to reduce the 
mass imbalance or to improve the polarized opsin distribution over the membrane 
compartments..  
As a secondary effect, the impaired outer segment assembly and/or integrity may 
eventually seriously compromise ion balance and homeostasis in the rod 
photoreceptor cell. Indeed it has been demonstrated that gradual loss of calcium 
homeostasis can in general induce apoptosis (52). It is still an open question 
whether a disturbed ion balance or a decreasing photosignal is the major trigger for 
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the rod photoreceptor cell to up-regulate its opsin expression in homozygous KI/KI 
mice. Increasing opsin expression requires concerted actions of transcription factors, 
like CRX (53,54), and proteomic approaches could be used to investigate expression 
levels of such factors in KI/KI mice during the first four months. Our studies with the 
heterozygous KI/+ and KO/+ animals indicate that an increase of approximately four-
fold in opsin level may be sufficient to prevent degeneration of the photoreceptor cell. 
At an age of 3-4 months only 4-5 rows of the normal 10-12 rows of outer nuclear 
layers are left, which would correspond to a cellular opsin level  between 40-50 % of 
wild type. This is quite close to the "safe" opsin expression level of about 60%. 
Nevertheless, rod cell degeneration still progresses. Possibly, the metabolic costs for 
increasing opsin expression in the remaining photoreceptor cells eventually becomes 
too high.  Additionally, factors like overflow of retinal or lipids can trigger oxidative 
damage to the photoreceptor cell and may eventually lead to photoreceptor cell 
death. Secondary insults may also play a role, as has been inferred for the slow 
cone cell degeneration observed following rod cell death triggered by certain 
rhodopsin mutants in human retinas (55). A reliable indicator for neuro-retinal injury 
or photoreceptor cell degeneration is the activation of Müller cells in the retina as 
manifested by increased expression of glial fibrillary acidic protein (GFAP) in these 
cells. In homozygous KI/KI and hemizygous KI/KO mice the up-regulation of GFAP 
expression in Müller cells starts at the periphery of the retina at the first month of 
age, and can still be observed at 6 months when degeneration is complete. In sharp 
contrast, in the central retina more than half of the photoreceptor cells is lost before a 
profound Müller cell activation is observable. Evidently, there is a correlation 
between the onset of Müller cell activation and the progression of photoreceptor cell 
degeneration. During this process of retina degeneration loss of photoreceptor cells 
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starts in the periphery at the ora serata and progresses towards the central retina. 
Müller cell activation displays the same pattern. We speculate that the activation of 
Müller cells not only serves to remove photoreceptor debris, but also plays a role in 
up-regulation of opsin expression in the still surviving photoreceptor cells. This is 
supported by recent findings of crucial cellular interplay between Müller and 
photoreceptor cells, which may entail mutual regulation of gene expression (56). In 
conclusion, not only the high metabolic costs for the photoreceptor cell that comes 
with up-regulating opsin expression and/or maintaining outer segment integrity, but 
also the cellular interplay with other retinal cells, like RPE and Müller cells, could 
contribute to the photoreceptor cell death that we observed in our bovine opsin 
knock-in mouse model.  
The collection of genotypes that can be established with our animal model in 
combination with others (e.g. KO/KO, KI/KO, KI/KI, KO/+, KI/+, +/+), and that results 
in a graded series of opsin expression levels in the retina, offers a unique opportunity 
to study in more detail the metabolic processes within the photoreceptor cell itself 
and the interplay between photoreceptors and other retinal cell types like RPE and 
Müller cells during photoreceptor cell degeneration. More insight in the cellular 
processes underlying photoreceptor cell death will ultimately contribute to the 
development of therapeutical interventions to counteract the process of retina 
degeneration.  
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Zien is één van de vijf zintuiglijke waarnemingen die wij gebruiken om gedetailleerde 
informatie over onze omgeving te verkrijgen. Het oog is het orgaan dat ons in staat 
stelt om licht te detecteren en in samenspel met de hersenen een beeld te vormen 
van de omgeving. Hoofdstuk 1 presenteert een inleiding waarin de structuur en 
functie van het oog, het lichtgevoelige weefsel (de retina) en de zeer 
gespecialiseerde lichtgevoelige cellen (de fotoreceptoren) worden beschreven. Deze 
fotoreceptoren zijn in staat licht te absorberen met behulp van lichtgevoelige 
eiwitten, de visuele pigmenten. Het licht wordt in de fotoreceptoren omgezet in een 
electrochemisch signaal dat uiteindelijk via diverse neuronen verder wordt geleid 
naar de visuele cortex waar beeldvoming plaatsvindt.  
 
7.1 Regulatie van het circadiaanse ritme. 
Lichtgevoelige pigmenten in de retina zetten licht niet alleen om in een signaal voor 
beeldvorming maar geleiden ook signalen naar de biologische klok, ook wel de 
“circadiaanse pacemaker” genoemd. Deze is gelegen in de suprachiasmatische 
nucleus (SCN), een kleine celkern in de hersenen en een onderdeel van de 
hypothalamus. Zonder ogen kunnen zoogdieren hun circadiaanse ritme niet 
aanpassen aan het dag-nacht ritme. Hieruit mag men concluderen dat de 
fotopigmenten die het circadiaanse systeem reguleren in het oog gelegen zijn. In 
een poging om dergelijke fotopigmenten te identificeren hebben we gebruik gemaakt 
van een ondergronds levend knaagdier, Spalax ehrenbergi. Geleidelijke aanpassing 
aan een leven ondergronds heeft bij deze soort na ongeveer 30 miljoen jaar 
uiteindelijk geresulteerd in een natuurlijke degeneratie van het visuele systeem (1). 
Het oog van Spalax is subcutaan gelokaliseerd en de voorste segmenten 
degenereren kort na de embryologische ontwikkeling. Echter, de morfologische 
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ontwikkeling en de karakteristieke gelaagde opbouw van de retina is bewaard 
gebleven (2). Desondanks zijn de neuronale componenten van het visuele systeem  
gedegenereerd of zelfs afwezig en kan er zowel anatomisch als elektrofysiologisch 
geen visuele cortex worden aangetoond (3,4). De bilaterale projecties van de retina 
naar de suprachiasmatische nucleus (SCN) daarentegen zijn uitgebreid (5) en 
Spalax heeft hiermee de mogelijkheid om zijn biologisch ritme door middel van licht 
te reguleren weten te behouden (6). 
Ook Spalax is na verwijdering van de beide ogen niet meer in staat zijn biologische 
klok te reguleren met licht. Hieruit mag worden geconcludeerd dat ook bij Spalax de 
circadiaanse fotoreceptor zich in het oog moet bevinden (7). Ondanks het 
gedegenereerde karakter van het visuele systeem heeft Spalax toch een 
morfologisch redelijk intacte retina behouden welke zowel staafjes-achtige als 
kegeltjes-achtige pigmenten bevat (6,8,9). 
In hoofdstuk 2 wordt de karakterisatie van het staafjes-achtige pigment van Spalax 
beschreven. De aminozuurvolgorde van dit pigment vertoont meer dan 90% 
homologie met dat van de staafjes-pigmenten in andere zoogdieren. Na functionele 
expressie en regeneratie blijkt het Spalax staafjes-pigment in vitro nog alle 
fotochemische eigenschappen karakteristiek voor een functioneel pigment te 
bezitten. Bovendien is het nog steeds in staat om het G-eiwit  transducine (Gtα ) 
(10,11) te activeren. Ook in vivo hebben we door middel van immunohistochemie 
met een antilichaam tegen het staafjes-pigment rhodopsine (12) en een antilichaam 
tegen het G-eiwit  transducine (Gtα ) (13) beide eiwitten kunnen aantonen. Hieruit 
blijkt een hoog gehalte van het Spalax staafjes-pigment in de buitensegment-laag en 
de buitenste kern-laag van de fotoreceptoren. Gtα blijkt in Spalax alleen in lage 
concentratie in de buitensegment-laag voor te komen terwijl bij de muis Gtα in alle 
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segmenten van de fotoreceptor-cel kan worden gedetecteerd. Onze verklaring 
hiervoor is dat de hoge dichtheid van het staafjes-pigment naar alle 
waarschijnlijkheid nodig is om bij zeer lage licht-intensiteit een zo hoog mogelijke 
“foton-catch” te realiseren. Daaruit volgt dat als er weinig staafjes-pigment wordt 
geactiveerd de signaal transductie in de cel in stand gehouden kan worden met veel 
lagere hoeveelheden Gtα dan bij ziende dieren. Door middel van 
microspectrofotometrie (MSP) hebben we de fotochemische functionaliteit van het 
pigment ook in vivo kunnen aantonen. De MSP analyse correspondeerde met een 
typisch vitamine A1 gebaseerd spectrum (14) met een absorptie-maximum tussen 
de 500 en 505 nm. Dit stemt redelijk goed overeen met de maximale absorptie 
gevonden voor het recombinant eiwit (497 nm). 
In hoofdstuk 3 beschrijven we een uitvoerige biochemische analyse van het groene 
kegeltjes-achtige pigment van Spalax ehrenbergi. Het geproduceerde recombinante 
eiwit vertoont alle karakteristieken van een functioneel groen kegeltjes-pigment. Het 
heeft een maximale absorptie bij 530 ± 2 nm welke aanzienlijk naar rood verschoven 
is ten opzichte van de andere groene kegeltjes-pigmenten in knaagdieren. Een 
mogelijke verklaring voor dit fenomeen is dat Spalax op deze manier heeft trachten 
te compenseren voor de onderhuidse lokalisatie van het oog en het dientengevolge 
filterende effect van het omliggende weefsel (15). Dit zou ook een verklaring zijn 
waarom Spalax geen functioneel blauw kegeltjes-pigment bezit (16). 
Het groene kegeltjes-pigment van Spalax blijkt het effector-eiwit transducine (Gt) in 
dezelfde mate te kunnen activeren als het humane groene kegeltjes-pigment. Na 
belichting doorloopt het groene kegeltjes-pigment diverse intermediaire stadia met 
karakteristieke biochemische eigenschappen. Meta II is het stadium dat de actieve 
receptor representeert, waaraan het G-eiwit transducine kan binden. De 
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vervalsnelheid van het humane en het Spalax Meta II stadium zijn vergelijkbaar en 
karakteristiek voor kegeltjes-pigmenten (17). Daarentegen blijkt de overgang van 
Meta I naar Meta II bij het Spalax pigment een andere temperatuursafhankelijkheid  
te hebben dan bij het humaan groene kegeltjes-pigment. Het verschil treedt echter 
pas op beneden de 10° C en zal geen fysiologische consequenties met zich 
meedragen. De spectrale eigenschappen van het groene kegeltjes-pigment van 
primaten kunnen worden beïnvloed door binding van anionen zoals chloride aan een 
specifieke plaats in het eiwit ook wel de anion- of chloride-bindingsplaats genoemd. 
De binding van chloride zorgt meestal voor een rood-verschuiving van het spectrale 
absorptie-maximum, hetgeen omkeerbaar is door chloride te vervangen door andere 
anionen zoals nitraat (18). De belangrijkste aminozuren die betrokken zijn bij de 
binding van chloride zijn een histidine op positie 197 (H197) en een lysine op positie 
200 (K200)(19,20).  Knaagdieren daarentegen bezitten een tyrosine op positie 197 
(Y197), vertonen geen spectrale veranderingen door vervanging van chloride (21) en 
hebben blijkbaar deze specifieke anion-bindingsplaats verloren. Als knaagdier heeft 
Spalax eveneens de tyrosine op positie 197 (Y197), maar het groene pigment 
vertoont desondanks wel een 12 nm blauw-verschuiving bij vervanging van chloride 
door nitraat. De blauw-verschuiving van het Spalax groene kegeltjes-pigment is veel 
kleiner vergeleken met die van het humaan groene kegeltjes-pigment welke een 
klassieke anion-bindingsplaats heeft en 19-25 nm verschuift door vervanging van 
chloride met nitraat (17,20). 
Blijkbaar heeft Spalax onder evolutionaire druk de absorptieband van zijn groene 
pigment naar rood opgeschoven. Waarom dit niet is gerealiseerd door de tyrosine op 
positie 197 terug te muteren naar histidine (Y197H) is vooralsnog onduidelijk, maar 
mogelijk kan de bioinformatica daar in de toekomst een antwoord op geven. 
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Een belangrijkere vraag is: waarom heeft een blind zoogdier ondanks de regressie 
van zijn visuele systeem toch functionele visuele pigmenten behouden? De 
aanpassing aan een ondergronds bestaan heeft geleid tot een negatieve selectie-
druk (of hoogstens het ontbreken van selectie-druk) op delen van het visuele 
systeem. Daarnaast heeft het blijkbaar ook geleid tot een positieve selectie-druk 
voor die delen noodzakelijk voor het behoud van de retina morfologie en van de 
circadiaanse fotoregulatie, zoals al werd opgemerkt door Hendriks et al.(22). In 
ziende zoogdieren zijn de fotoreceptoren die noodzakelijk zijn voor fotoregulatie van 
het circadiaanse systeem uiteindelijk recentelijk geïdentificeerd (23,24). Op basis 
van diermodellen die fotoreceptor-degeneratie vertonen was al aangetoond dat 
staafjes noch kegeltjes essentieel zijn voor fotoregulatie van het circadiaanse 
systeem en dat de belangrijkste circadiaanse fotoreceptoren gelegen moeten zijn in 
de binnenste nucleaire laag of ganglion cel-laag van de retina (25,26). Sindsdien zijn 
nieuwe licht-gevoelige eiwitten in de retina van zoogdieren ontdekt, die gelegen zijn 
in de binnenste lagen van de neurale retina. Eén familie van nieuwe fotogevoelige 
pigmenten zijn de cryptochromen of blauw licht receptoren, Cry1 en Cry2. Recente 
gegevens tonen echter aan dat deze eiwitten niet functioneren als licht-gevoelige 
pigmenten maar als componenten van de biologische klok (27-30). Een ander 
kandidaat-eiwit is het met opsine verwante eiwit, melanopsine (31,32). Melanopsine 
is gelocaliseerd in de membranen van een speciaal type ganglion-cellen, de 
“intrinsically photosensitive retinal ganglion cells” (ipRGC). Deze cellen produceren 
een neurotransmitter, het  “pituitary adenylate cyclase-activating polypepetide” 
(PACAP) dat werkzaam is tussen de neuronen die een verbinding vormen tussen 
retina en hypothalamus, ook wel het “retinohypothalamic tract” (RHT) genoemd 
(33,34). Retrograde labeling van de SCN bevestigt dat de ipRGC via het RHT in 
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direct contact staan met de SCN (35). Muizen waarbij de functie van het 
melanopsine-gen is uitgeschakeld vertonen nog steeds een circadiaanse licht-
respons, maar deze is met name bij lage licht-intensiteit aanzienlijk gereduceerd 
vergeleken met normale muizen (29,36). Dit is een indicatie dat melanopsine niet als 
enige verantwoordelijk is voor de fotoregulatie van de klok. Recente studies met een 
driedubbele knock-out muis, waarbij de functie van zowel melanopsine als van de 
staafjes- en kegeltjes-fotoreceptoren is uitgeschakeld, tonen aan dat onder deze 
omstandigheden de fotoregulatie van de klok volledig is geblokkeerd. Hieruit kan 
geconcludeerd worden dat staafjes, kegeltjes en melanopsine samen 
verantwoordelijk zijn voor de licht-afhankelijke sturing van het circadiaanse systeem 
(23,24).  Dit wordt ondersteund door het feit dat recent is aangetoond dat de ipRGC 
ook signalen ontvangen van bipolaire cellen en diverse typen amacrine cellen, 
hetgeen waarschijnlijk maakt dat staafjes en/of kegeltjes in staat zijn de licht-respons 
in de ipRGC te beïnvloeden (37). De samenwerking van deze drie fotoreceptoren is 
fascinerend en zal ongetwijfeld nog verder onderzocht worden. Een eerste vraag is 
bijvoorbeeld al hoe de lichtrespons in de ipRGC wordt gemoduleerd door signalen 
van de staafjes en kegeltjes.  
Om goed te kunnen functioneren heeft het circadiaanse systeem van ziende dieren  
gedurende een bepaalde periode een minimum licht-intensiteit nodig die 
vergelijkbaar is met schemerlicht. Dit zal waarschijnlijk niet goed functioneren in een 
ondergrondse omgeving met maar zeer incidentele lichtpulsen (38,39). Echter, zelfs 
na een 30 miljoen jaar lange evolutionaire aanpassing van Spalax aan zijn 
ondergrondse omgeving is nog steeds melanopsine in de ipRGC aantoonbaar (40). 
Men kan zich daarbij wel afvragen of dit nog adequaat kan functioneren.  
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Het lijkt tegen de wetten van de evolutie-theorie in te gaan om een fotoreceptor-laag 
met functionele visuele pigmenten of een eiwit zoals melanopsine in stand te houden 
zonder een duidelijke fysiologische betekenis. Onze conclusie is derhalve dat Spalax 
de visuele pigmenten en melanopsine als fotoregulatoren van het circadiaanse 
systeem zodanig heeft weten aan te passen dat deze kunnen functioneren bij 
extreem lage licht-intensiteiten. Hiertoe heeft Spalax waarschijnlijk gebruikt gemaakt 
van de veel hogere gevoeligheid van de visuele receptoren (de staafjes en de 
kegeltjes) die niet meer nodig waren voor het zien. Dit zou verklaren waarom de 
fotoreceptor-laag met daarin staafjes- en kegeltjes-pigmenten functioneel en 
structureel intact is gebleven. Of de staafjes en kegeltjes in Spalax beide een 
belangrijke rol spelen in de circadiaanse fotoregulatie moet verder worden 
onderzocht. In feite is er nog niets bekend over de locatie van het groene kegeltjes-
pigment en zijn de corresponderende kegeltjes-cellen nog niet geïdentificeerd (41). 
In hoeverre het circadiaanse systeem van Spalax is gaan afwijken van dat van 
ziende zoogdieren is eveneens een interessante vraag. Morfologisch gezien lijken 
de fotoreceptoren in de retina van Spalax op de fotogevoelige cellen in de 
pijnappelklier van lagere vertebraten. Dit lijkt ook een aanwijzing dat de functie van 
de fotoreceptoren in Spalax volledig verschilt van die van ziende zoogdieren (41). 
Diepgaand onderzoek aan het mechanisme van de lichtrespons in Spalax is 
waarschijnlijk alleen mogelijk met behulp van transgene Spalax modellen waarbij de 
functie van melanopsine en/of staafjes- of kegeltjes-pigment is uitgeschakeld of 
gemodificeerd. Het maken van transgene Spalax diermodellen is echter momenteel 
nog niet mogelijk. 
In conclusie: de evolutionaire ontwikkeling in Spalax lijkt gepaard gegaan met een 
negatieve selectie van veel delen van het oog met uitzondering van die 
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componenten die noodzakelijk zijn voor een basale ontwikkeling van de retina en 
voor het in stand houden van de circadiaanse fotoregulatie (22). Om te kunnen 
functioneren bij zeer lage licht-intensiteiten is het mechanisme hiervan in Spalax 
waarschijnlijk bijgesteld in vergelijking met ziende dieren, waarbij de “afgedankte” 
visuele fotoreceptoren een belangrijke rol zijn gaan spelen. 
 
7.2 Fotoreceptor degeneratie. 
In ziende dieren heeft rhodopsine niet alleen een functie bij het proces van 
beeldvorming en circadiaanse regulatie maar is rhodopsine ook noodzakelijk voor de 
homeostase (het werkzaam blijven) van de fotoreceptor-cel. Functie-verlies van 
rhodopsine door een verstoorde biosynthese of door blokkades in het intracellulaire 
transport zoals zijn aangetoond in patiënten met retinitis pigmentosa (42), of door het 
volledig ontbreken van rhodopsine  (43,44), leidt tot verstoring van het metabolisme 
en vervolgens tot verlies van de structurele integriteit van de fotoreceptor-cel. Dit 
heeft uiteindelijk tot gevolg dat de fotoreceptor-cellen afsterven, hetgeen leidt tot 
degeneratie van de buitenste delen van de retina. Om beter de rol van rhodopsine te 
kunnen bestuderen en inzicht te verkrijgen in het proces van fotoreceptor-cel 
degeneratie hebben wij geopteerd voor het maken van een transgeen muizen model 
waarbij het opsine is vervangen door een mutant opsine. In hoofdstuk 4 beschrijven 
we de eerste stap in deze richting, waarbij het principe wordt uitgelegd voor het 
maken en bestuderen van een knock-in muizen model waarbij het muizen opsine-
gen is vervangen door het cDNA van runder opsine. Het knock-in construct is 
opgebouwd uit respectievelijk een β-globine intron van het konijn, het normale 
runder opsine cDNA, een IRES (“internal ribosome entry site”) sequentie en het lacZ 
gen. De opsine-lacZ combinatie bevat geen intron-sequenties. Daarom hebben we 
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het laten voorafgaan door het  β-globine intron II van het konijn zodat de omzetting 
van afgelezen RNA naar een actief boodschapper-RNA beter verloopt. Om 
eenvoudig te kunnen bepalen of het construct werkzaam is hebben we het lacZ gen 
ingevoerd, waarbij het genproduct β-galactosidase als een snel aantoonbare merker 
kan worden toegepast. De inbouw van een IRES-sequentie tussen opsine en lacZ 
heeft een bicistrone mRNA tot gevolg, waarin opsine en β-galactosidase niet als 
fusie-eiwit worden geproduceerd maar als twee aparte eiwitten. Gezien de hoge 
homologie tussen opsine en transducine van muis en rund zou het gebruik van 
runder opsine in een muis minimale functionele consequenties moeten hebben. De 
uiteindelijk verkregen transgene muizen werden onderzocht op opsine en β-
galactosidase expressie. We konden aantonen dat het bicistrone mRNA inderdaad 
leidt tot de productie van twee aparte eiwitten en niet tot dat van een fusieproduct. 
Dit bleek onder meer uit de immunohistochemische analyse beschreven in 
hoofdstuk 5. Deze liet een normale opsine-lokalisatie in het staafjes-buitensegment 
en in de buitenste kern-laag zien, met slechts beperkte expressie in het 
binnensegment. Dit in tegenstelling tot β-galactosidase, dat in alle segmenten van de 
fotoreceptor-cel bleek voor te komen, tot in de buitenste plexiforme laag toe. Dit is 
niet verrassend omdat β-galactosidase een cytosolisch eiwit is dat zich in principe 
door de hele fotoreceptor-cel kan bewegen. In de fotoreceptor-laag waren een aantal 
cellen te onderscheiden die het β-galactosidase niet tot expressie brengen. Dit zijn 
waarschijnlijk kegeltjes-cellen. Het gehalte van opsine en rhodopsine in de 
transgene retina verschilt nauwelijks, hetgeen erop duidt dat het runder opsine 
functioneel tot expressie wordt gebracht. Dit was verwacht omdat het opsine van 
muis en rund een zeer hoge graad van homologie vertoont. Desondanks wordt in de 
homozygote knock-in (KI/KI) muis maar 10-15% van het normale opsine-gehalte 
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aangemaakt. Alvorens er nieuwe transgene muismodellen kunnen worden 
gegenereerd zullen eerst de oorzaken van de verminderde opsine biosynthese 
moeten worden achterhaald. Momenteel hebben we nog geen verklaring voor het 
lage opsine-gehalte. De bicistrone aard van het mRNA zou misschien een negatieve 
invloed kunnen hebben op de translatie-efficiëntie of -snelheid. Dit zou onderzocht 
kunnen worden door een muizenmodel te maken zonder de IRES-sequentie en het 
lacZ gen. Mocht het opsine-gehalte in een dergelijke muis op een normaal niveau 
liggen dan is de weg vrij om transgene muizen te genereren waarbij het opsine gen 
is vervangen door een mutant opsine cDNA. De alternatieve optie is om het natieve 
opsine gen te vervangen door het complete gen met de gewenste mutatie in plaats 
van door een cDNA. 
In het huidige knock-in model blijft het opsine-gehalte gedurende de eerste 4 
maanden stabiel op 15% van normaal. Na 6 maanden is het opsine gehalte 
afgenomen tot maar 3%. Dit is een duidelijke aanwijzing dat retina degeneratie 
optreedt en er op die leeftijd vrijwel geen staafjes fotoreceptor cellen meer aanwezig 
zijn. Uit de histologie blijkt daarentegen dat tijdens de eerste 4 maanden een 
duidelijke progressie van de degeneratie optreedt, waarna rond 6 maanden 
inderdaad nauwelijks nog staafjes fotoreceptoren over zijn. Uit literatuurgegevens 
kan worden afgeleid dat zowel het volledig ontbreken van opsine als opsine 
overexpressie zal leiden tot fotoreceptor-schade en retina-degeneratie (43-45). De 
fotoreceptor-populatie in de homozygote knock-out muis is reeds volledig 
afgestorven binnen 3 maanden. Kruising van de homozygote knock-out (KO/KO) 
muis met de homozygote knock-in (KI/KI) muis levert hemizygote KI/KO 
nakomelingen, die ook retina-degeneratie laten zien, maar deze verloopt langzamer 
zodat pas na 4 maanden geen fotoreceptoren meer te detecteren zijn. In 
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heterozygote dieren, KI/+ en KO/+ lijkt geringe verkorting van het fotoreceptor 
buitensegment waar te nemen rond de leeftijd van 4 maanden en een geringe 
achteruitgang in het aantal fotoreceptorcellen rond de 6 maanden (43,44). Wij 
hebben echter zelfs bij oude heterozygote KI/+ muizen (14 tot 21 maanden) geen 
significant verlies van de buitensegment-lengte of van het aantal fotoreceptor-cellen 
ten opzichte van normale muizen gevonden. Dit wijst erop dat er hoogstens een zeer 
marginaal verschil is tussen de KI/+ en de normale muis, en dat meer uitgebreide 
studies noodzakelijk zijn om mogelijke fysiologische of morfologische verschillen 
vast te stellen. Vrij recent is er een ander knock-in muizenmodel beschreven waarbij 
het muizen opsine gen is vervangen door een humaan opsine gen gefuseerd met 
een gen dat codeert voor EGFP (46). Dit muizen-model vertoont ook een duidelijke 
vermindering in opsine-gehalte en een langzame degeneratie van de fotoreceptor-
cellen ondanks het feit dat hier geen cDNA maar een compleet gen is ingebracht. In 
dit geval zou de vorming van het opsine-EGFP fusie-eiwit de oorzaak voor de 
degeneratie kunnen zijn. Het fusie-eiwit zou op diverse niveaus problemen kunnen 
veroorzaken; bij transcriptie, translatie, transport, assemblage van de 
buitensegmenten, of excitatie en inactivering van de fotoreceptor-cel. Om die 
redenen is dit model moeilijk te vergelijken met ons muizenmodel. Onze gegevens 
tonen voor het eerst aan dat de homeostase van de fotoreceptor-cel sterk afhankelijk 
is van het opsine-gehalte, in die zin dat er een correlatie lijkt te bestaan tussen de 
snelheid van degeneratie en het opsine-gehalte. Hoe hoog het opsine-gehalte 
minimaal moet zijn om een gezonde fotoreceptor-cel te waarborgen kunnen we nog 
niet met zekerheid vaststellen. Gezien de resultaten van de heterozygote KI/+ 
(Hoofdstuk 4 en 5) en KO/+ muizen (43,44) kunnen we stellen dat de onderste limiet 
ergens tussen de 50 tot 60% van het normale niveau moet liggen. 
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Daarnaast is het zeer uitzonderlijk dat gedurende de eerste 4 maanden bij de KI/KI 
muis het aantal fotoreceptor-cellen afneemt terwijl het opsine-gehalte stabiel blijft op 
ongeveer 15%. Deze gegevens suggereren dat de retina het verlies van 
fotoreceptor-cellen probeert te compenseren door de opsine-expressie in de 
resterende fotoreceptor-cellen te verhogen. Over de cellulaire processen tijdens 
retina-degeneratie is nog zeer weinig bekend en bestudering van dit mechanisme is 
van groot belang voor toekomstige studies. Het is onduidelijk waaraan de 
fotoreceptor-cellen uiteindelijk ten gronde gaan. Bekend is nu dat lage opsine-
gehaltes leiden tot een verstoring van de structuur van de buitensegmenten. Andere 
muizenmodellen, waarbij opsine ontbreekt of waar opsine niet naar het 
buitensegment wordt getransporteerd, vertonen vergelijkbare problematiek: de 
assemblage van de disks in de buitensegmenten verloopt slecht of de 
buitensegmenten worden in het geheel niet gevormd (43,44,47-50). Verstoring van 
de disk-assemblage in de buitensegmenten door gebrek aan opsine is mogelijk te 
verklaren door een verstoorde massa-balans of door een verstoorde distributie van 
opsine over het “connecting cillium” en het buitensegment. Een verstoorde distributie 
van opsine is beschreven voor de Rpgr knock-out muis (51) en in verband gebracht 
met verkorte buitensegmenten met een afwijkende morfologie. Door het opsine-
gehalte te verhogen probeert de fotoreceptor mogelijk de massa-balans of de 
opsine-distributie over de membraancompartimenten te herstellen. Verstoring van de 
structuur van het buitensegment kan leiden tot een verstoring van een hele cascade 
van intracellulaire processen zoals de handhaving van de ionen-balans. Langzaam 
verlies van calcium-homeostase kan bijvoorbeeld leiden tot apoptose (52). Het blijft 
de vraag of in homozygote KI/KI muizen een verstoorde massa- of ionenbalans of 
een afname in licht-gevoeligheid uiteindelijk het signaal is om de opsine-expressie te 
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verhogen. De analyses van de heterozygote muizen geven aan dat een drie- tot vier-
voudige toename in opsine-gehalte voldoende zou zijn om de integriteit van de 
fotoreceptor te behouden en degeneratie te voorkomen. Rond 3-4 maanden resteren 
nog maar 4-5 kernlagen van de totaal 10-12 kernlagen in de fotoreceptor-laag, 
hetgeen theoretisch correspondeert met een cellulair opsine-gehalte van ongeveer 
40-50% van normaal. Dit is vlakbij het “stabiele” niveau maar desondanks gaat het 
proces van degeneratie door. Mogelijk is het metabolisme van de fotoreceptor-cel 
inmiddels te sterk overbelast. Daarnaast kan ophoping van lipiden extra oxidatieve 
schade aan de cel toebrengen. Een betrouwbare indicator voor retina-beschadiging 
al dan niet met fotoreceptor-degeneratie is de activering van de Müller-cellen, 
resulterend in overexpressie van “glial fibrillary acidic protein” (GFAP). GFAP-
overexpressie in Müller-cellen was in eerste instantie te detecteren in de perifere 
retina van homozygote KI/KI en hemizygote KI/KO muizen van 1 maand oud en kan 
nog steeds worden waargenomen in 6 maanden oude muizen als de fotoreceptor-
degeneratie nagenoeg voltooid is. Blijkbaar bestaat er een correlatie tussen 
activering van de Müller-cellen en fotoreceptor-cel degeneratie. Het verlies aan 
fotoreceptor-cellen treedt het eerst op in de periferie, bij de ora serata, en breidt zich 
langzaam uit naar het centrale deel van de retina. De activering van de Müller-cellen 
in de retina verloopt in dezelfde volgorde. 
Onze hypothese is dat de geactiveerde Müller-cellen niet alleen zorgen voor het 
opruimen van cel-afval maar dat ze mogelijk ook een rol spelen in de verhoging van 
de opsine-expressie van de overlevende fotoreceptoren. Er zijn namelijk 
aanwijzingen dat wederzijdse modulatie van genexpressie een onderdeel van de 
veelzijdige communicatie tussen Müller-cellen en fotoreceptoren vormt (53).  
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Concluderend kan gesteld worden dat het afsterven van de fotoreceptor-cel nog met 
veel mysteries omgeven is. Zowel over- als onder-expressie van opsine kan blijkbaar 
tot te hoge metabole stress leiden. De ingewikkelde relatie van de staafjes 
fotoreceptor-cel met andere cellen zoals RPE, kegeltjes en Müller-cellen is een extra 
complicerende factor. 
De diverse muismodellen (KO/KO, KI/KO, KI/KI, KO/+, KI/+, +/+) die nu beschikbaar 
zijn gekomen lijken uitermate geschikt om de processen in de fotoreceptor-cel en de 
communicatie met omringende cellen tijdens het degeneratie-proces in detail te 
bestuderen. Gedetailleerd inzicht in de cellulaire processen die uiteindelijk leiden tot 
de dood van de fotoreceptor-cel is absoluut nodig voor het ontwikkelen van nieuwe 
therapeutische mogelijkheden om het degeneratieve proces te vertragen of, zo 
mogelijk, tot stilstand te brengen. 
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AC    amacrine cells 
ADRP    autosomal dominant retinitis pigmentosa 
ALO    Ammonyx-LO 
AMD    age-related macular dystrophy 
ARRP    autosomal recessive retinitis pigmentosa 
ASPS    advanced sleep phase syndrome 
bp    base pair(s) 
BSA    bovine serum albumin 
cDNA  complementary DNA 
cGMP  cyclic guanosine monophosphate 
CHAPS  3-[(3 cholamidopropyl)-dimethylammonio]-propanesulfonate 
CHM    choroideremia 
CM    calmodulin 
CMV    cytomegalo virus 
CNGC   cyclic nucleotide gated cation channels 
CRD    cone-rod dystrophy 
CRALBP   cellular retinal binding protein 
CRBP    cellular retinol binding protein 
CRSD    circadian rhythm sleep disorders 
CSNB    congenital stationary night blindness 
DMF    dimethylformamide 
DMSO   dimethylsulfoxide 
DoM  n-dodecyl-β-1-D-maltoside 
dpi    days post-infection 
DSPS    delayed sleep phase syndrome 
DTE  1,4-dithioerythritol 
EDTA   ethylene-diamino-tetra-acetate 
ELISA  enzyme-linked immunosorbent assay 
ELM    external limiting membrane 
ES  embryonic stem cell 
FCS  fetal calf serum 
FIAU    1-[2-deoxy,2-fluoro]-β-D-arabinofuranosyl 
FTIR  Fourier Transform Infrared Spectroscopy 
GAR FITC  goat anti rabbit conjugated with fluoresceine-isothiocyanate 
GC    guanylate cyclase 
GCAP    guanylate cyclase activating protein 
GCL     ganglion cell layer 
GDP  guanosine diphosphate 
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GFAP    glial fibrillary acidic protein 
GPCR   G-protein coupled receptors 
Gtα  G-protein transducin α subunit 
GTP    guanosine triphosphate 
HC    horizontal cells  
HSV-TK   herpes simplex  virus thymidine kinase 
IGL    intergeniculate leaflet 
ILM    internal limiting membrane  
IMAC    immobilised metal affinity chromatography 
IMH    isomerohydrolase 
INL    inner nuclear layer 
IPL    inner plexiform layer 
ipRGC    intrinsically photosensitive retinal ganglion cell 
IRBP  interphotoreceptor retinoid binding protein 
IRES    internal ribosomal entry site 
IS    inner segment 
kbp  kilobase-pairs     
kDa  kiloDalton 
KI/+    heterozygous knock-in 
KI/KI    homozygous knock-in 
KI/KO    hemizygous knock-in knock-out 
KO/KO   homozygous knock-out 
KO/+    heterozygous knock-out 
LCA    Leber congenital amaurosis 
LRAT    lecithin:retinol acyltransferase 
LWS     long wavelength sensitive 
MC    Müller cells 
MD    macular dystrophy 
MOI    multiplicity of infection 
mRNA   messenger RNA 
MSP    microspectrophotometry 
NTA    nitrilotriacetic acid 
ONL    outer nuclear layer 
ONPG   O-nitrophenyl-β-D-galactopyranoside 
OPL     outer plexiform layer  
ORF          open reading frame 
OS    outer segment 
PACAP   pituitary adenylate cyclase-activating polypeptide 
PBS    phosphate buffered saline 
PBST    phosphate buffered saline with Tween-20 
PCR    polymerase chain reaction 
PDE    phosphodiesterase 
PP2A    protein phosphatase 2A 
PRC    phase response curve 
RACE  rapid amplification of cDNA ends 
RAM FITC  rabbit anti mouse conjugated with fluoresceine-isothiocyanate 
11-cis RDH   11-cis retinol dehydrogenase 
RDH    all-trans retinol dehydrogenase 
REH    retinyl ester hydrolase 
RHT    retinohypothalamic tract 
RL  retina lipids 
RP    retinitis pigmentosa 
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RPE    retina pigment epithelium  
RT-PCR  reverse transcriptase polymerase chain reaction 
SAR    swine anti rabbit 
SARPO   swine anti rabbit conjugated with peroxidase 
SCN    suprachiasmatic nucleus 
SDS    sodium dodecyl sulphate 
Sf9  Spodoptera frugiperda 
SFD    Sorby’s fundus dystrophy 
SGH     histidine-tagged Spalax green cone pigment 
STGD    Stargardt’s macular dystrophy 
SWS    short wavelength sensitive pigment 
UTR    untranslated region 
UV/VIS   ultraviolet visible 
XLRP    X-linked retinitis pigmentosa 
+/+    wild type 
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                            Dankwoord 
 
 
 
De weg die je af moet leggen in je aio tijd was nog niets vergeleken met de tijd die 
erna volgde voordat het proefschrift eindelijk klaar was. Graag liet ik altijd drie of vier 
experimenten op een dag tegelijk lopen en als de tijdsplanning dan goed liep en de 
resultaten goed waren dan gaf het veel genoegdoening. Toch wil ik niemand 
adviseren dit in het leven ook te doen. Een proefschrift afmaken, een opleiding tot 
klinisch cytogeneticus afronden en moeder zijn naast alle andere dingen die het 
leven met zich meebrengt is op zijn zachts uitgedrukt niet gemakkelijk.  De laatste 
loodjes waren zeker het zwaarst en vaak heeft de gedachte in mijn hoofd gespeeld 
om het proefschrift maar niet meer af te maken. Maar mijn vader heeft me geleerd 
om de dingen waar je aan begint ook af te maken hoe dan ook. Dus pappa hier is 
het dan alleen jammer dat je er niet meer bij kunt zijn.  
Ook de rest van mijn familie wil ik bedanken maar met name mijn moeder, mijn zus 
en zwager en zeker Piet want die hebben altijd veel begrip getoond als ik weer eens 
tijd nodig had om aan het proefschrift te werken. 
Voor de medewerking aan dit boekje wil ik graag vele mensen bedanken die in 
welke vorm dan ook een bijdrage hebben geleverd. 
Allereerst natuurlijk mijn promoter Wim de Grip. Het waren zeker niet altijd de 
makkelijkste tijden maar we zijn elkaar op het eind beter gaan begrijpen en 
waarderen. Ik heb de grootste bewondering voor je schrijfstijl. Jij kon gelukkig dingen 
veel beter en uitvoeriger beschrijven daar waar ik maar een paar zinnetjes aan had 
gewijd. Dit is van onschatbare waarde gebleken anders was het boekje niet half zo 
goed geweest. Ook Jan Joep wil ik bedanken want formeel gezien ben jij toch het 
merendeel van mijn promotie tijd mijn promoter geweest. 
Ook mijn co-promoter en ex-collega Wiljan wil ik heel hartelijk bedanken voor de 
steun en de ideeën. Er waren vele dingen die ons in het verleden hebben 
verbonden. Something old, something new, something borrowed and something 
blue. Wat dacht je van Spalax een oud maatje uit jouw promotie tijd, de nieuwe 
transgenen, de vele “geleende” vectoren (Cre-lox P) en het β-galactosidase om 
maar eens een paar dingen te noemen. Maar ook Bé wil ik niet vergeten. Veel van 
het idee een knock-in te maken en hoe die eruit moest komen zien kwam van jouw. 
Je hebt me bovendien de mogelijkheid gegeven een klein jaar op je afdeling de 
kunst van het maken van transgenen af te mogen kijken voordat ik aio ben 
geworden. 
Iemand die het echt verdiend een groot teken van waardering te krijgen is Petra. De 
grote steun en toeverlaat. Ik heb nog nooit iemand met zoveel toewijding voor het 
werk bezig gezien. Je ging ons aio’s nog ver voorbij. Een analiste met heel veel hart 
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voor het werk ondanks alles. Petra je hebt al menigeen aan een doctorstitel 
geholpen en ik zou niet weten hoe ik je voor alle steun en hulp kan bedanken.  
Giel, in vele opzichten was jij de buffer in zure tijden. Dat moet niet altijd makkelijk 
zijn geweest zeker omdat je eigen onderzoek ook niet wilde vlotten. 
Frank en Arthur, jullie fysica en informatica dingetjes waren meestal hokus-spokus 
voor mij. Frank onze projecten hadden jammer genoeg niet veel gemeen  maar van 
je humor en postieve kijk op het leven heb ik veel genoten. Hou die ten alle tijden 
vast want die maakt jouw heel bijzonder. Arthur, jij hebt me veel op weg geholpen in 
de informatica. Accounts voor de software van de B-faculteit en de BIC server. 
Helaas heeft je passie voor het LATEX geen grip op me gehad. 
Francy, jij was een verademing voor mij toen je bij de groep kwam. Eindelijk iemand 
die zich ook bezig hield met moleculair werk en het maken van transgene muizen. 
Jammer dat je wegging maar door jouw ben ik wel op het idee gebracht om eens 
rond te kijken naar een opleidingsplaats als klinisch cytogeneticus of iets anders dan 
post-doc plaats. 
Jenny en Irene. Jenny onze paden hebben zich niet veel gekruist tijdens mijn 
promotie tijd maar voor alle kleinigheden toch mijn hartelijke dank. Irene wij hebben 
ons een hele tijd met IFA’s vermaakt. Maar goed dat jij een goede administratie 
bijhield want anders hadden we door de bomen het bos niet meer gezien. 
Githa, je was me net een stapje voor en ik hoop dat je in je dierbare zuiden een 
leuke vaste baan zult vinden.  
Wie ik zeker niet wil vergeten zijn de stagiaires, Olga en Mascha. Helaas heeft jullie 
werk uiteindelijk weinig sporen in het boekje achtergelaten maar toch mijn dank. 
Sinds kort hebben wij weer contact Olga en het doet me goed te zien dat je na je 
HBO nu zelf ook het promotietraject bent ingeslagen. Ik wacht in spanning af.  
Wie ik niet wil vergeten is Zan. Zan je was officieel niet mijn stagiaire maar 
uiteindelijk ben jij wel degene die een stempel heeft weten te drukken op een deel 
van mijn werk. Zo zie je maar weer eens dat het leven soms rare kronkels kan 
maken. 
Special thanks to Russel and Zoë for the collaboration with the Spalax green work. I 
still regret that I didn’t visit you in London. Blimey!!!!   I never thought we would score 
so many papers with our Spalax work. 
De collega’s van Oogheelkunde, Jacques, Carola, Huub, Bert, Leonoor en Anke 
voor al jullie steun heel hartelijk bedankt. Met name Huub, jij hebt me de histologie 
een beetje geleerd waar ik veel aan heb gehad. Carola, ik heb nog altijd een super 
herinnering aan de ARVO van 1999. 
De collega’s van de afdeling Celbiologie, en met name Jan, Frank en Patricia en 
Walter. Jan je was van onschatbare waarde. Je hebt gouden handjes voor wat 
betreft het kloneren en ik heb veel van je geleerd. Frank, Patricia en Walter, jullie 
hebben me bijzonder geholpen met de ES cellen en de transfecties zonder die hulp 
was het nooit tot een knock-in muis gekomen. 
Ik heb nog een aantal mensen niet genoemd zoals, Paola, Corne, Peter, Lieveke, 
Margriet, Gerrit, Connie, Wilma, Anke, Rob, Jos, Caroline, en de mensen waarmee 
ik dagelijks veel in de trein op en neer reisde, Richard, Ruud, Arthur en Marco. Het 
was een leuke, leerzame en vooral goede oude tijd waar ik met heel veel plezier 
naar terugkijk. 
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